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 Abstract 
Previous work has identified a novel dopamine receptor interacting protein, Alix 
(ALG-2 (apoptosis-linked gene 2-interacting protein X), using D1 receptor C-terminal 
domain or D3 receptor third cytoplasmic loop as 'baits' in separate yeast two-hybrid 
screens. Alix is thought to be important for the stability and trafficking of dopamine 
receptors and is an ubiquitous adaptor protein that was first described for its capacity to 
bind to the calcium-binding protein, ALG-2. It is known to be involved in apoptosis, 
regulation of cell adhesion, protein sorting, adaptation to stress conditions, endosomal 
trafficking and neuronal cell death. However, the exact cellular role for this protein in 
neuronal signalling remains poorly understood.  
 There is strong evidence to support the existence of direct interactions between 
dopamine receptors and NMDA receptors and dopamine receptor interacting proteins such 
as Alix may facilitate intracellular ‘cross talk’ between both neurotransmitter signalling 
pathways. Furthermore, Alix has been recently found within the human postsynaptic 
density (PSD) and since NMDA receptors are central components of the PSD, we 
hypothesized that Alix may be able to influence NMDA receptor function.  
 We have evaluated the effects of recombinant wildtype and truncated Alix 
proteins in NMDA receptor function using an NMDA receptor cell death assay in 
transiently transfected human embryonic kidney-293 cells (HEK293). We found that 
coexpression of Alix had a significant effect on NMDA receptor triggered cell death and 
we have examined Alix expression and colocalisation with NMDAR in HEK293 cells as 
well as endogenous Alix expression within cultured primary cortical and hippocampal 
neurons. Our results suggest that Alix can influence the NMDA receptor induced cell death 
pathway and suggests a previously unreported role for Alix as a potential modulator of 
NMDA receptor function. 
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1. Introduction 
1.1 Dopamine receptors 
Dopamine receptors are a class of metabotropic G protein-coupled receptors  (Zhan 
et al., 2008). They are composed of mainly seven homomeric transmembrane α helices that 
are prominent in the mammalian brain (Missale et al., 1998). The 
neurotransmitter dopamine is the primary catecholamine endogenous ligand for dopamine 
receptors (Missale et al., 1998). There are mainly five subtypes of dopamine receptors, D1, 
D2, D3, D4, and D5 (Missale et al., 1998; LaHoste et al., 2000).The D1 and D5 receptors are 
members of the D1-like family of dopamine receptors, and the D2, D3 and D4 receptors are 
members of the D2-like family (Missale et al., 1998, LaHoste et al., 2000). The activation 
of the D1-like family of dopamine receptors is coupled to the G protein Gs, which 
subsequently activates adenylyl cyclase increasing the intracellular concentration of 
the second messenger cyclic adenosine monophosphate (cAMP) thereby activating
 
a 
cAMP-dependent protein kinase (PKA) and mediating the phosphorylation of dopamine 
(Figure 1.1)  (Missale et al., 1998; Gould and Manji, 2005; Girault and Greengard, 2004). 
Whereas, the activation of the D2-like family of receptors is coupled to the G protein Gi, 
which directly inhibits the formation of cAMP by inhibiting the enzyme adenylate cyclase 
Figure 1.1) (Gould and Manji, 2005; Missale et al., 1998; Girault and Greengard, 2004). 
.  
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Figure 1.1 D1-like receptors couple with G proteins and activate adenylyl cyclase which catalyses the 
conversion of ATP to cAMP and pyrophosphate, which in turn serve as a regulatory signal to activate various 
other molecules. D2-like receptors which includes dopamine receptors D2, D3 and D4, also couple with G 
proteins but act in inhibiting adenylyl cyclase (Finch, 2013). 
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1.2 Dopamine receptor interacting proteins (DRIPs) 
Dopaminergic neurons are mainly found in substantia nigra and ventral tegmental 
area and are thought to be involved in the control of movements, the signalling of error in 
prediction of reward, motivation, and cognition (Carrion and Poppel, 2007). There is 
abundant evidence that the dopamine system is involved in schizophrenia especially from 
the observation that a large number of antipsychotics such clozapine and chlorpromazine 
have dopamine-receptor antagonistic effects on D2 receptors (Greengard, 2001), Tenn et 
al., 2003, Peleg-Raibstein et al., 2008). Eleven dopamine receptor interacting proteins 
(DRIPs) were identified from a human adult brain cDNA library (Table 1.1) (Zhan et al., 
2011). In this study they found that all the DRIPs might play an important role in 
dopamine signalling and are mapped to regions of the genome implicated in schizophrenia 
(Zhan et al., 2011). Amongst the identified dopamine receptor interacting protein include 
DOCK10  which is an interleukin-4 (IL4)-inducible gene in chronic lymphocytic leukemias 
(CLLs) mainly expressed in peripheral blood (PB) leukocytes (Yelo et al., 2008), guanine 
nucleotide binding protein, β-peptide 2-like I (GNB2LI) which is a housekeeping gene and 
a novel dopamine receptor interacting protein, Alix (ALG-2 interacting protein 1). Alix is 
a calcium-binding protein necessary for caspase-dependent and –independent cell death 
under the control of ALG-2 (Trioulier et al., 2004). Zhan and colleagues proposed that 
Alix may be important for the stability and trafficking of dopamine receptors at the 
membrane surface and found that it was able to up-regulates D1 and D3 receptor 
expression (Zhan et al., 2008).  
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Table 1.1 Dopamine receptor interacting proteins (DRIPs) 
Receptor DRIP Gene Protein Name Chromosome Function 
D1 DRIP-4 PDCD6IP AIP1, Alix, 
HP95 
3p23 Cell death 
 DRIP-7 GNB2LI Unknown  5q35 G-protein 
signalling 
 DRIP-1 CI4ORF28 Unknown 14q21 Unknown 
 DRIP-2 DOCK10 Nbla10300, 
ZIZ3 
2q36 G-protein 
signalling 
 DRIP-6 LM02YRDC Unknown  11p13 Neuronal 
development 
 DRIP-3 TERF2IP RAP1 1p34 Translation 
D2 DRIP-5 MLLT3 AF9, 
YEATS3 
16q23 Telomeric repeat 
maintenance 
 DRIP-8 PDCD6IP AIP1, Alix, 
HP95 
9p21 Development 
D3 DRIP-4 P4HAI Unknown 3p23 Cell death 
D4 DRIP-10 KIFIA ATSV, 
C2orf20, 
HSN2C, 
MRD9, 
SPG30, 
UNC104 
10q22 Enzyme 
 DRIP-11 PIM2 PIM2 2q37 Molecular motor 
D5 DRIP-9  Unknown Xp11 Cell death 
 
Table 1.1: The 11 DRIPs that were identified from a human adult brain cDNA library (Zhan et al., 2011).  
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1.3 Glutamate receptors 
Glutamate receptors are a family of ionotropic or metabotropic glutamate receptors  
(Kristiansen et al., 2007) that are responsible for the glutamate-mediated post-synaptic 
excitation of neuronal cells, and play vital roles in neural communication, memory 
formation and learning (Debanne et al., 2003; Liu et al., 2006, Kantrowitz and Javitt, 
2010).   
The ionotropic glutamate receptors are split into three main families, 
AMPA receptor (α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate), NMDA 
receptor (N-Methyl-D-Aspartate) and Kainate receptor. Each receptor family is composed 
of a number of specific subunits, GluA1–GluA4 ( AMPA receptors), GluK1–GluK5  
(kainate receptors), GluN1, GluN2A–GluN2D, GluN3A, and GluN3B (NMDA 
receptors)(Traynelis et al., 2010). All ionotropic glutamate receptors are tetrameric 
assemblies and although AMPAR and kainate can be heteromeric or homomeric, 
NMDARs are only functional as heteromeric complexes of GluN1 and GluN2 subunits 
(Traynelis et al., 2010).  The metabotropic glutamate receptors are G-protein coupled 
receptors (GPCRs) that have been subdivided into three groups. Group I mGlu receptors 
(mGlu1 and mGlu5) are coupled to PLC and intracellular calcium signalling, while group 
II (mGlu2 and mGlu3) and group III receptors (mGlu4,mGlu6, mGlu7 and mGlu8) are 
negatively coupled to adenylyl cyclase (Endoh, 2004).   
All ionotropic glutamate receptors are ligand-gated nonselective cation channels 
which allow the flow of K
+
 out, Na
+
 and sometimes Ca
2+
 in to the cell following  glutamate 
binding whereas metabotropic receptors indirectly  modulate ion-channels on the plasma 
membrane through  G protein dependent signalling cascade (Kantrowitz and Javitt, 2010). 
Upon glutamate binding, an agonist will  trigger a series of conformational changes in the 
multisubunit receptor complex which results in  the opening of the central  ion channel of 
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the receptor and allows cation flow and a subsequent change in membrane excitability. 
This change in membrane excitability results in  the generation of an excitatory 
postsynaptic current (EPSC) (Nicoll and Malenka, 1999)(Figure 1.2). This will then cause 
current depolarization, and, if enough glutamate receptors are activated may trigger an 
action potential in the postsynaptic neuron that then produce excitatory postsynaptic  
potential which results in an increase of Ca
2+
 concentration triggering a cascade of 
molecular events in the postsynaptic cells (Karakas et al., 2015). The duration of EPSP 
would depend on the agonist binding rate and the opening rate of the postsynaptic receptors 
(Hammond C. 2008). At resting membrane potentials, NMDA receptors are functionally 
‘silent’ due to  an internal binding site within the ion pore for an Mg2+ ion,  and are subject 
to  voltage-dependent Mg
2+
blockThis blockade  is removed by membrane depolarisation 
(Johnson and Ascher, 1990). Therefore for NMDA receptors to open, they rely on the 
coincident depolarisation produced by AMPA receptor opening. Furthermore NMDA 
receptors are permeable to Ca
2+ 
which is an important  intracellular signalling molecule in 
the nervous system (Pearlstein et al., 2015). Through transducing signaling cascades and 
regulating gene expression, the flow of Ca
2+
 through NMDA receptors is thought to cause 
both long term potentiation (LTP) and long term depression (LTD) (Lau et al., 2009).  
The NMDA receptor is of considerable interest as it is thought to play a critical role 
in synaptic plasticity through calcium flux, a cellular mechanism for learning and memory 
(Paoletti et al., 2013). The NMDA receptor which is clustered at the synapse by 
components of the post synaptic density (PSD) is  distinctive as it is both ligand-gated and 
voltage-dependent and it requires coactivation by two ligands, glutamate and either D-
serine or glycine (Anson et al., 1998). The NMDA receptor forms a heterotetramer of two 
GluN1 and two GluN2 subunits. There are several receptor isoforms with distinct brain 
distributions and functional properties derived by alternate splicing of the GluN1 
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transcripts and differential expression of the GluN2 subunits (GluN2A, GluN2B, GluN2C 
and GluN2D) with both the GluN2A and GluN2B isoforms dominating expression in the 
adult brain (Kantrowitz and Javitt, 2010).   
Figure 1.2 The NMDA receptor is different from most receptor molecules because it is both ligand-gated and 
voltage-sensitive. When the NMDA receptor is activated, Ca
2+
 ions flow through its channel into the neuron. 
The reason for the low Ca
2+
 conductance at these membrane potentials is that magnesium ions (Mg
2+
) block 
the NMDA receptor’s central Ca2+ channel. AMPA receptor activation allows Na+ ions to flow into the 
neuron, so sufficient activation of AMPA receptors can partially depolarize the membrane that removes the 
Mg
2+
 block. The NMDA receptor now responds strongly and admits large amounts of Ca
2+
 through the 
channel which starts a cascade of effects (Breedlove, S. Marc., Watson, Neil. V., 2013).  
 Among the glutamate receptor channels, NMDA receptors are generally the most 
permeable to Ca
2+
 (Lipton, 2004). Excessive activation of the NMDA receptor leads to 
production of damaging free radicals and other enzymatic processes that contributes to cell 
death (Figure 1.3) (Budd et al., 2000; Lipton and Nicotera, 1998; Lipton, 2004). The 
activation of NMDA receptors allows Ca
2+ 
(and other cations) to  enter the cell (Lipton and 
Nicotera, 1998). In synaptic transmission  under normal conditions the NMDA receptor 
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channel is blocked by Mg
2+
 and only activated for brief periods of time (Lipton, 2004). 
Over activation of the NMDA receptor causes an excessive amount of Ca
2+
 influx into the 
nerve cell which then triggers a variety of processes that can lead to necrosis or apoptosis 
(Tenneti et al., 1998)(Figure 1.3). They include processes such as Ca
2+
 overload of 
mitochondria, resulting in oxygen free radical formation and activation of caspases, Ca
2+
-
dependent activation of neuronal NOS, leading to increase NO production and the 
formation of toxic peroxynitrite (ONOO
−
), and stimulation of mitogen-activated protein 
kinase p38 (MAPK p38), which activates transcription factors that can go into the nucleus 
and influence neuronal injury and apoptosis (Dawson et al., 1991; Lipton and Nicotera, 
1998; Lipton, 2004). 
 
Figure 1.3: Schematic illustration of the apoptotic pathways triggered by excessive NMDA receptor activity. 
The cascade includes NMDAR overexpression, activation of the p38 mitogen-activated kinase (MAPK)–
MEF2C (transcription factor) pathway (MEF2 is then cut by caspases to form an endogenous dominant-
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interfering form that contributes to neuronal cell death, toxic effects of free radicals such as nitric oxide (NO) 
and reactive oxygen species (ROS) and activation of apoptosis-inducing enzymes including caspases and 
apoptosis-inducing factor (Lipton, 2006). 
 
1.4 Post Synaptic Density 
 
 The post synaptic density is a structure located beneath the postsynaptic membrane 
and is comprised of membrane receptors, ion channels, scaffold and adaptor proteins, 
signalling proteins, cell adhesion molecules and components of the cytoskeleton (Kennedy, 
1997) (Figure 1.4). Several functions have been proposed for this structure including 
regulation of adhesion, control of receptor clustering, and regulation of receptor function 
(Siekevitz, 1985). Glutamate receptors, such as NMDARs (N-methyl-D-aspartate 
receptors)  are located more to the centre of the membrane and AMPARs ( -amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid receptors), are located more at the peripheral 
of the postsynaptic membrane (Feng and Zhang, 2009). On stimulation, the excitatory 
glutamatergic synapses such as glutamate is released from the presynaptic terminal and acts 
on the glutamate receptor channels NMDA and AMPA on the postsynaptic side to allow 
the influx of specific ions that depolarize postsynaptic membranes and thus, neuronal 
signals are received, decoded and further propagated by the PSD (Feng and Zhang, 2009).  
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Figure 1.4: Schematic diagram of the network of proteins in the postsynaptic density. Only major pathways 
and certain classes of PSD are shown (Feng and Zhang, 2009). The post synaptic density comprises of 
membrane receptors, ion channels, adaptor proteins, signalling proteins, cell adhesion molecules and 
components of the cytoskeleton. 
1.5 Potential crosstalk pathways between dopamine and glutamate receptors and their 
implications 
There have been many studies that support the idea of a functional interaction 
between dopamine receptors and glutamate receptors (Greengard, 2001, Lee et al., 2002, 
Liu et al., 2006). One of these is the interaction of D1 receptor carboxyl tail that directly 
couples to NMDA receptor subunit GluN1-1a and GluN2A (Lee et al., 2002) and enhances 
D1 receptor cAMP accumulation (Pei et al., 2004). However, it is still not known how the 
other potential interactions further downstream of the receptors might take affect at the 
molecular level such as downstream targets DARPP-32 (Figure 1.5). Alix and other 
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DRIPs known to interact with dopamine receptors identified by Zhan et al., 2011 may 
also play a role in glutamate receptor signalling and potentially make an important 
contribution to in the interactionsbetween dopaminergic and glutamatergic signalling 
pathways.  
Alix is a calcium-binding protein necessary for caspase-dependent and –
independent cell death under the control of ALG-2 which is a protein with sequence 
homology to calmodulin that is implicated in regulating DARPP-32 (Figure 1.5) (Trioulier 
et al., 2004,(Sadoul, 2006).  Calcium/calmodulin-dependent protein kinase IV (CaMKIV) is 
the most important Ca
2+
-activated CREB kinase along with NR2B and CaMKIV are 
considered to be memory related genes and synaptic plasticity genes (Li et al., 2011).  
NMDA receptors are of considerable interest in schizophrenia as evidenced by the 
ability of NMDAR antagonists such as phencyclidine (PCP) and ketamine to induce 
many symptoms and deficits that  are associated with schizophrenia (Hirsch et al., 
1997, Scott and Aperia, 2009, Kantrowitz and Javitt, 2010). There is also evidence 
that glutamate receptor deficiencies occur in some cases of schizophrenia where a 
restricted deletion of the essential GluN1 subunit of the NMDA receptor was 
selectively eliminated in 40–50% of cortical and hippocampal in early postnatal 
corticolimbic interneurons as well as another study that generated a mouse model 
expressing only 5% of the GluN1 subunit that triggers behavioural and 
pathophysiological symptoms that resemble schizophrenia (Hirsch et al., 1997).  
The excitatory postsynaptic potential (EPSP) produced by the activation of NMDA 
receptor increases the concentration of Ca
2+
 in the cell which can in turn function as 
a second messenger in various signalling pathways such as the extracellular signal 
regulated kinase (ERK) pathway and reverse cyclic AMP-stimulated phosphorylation 
through activation of calcineurin that affects DARPP-32 (Figure 1.5) (Gould and Manji, 
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2005; Hirsch et al., 1997). DARPP-32 has a central role in dopaminergic and glutamatergic 
signaling in integrating the activity of these two pathways (Gould and Manji, 2005). 
DARPP-32 mediates the drug-related changes in the activity of the ERK pathway (Gould 
and Manji, 2005). Activation of the ERK cascade depends on both dopamine and glutamate 
receptor activation and is known to be important for long-term synaptic plasticity (Gould 
and Manji, 2005). 
 
 
 
Figure 1.5: Diagram of the downstream signalling pathways for glutamate and dopamine receptors and 
potential intracellular 'crosstalk' pathways (Gould and Manji, 2005) 
 
 
 
 
 
 
Alix/DRIPs? 
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1.6 ALG-2 interacting protein X (Alix)  
Alix is a cytoplasmic adaptor protein that is 95 kDa in size, contains a proline rich C 
terminal region and is widely conserved in eukaryotes (Subramanian et al., 2004). It was 
first characterized as an interactor of ALG-2 (apoptosis-linked gene 2) and is involved in 
apoptosis, regulation of cell adhesion, protein sorting, adaptation to stress conditions, 
ESCRT (endosomal sorting complex required for transport)-mediated membrane 
invagination, abscission in cytokinesis and budding of human immunodeficiency virus 
(HIV) (Trioulier et al., 2004; Ohkouchi et al., 2004).  
ALG-2 is a calmodulin type calcium binding protein that is required for apoptotic 
induction while the down regulation of ALG-2 enhances cell survival by interfering with 
Ca
2+ 
mediated apoptotic signals (Wu et al., 2002; Subramanian et al., 2004). The ability of 
Alix to participate in a spectrum of activities stems from its domain architecture (Figure 
1.6). BLAST analysis of Alix amino acid sequences shows that Alix has a 97% sequence 
homology between human and mouse (Figure 1.6.1). Therefore there is a high degree of 
amino acid sequence conservation within the Alix protein sequence and within the 
functional domains (Bro1 and SH2) between these species. 
 
 
Figure 1.6: Domain architecture of Alix. The N-terminal of Bro1 domain mediates localization to endosomes, 
an important functional site for Alix. The C-terminal region interacts with the majority of proteins that 
connect Alix to cellular processes. The Bro1 domain and C-terminal region are linked by a relatively 
uncharacterized sequence containing two coiled-coil domains (Odorizzi, 2006).  
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Homo sapiens  1    MATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDK  60  
Mus musculus  1    MASFIWVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRSALGRPLDK  60  
<<<------------------------------------------------------- 
Homo sapiens  61   HEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEK  120  
Mus musculus  61   HEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEK  120  
------------------------------------------------------------ 
Homo sapiens  121  SCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDIS  180  
Mus musculus  121  SCVLFNCAALASQIAAEQNLDNDEGLKTAAKQYQFASGAFLHIKDTVLSALSREPTVDIS  180  
------------------------------------------------------------ 
Homo sapiens  181  PDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKY  240  
Mus musculus  181  PDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKY  240  
------------------------------------------------------------ 
Homo sapiens  241  FYFQEVFPVLAAKHCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKTVASRYDEYV  300  
Mus musculus  241  FYFQEVFPTLAAKQCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKNVASRYDEYV  300  
------------------------------------------------------------ 
Homo sapiens  301  NVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLF  360  
Mus musculus  301  NVKDFSDKINRALTAAKKDNDFIYHDRVPDLKDLDPIGKATLVKPTPVNVPVSQKFTDLF  360  
------------------------------------------------------------ 
Homo sapiens  361  EKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQ  420  
Mus musculus  361  EKMVPVSVQQSLAVFSQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQ  420  
------------------------------------------------------------ 
Homo sapiens  421  SILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKER  480  
Mus musculus  421  SILTKSTSVVEQGGIQTVDQLIKELPELLQRNREILEESLRLLDEEEATDNDLRAKFKDR  480  
-N Terminal-<<------->>-C terminal--------------- 
Homo sapiens  481  WQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIP  540  
Mus musculus  481  WQRTPSNDLYKPLRAEGAKFRAVLDKAVQADGQVKERYQSHRDTIALLCKPEPELNAAIP  540  
------------------------------------------------------------ 
Homo sapiens  541  SANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVIN  600  
Mus musculus  541  SANPAKTMQGSEVVSVLKSLLSNLDEIKKERESLENDLKSVNFDMTSKFLTALAQDGVIN  600  
------------------------------------------------------------ 
Homo sapiens  601  EEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKN  660  
Mus musculus  601  EEALSVTELDRIYGGLTSKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKN  660  
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------------------------------------------------------------ 
Homo sapiens  661  LATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARKTERDELLKDLQQSIAR  720  
Mus musculus  661  LATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARKTERDELLKDLQQSIAR  720  
------------------------------------------------------------ 
Homo sapiens  721  EPSAPSIPTPAYQSS  735  
Mus musculus  721  EPSAPSIPPPAYQSS  735  
----------------------->>> 
Figure 1.6.1 : BLAST sequence analysis between human Alix (Homo sapiens) and mouse Alix (Mus musculus). N terminal 
indicated with green spaced lines underneath  include the Bro domain and Src homology domain (Src SH2). C terminal indicated 
with red spaced lines underneath include the proline rich region, the ALG-2 interacting domain and Src homology domain (Src 
SH3). The grey marked background indicates sequences that differ between human Alix (Homo sapiens) and mouse Alix 
(Mus musculus). We noticed that there is little difference between the sequences and most changes were homologous and spread 
out throughout the protein sequence.  
 
A common factor in many apoptotic proceses is the cytosolic Ca
2+
  release from ER 
stores which induce caspase 9 activation and regulated by ALG-2 (Strappazzon et al., 
2010). The interaction between Alix and ALG-2 through its C-terminal proline-rich region 
is shown to be Ca
2+
  dependent, where Ca
2+
 binding to ALG-2 induces a conformational 
change which allows it to interact with Alix (Katoh et al., 2003; Strappazzon et al., 2010). 
It is suggested that interaction of Alix with ALG-2 in a Ca
2+
-dependent manner implies that 
there is a relationship between Alix and Ca
2+ 
signalling (Ohkouchi et al., 2004). 
Strappazzon et al., 2010 theorise that ALG-2 and Alix cooperate in transducing the Ca
2+ 
regulated signal during cell death considering ALG-2 needs to bind to Ca
2+ 
in order to 
interact with Alix. They also found that Alix is required for the caspase 9 activation that is 
induced by calcium elevation which suggest that Alix and ALG-2 act upstream of caspase 
9. 
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The endosomal system is a series of intracellular compartments of endocytosed 
trafficked molecules where most endocytosed protein are returned to the membrane and 
some degraded proteins are trapped in vesicles budding from the membrane to the lumen of 
the endosomes (Mahul-Mellier et al., 2009). This leads to the formation of multivesicular 
bodies (MVBs) that will be hydrolysed after fusion with lysosomes which trigger the 
sequential building of the ESCRTs on to the endosomal membrane (Gruenberg and 
Stenmark, 2004). Endosomal membrane vesiculation is triggered by CHMPs (charged 
multi vesicular body proteins) and Alix which binds to both ESCRT-I and ESCRT-III, as 
well as to LBPA (lysobisphosphatidic acid) to form a lattice entrapping transmembrane 
proteins facilitating the budding of vesicles inside MVBs (Sadoul, 2006). (Mahul-Mellier et 
al., 2009) suggest that endosomal function is central to neurodegenerative pathologies and 
adaptor protein Alix seems to mediate interaction within endosomes control the initiation of 
a neuronal death programme. 
The ESCRT machinery can be recruited to many different biological membranes to 
help mediate membrane fission events and most of the ESCRT pathway proteins involve 5 
complexes which are ESCRT-0,-I,-II,-III and VPS4 (vacuolar protein sorting associated 
protein 4), whilst Alix would function as a discrete protein in the ESCRT pathway (Wollert 
and Hurley, 2010). Early acting factors such as ESCRT-I, ESCRT-II and Alix would 
interact with upstream recruiting factors and deform membranes, recruit ESCRT-III subunit 
and form filaments within the necks of membrane tubules and mediate membrane fission 
(Wollert and Hurley, 2010). Endosomal ESCRT-III is thought to be very transient and 
(Chassefeyre et al., 2015) hypothesize that ESCRT-III assemblies comprising of Alix, 
Chmp4, and Chmp2 can reshape the plasma membrane during cytokinesis and membrane 
repair and that the endosome has been shown to play an important role in postsynaptic 
plasticity. 
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Figure 1.7 The endosomal ESCRT pathway. The MVB pathway appears to require the sequential function of 
the ESCRT complexes and recruitement of Alix mediated by Chmp4 to the Bro1 domain of Alix for apoptotic 
signalling (Hurley and Odorizzi, 2012). 
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1.7 Cellular mechanism of Alix in apoptosis  
Programmed cell death (PCD) has been divided into two general types: PCD, in 
which the cell plays an active role; and passive cell death such as necrotic cell death. The 
PCD development has been classified morphologically into three main types, type 1, 
apoptotic, type 2, autophagic, and type 3, cytoplasmic (Clarke, 1990). The best 
characterized PCD is apoptosis where cells display membrane blebbing, loss of the 
asymmetry, nuclear fragmentation, and activation of caspases which is family of cell-
suicide cysteine proteases (Thornberry and Lazebnik, 1998; Sperandio et al., 2004).  
 
Figure 1.8: Schematic illustration of PCD. PCD can be divided to three types: (a) classical apoptosis 
(featuring ‘crescent-like’ chromatin condensation), (b) apoptosis-like PCD (featuring partial and peripheral 
chromatin condensation) and (c) necrosis-like PCD (featuring no primary chromatin condensation) (Krantic et 
al., 2005). 
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Apoptosis is activated through two major pathways (Figure 1.8). The first is the 
intrinsic pathway, which is initiated by the mitochondrial release of cytochrome c, and 
activation of caspase-9 and the second is the extrinsic pathway, initiated by the activation 
of cell surface death receptors such as Fas, and resulting in the activation of caspase-8 or -
10 (Salvesen and Dixit, 1997). Cytochrome c associates with procaspase-9 to form a 
complex called the apoptosome after being released in the cytosol due to permeabilization 
of the outer mitochondrial membrane. (b) Apoptosis-like PCD is mediated by effectors 
such as apoptosis-inducing factor (AIF). Nuclear DNA damage leads to AIF release and its 
translocation to the nucleus, which is then associated with chromatin condensation and 
large-scale DNA fragmentation. (c) Necrosis-like PCD is not as well known. However, the 
existence of at least two forms of such PCD has been proposed with both forms displaying 
cytoplasmic vacuoles. The first is paraptosis, is triggered by the activation of the insulin-
like growth factor 1 receptor (IGFIR) via the mitogen-activated protein kinase (MAPK) 
pathway. The activation of paraptosis is accompanied by the formation of large empty 
vacuoles and can be selectively inhibited by Alix (Sperandio et al., 2004). The second form 
is ‘autophagic degeneration’ and is mediated by the activation of mutated Ras. This death is 
associated with the formation of lysosome derived vacuoles with a double-membrane 
appearance (Sperandio et al., 2004; Krantic et al., 2005). It is found that cells that lack Alix, 
exhibits minor mitotic defects and abscission failure which results in termination of the 
midbody and coalescence into single cells with multiple nuclei (Morita et al., 2010). 
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1.8 Alix in the PSD and role in neuronal function 
Alix was recently found in the human post synaptic density (hPSD) which is an 
important structure for nervous system disease and behaviour (Bayes et al., 2011). Using rat 
forebrain extracts, Alix was coeluted with Chmp2b and PSD-95 and at the synapse 
Chmp4b and Alix were found to form a stable polymer representing the ESCRT-III 
complex that associates with synaptic structures (Chassefeyre et al 2015). Further analysis 
of the immunoprecipitated ESCRT-III complex using mass spectrometry, revealed Alix 
within the ESCRT-III complex as well as Chmp 2b and GluN2B suggesting that the lysates 
contain a detectable amount of NMDA receptor subunit. These data indicate that Chmp2b 
and Alix exist within stable ESCRT-III and are attached to the spinos skeleton, around the 
PSD, at the spine shell and may play an unsuspected role in the regulation of long-term 
synaptic plasticity.  
Calcium is important for regulating a variety of cellular responses especially 
in neurons and it is now well established that alterations in intracellular Ca
2+ 
is a common 
factor of many apoptotic processes (Strappazzon et al., 2010). Overexpression of Alix in 
vivo correlates with calcium induced cell death in degenerating neurons of 
rat hippocampus undergoing epileptic seizures and in cultured neurons overexpression was 
sufficient to activate caspases and thereby apoptosis (Strappazzon et al., 2010). However, 
Alix apoptotic functions were dependent on their capacity to bind to ALG-2 where the 
expression of Alix lacking its ALG-2 binding site could block naturally occurring death 
of motor neurons during development of the chick embryo (Strappazzon et al., 2010; 
Mahul-Mellier et al., 2008).  It was recently found that exosomes are secreted by neurons, 
and cortical neurons in culture have been found to release exosomes that contain Alix and 
AMPA receptors and the cell adhesion molecule L1/NgCAM, which, in the central nervous 
system is expressed only by neurons (Chivet et al., 2012). 
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Aims and Objectives: 
 
1. Assess the role of the dopamine receptor interacting protein (DRIP), Alix in NMDA 
receptor function by examining its effect on recombinant NMDA receptor activity in 
mammalian cell lines such as HEK293 cells. 
2. Analyse the co-expression of recombinant Alix and recombinant glutamate 
receptors using immunocytochemistry in mammalian cell lines and investigate endogenous 
expression of Alix in cultured primary neurons. 
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2.1 Materials  
2.1 General chemicals  
2.1.1 Reagents purchased from Sigma-Aldrich Co. Ltd. (Poole, Dorset, England)  
2-Propanol, α- Minimum Essential Medium (DMEM), Beta-Mercaptoethanol, Dithiotreitol 
(DTT), Calcium Chloride Chloride (CaCl2), Glucose, Horse Serum, HEPES, Laminin, 
Magnesium Chloride, Nonidet p-40 (NP40), Phosphate Buffered Saline (PBS), Poly-D-
Lysine Hydrobromide, Potassium Chloride,  Sodium Dodecyl Sulfate (SDS), Terrific broth 
(TB) tablets, TWEEN20, Sodium Bicarbonate (NaHCO3), Sodium Chloride, Sodium 
Dihydrogen Phosphate (NaH2PO4), TritonX-100.  
 
2.1.2 Reagents purchased from other suppliers  
Agarose, (Bioline, London England) 
Amino-5-Phosphonovaleric Acid (D-AP5) (Ascent Scientific, Cambridge, Cambridgeshire, 
UK)  
Bradford dye (Bio Rad, Hemel Hempstead, Hertfordshire, UK) 
Ethidium bromide (Bio-Rad Laboratories, Hemel Hempstead, Hertfordshire England) 
Ethanol, Dimethyl Sulfoxide (DMSO), Methanol, Paraformaldehyde (PFA), Phenol: 
Chloroform: Iso-Amyl Alcohol (VWR International Ltd., Lutterworth, Leicestershire, 
England).  
B-27 Supplement (50x),  Fetal Bovine Serum (FBS), Gentamycin, Glycine, Lipofectamine 
2000, L-Glutamine 200mM, Neurobasal Medium, NuPage MOPS buffer, NuPage transfer 
buffer, NuPage SDS-polyacrylamide gel, Penicilin Streptomycin, TrypLE Express, Ultra 
Pure Tris, ProLong Gold reagent (Life Technologies, Paisley, UK) 
Magnetofection - NeuroMag (Oz Biosciences, Marseille, France) 
N-methyl-D-aspartate (NMDA) (Abcam, Cambridge, Cambridgeshire, UK) 
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Protease Inhibitor, EDTA Free (Roche, Mannheim, Germany) 
NEB 5-alpha E.coli. competent cells (New England Biolabs, Hitchin, UK)  
Restriction enzymes (New England Biolabs, Hitchin, UK or Roche, Mannheim, Germany) 
 
2.1.3 Molecular weight standards  
BLUE Wide Range Prestained Protein Ladder (Geneflow, Swift Valley, Rugby, UK)   
 
2.1.4 Antibodies  
Anti-Alix mouse antibody (Abcam, Cambridge, Cambridgeshire, UK)  
Anti-FLAG rabbit antibody (Sigma Aldrich, Poole, Dorset, UK)  
Anti-NMDAR1 mouse antibody (BD Biosciences, San Jose, California, USA)  
Anti-EEA1 mouse antibody (BD Biosciences, San Jose, California, USA) 
Anti-LAMP1 mouse antibody (Enzo Life Sciences, Matford Court, Exeter, UK)  
Anti-PSD95 mouse antibody (Abcam, Cambridge, Cambridgeshire, UK)  
Anti-NR2A/2B rabbit antibody (Millipore UK) 
Anti-PSD95 rabbit antibody (Abcam, Cambridge, Cambridgeshire, UK) 
Anti-EEA1 rabbit antibody (Abcam, Cambridge, Cambridgeshire, UK)  
Alexa Fluor 568 Goat Anti-Mouse (Life Technologies, Paisley, UK) 
Alexa Fluor 488 Donkey Anti-Rabbit (Life Technologies, Paisley, UK) 
Alexa Fluor 488 Goat Anti-Mouse (Life Technologies, Paisley, UK) 
IRDye 800 Goat Anti-Mouse (Licor bioscience Ltd, Nebraska, USA)  
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2.1.5 Kits  
Qiagen EndoFree Plasmid Maxi Kit (Qiagen Ltd, Crawley, West Sussex, UK)  
 
2.1.6 Equipment  
Bio-Rad gel casting system, Bio-Rad wide mini-sub cell electrophoresis system, Gel Doc 
XR system, PowerPac 300 power supply, GenePulser Xcell electroporator (Bio-Rad 
Laboratories, Hemel Hempstead, Hertfordshire England)  
Nanodrop spectrophotometer (Thermo Scientific, Wilmington, USA) 
Odyssey Infrared Imagining System (Li-cor Biosciences, Nebraska, USA).  
Olympus spinning disc confocal system (CARV from Digital Imaging Solutions) with an 
EM-CCD camera (Rolera/QI Cam 3500) mounted on an Olympus X71 microscope, using a 
100x fluoplan objective. 
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2.2 Methods  
2.2.1 Plasmid cDNAs 
In order to assess the effects of Alix co-expression on NMDA receptor triggered cell death 
in HEK293 mammalian cells we obtained cDNAs of various recombinant proteins from a 
number of sources. cDNA plasmids for  Alix (GFP tagged in pCMVTag2C) were kindly 
donated by Dr. Jamal Nasir (Zhan et. al. 2008), Alix (Flag tagged in pCi) donated by Dr. 
Remy Sadoul (Chatellard-Causse et al., 2002a) GluN1 in pRK7 and GluN2A in pRK7 
(Schorge and Colquhoun, 2003) kindly donated by Dr. Philip Chen.Variants of the Alix 
plasmids are represented in the figures below created using SNAPGENE. Alix human 
corresponds to human Alix cDNA subcloned into GFP tagged in pCMVTag2C. Alix wild 
type coresponds to mouse Alix cDNA subcloned into pCI Flag. Alix CT corresponds to a 
fragment expanding from amino acid 468 to 869 of Alix and Alix NT corresponds to amino 
acids 1-434. Alix DPRD lacks a fragment encompassing a proline rich region from amino 
acids 717 to 867 of Alix. 
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Alix Human in pcDNA3.1 His A 
 
Figure 2.1 The figure represents the cDNA plasmid Alix GFP tagged in pCMVTag2C with full human Alix cDNA subcloned into GFP tagged in pCMVTag2C. 
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Alix WT Mouse in pCI Neo 
 
Figure 2.2 The figure represents the cDNA plasmid Alix wild type which coresponds to full mouse Alix cDNA subcloned into pCI Flag tagged plasmid. 
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Alix NT Mouse in pCI Neo 
 
Figure 2.3 The figure represents the cDNA plasmid Alix NT corresponds to a fragment containing amino acids 1 to 434 of Alix subcloned into pCI Flag tagged plasmid. 
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Alix CT Mouse in pCI Neo 
 
Figure 2.4 The figure represents the cDNA plasmid Alix CT corresponds to a fragment containing amino acids 468 to 869 of Alix subcloned into pCI Flag tagged 
plasmid. 
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Alix DPRD Mouse in pCI Neo 
 
 
Figure 2.5 The figure represents the cDNA plasmid Alix Alix DPRD lacks a fragment encompassing a proline rich region from amino acids 717 to 867 of Alix 
subcloned into pCI Flag tagged plasmid. 
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2.2.2 Transformation of plasmid DNA 
Transformations were done using frozen bacterial stocks of NEB 5α competent cells (New 
England Biolabs). We used a ratio of 50 µl of the competent cells to 0.5-1 µg/µl of 
plasmids. The mixture was mixed by gentle flicking and left on ice for 30 minutes. It was 
then put in a 42 ºC water bath for 30 seconds for heat shock. This was then placed on ice 
for 5 minutes without prior mixing. A prewarmed SOC media was added to the mix with a 
ratio of 950 µl per each 50 µl of competent cell and plasmid mixture. This was then placed 
in a prewarmed 37 ºC shaker for 60 minutes at 250 rpm. Each sample was mixed properly 
by gentle flicking before streaked on to a Luria Bertani (LB) agar selection plate (with the 
appropriate antibiotic of 100 μg/ml ampillicin or kanamycin) and incubated overnight at 37 
ºC. A single, well isolated colony was grown overnight in 1 ml of Terrific Broth (TB) 
medium (with the appropriate antibiotic of 100 μg/ml ampillicin or kanamycin) as a small 
scale culture at 37 ºC. This was used to start a large-scale culture using 5 ml of sample in 
50 ml of TB medium (with the appropriate antibiotic of 100 μg/ml ampillicin or 
kanamycin) grown overnight in a shaker at 37 ºC. Cells were then centrifuged at +4 ºC for 
15 minutes at 4,000g and the medium aspirated. Cells were plated on an LB-agar plate 
supplemented with 100 μg/ml ampillicin or kanamycin. 
 
2.2.3 Miniprep of plasmid DNA 
Bacterial colonies were grown overnight in TB medium with the respective antibiotics of 
kanamycin (Alix plasmid) and ampicilin (GluN1 plasmid and GluN2A plasmid). 1.5 ml 
volume of bacterial culture was taken and spun down at 8000 rpm for 3 min. The 
supernatant was aspirated. 150 µl Solution 1 (50 mM glucose, 25 mM Tris-Cl (pH 8.0), 10 
mM EDTA (pH8.0)) was added and pellet resuspended using pipette tip. 300 µl fresh 
Solution 2 (0.2 N NaOH, 1% SDS) was added and mixed by inverting rapidly and 
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vigorously. 200 µl of Solution 3 (3 M potassium acetate, 11.5% acetic acid) was 
immediately added and mixture vortexed and shaken for a few seconds and incubated on 
ice for 5 minutes. The mixture was then centrifuged at maximum speed for 5 min and 
transfered to a new tube. 3 µl RNase A added (10 mg/ml), mixed and incubated at 37 ºC for 
30 min. 400 µl Phenol : Chloroform : Isoamylalcohol was added and vortex for 15 seconds 
and centrifuged for 2 minutes at maximum speed and aqueous layer transferred to a new 
tube. 850 µl 99% Ethanol was added and centrifuged at maximum speed for 5 minutes. The 
DNA pellet was washed with 1x 500 µl of 70 % ethanol and dried at room temperature and 
resuspended in 50 µl 1x TE buffer (10mM Tris-Cl, 1mM EDTA, pH 8.0). 
 
2.2.4 Maxiprep of plasmid DNA 
2.2.5 Qiagen Maxiprep protocol 
Large scale preparation of the plasmid (Maxiprep) (Qiagen) was done following the 
manufacturers protocol. We diverged slightly from the protocol at the final DNA 
precipitation step by centrifuging the final isopropanol DNA elution for 60 min at 5000 
rpm, 4 ºC, transferring the DNA pellet to a 1.5 ml microcentrifuge tube,  washing the DNA 
pellet in 70 % ethanol centrifuging in a benchtop microfuge for 5 minutes at 13000 rpm to 
spindown the DNA pellet before resuspending in 200 µl 1 x TE buffer. Restriction digests 
with the appropriate restriction enzymes were performeds and digested plasmids were run 
on a 1 % agarose gel in 1 x TAE buffer. All plasmids were sequenced for verification 
before the tissue culture experiments. 
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2.2.6 Restriction Enzyme Digestion 
A typical analytical digestion reaction was made of the following components: 
 
10x restriction enzyme buffer  1.0 μl 
 
Miniprep/maxiprep DNA  1.0 μl (approx. 0.5 μg) 
 
(10xBovine Serum Albumin)  1.0 μl (if required) 
 
Restriction enzyme   0.5 μl (approx. 5U) 
 
(2nd restriction enzyme)  0.5 μl (if required) 
 
Deionised water   made up to a final volume of 10 μl 
 
 
Preparative digestion reactions of DNA contained 1x restriction enzyme buffer 
(NewEnglandBiolabs), 1-5 μl DNA, 0.5 μl restriction enzyme at a concentration of 5 U/ μl 
(NewEnglandBiolabs) and deionised water (Purite, Thane, UK) making the final volume to 
10 μl. Reactions were carried out at 37 ºC for 1 hour. 
Plasmid fragments were separated by gel electrophoresis in a 1 % agarose (Sigma) gel 
made in 1x TAE buffer (40 mM Trisacetate, 1 mM EDTA (pH 8.0)) for 30 minutes at 
100V. To visualize DNA under UV light (wavelength = 302 nm) 3 μl 10 mg/ml ethidium 
bromide was added while 100ml of agarose was in liquid form. To estimate the molecular 
size of the DNA bands, 1.0 μg λ–bacteriophage digested with Sty I (size 19329, 7743, 
6223, 4254, 3472, 2690, 1882, 1489, 925 bp) was added in an adjacent well. This was done 
in electrophoresis tanks filled with 1x TAE buffer. The bands are visualised using a UV 
transilluminator and the yield of the DNA was determined by spectrophotometry using the 
Nanodrop spectrophotometer. 
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2.2.7 Starting HEK 293 cell cultures from frozen  
HEK293 cells were cultured from frozen and thawed by briefly immersing the vial in a 37 ºC 
water bath or thawed by hand for a few minutes.  Upon thawing, the outside of the vial was 
immediately wiped with 70 % Ethanol, cells were then centrifuged at 6000 rpm for 10 min. 
The supernatant was aspirated and later the pellet resuspended. The contents of the vial were 
added to a 25 cm² flask. 9 ml of  DMEM medium (Minimum Essential Medium,  
Modification [-MEM]) supplemented with 100 units/ml penicillin G sodium, 100 µg/ml 
streptomycin, 4 mM L-glutamine, and 10 % fetal bovine serum) was added to the flask. The 
flask was gently rocked to distribute cells evenly over the growth surface and incubated in 
a 37 ºC, 5 % CO2, humidified incubator. The cells were examined under a microscope 
the next day and the medium aspirated and replaced with fresh, prewarmed growth 
medium. The culture was expanded to an estimated 70-80 % confluency confirmed visually 
under an inverted microscope. The cells were expanded by aspirating the medium and 
washed twice with prewarmed sterile PBS. 1-2 ml of TrypLE Express (Invitrogen) was added 
and the cells were treated for 1-2 minutes or until the cells detached. 10 ml of growth medium 
was added to stop trypsinization and the cells were resuspended gently. The cells were 
counted using a haemocytometer and then the desired numbers of cells were added to a new 
flask with and an appropriate volume of growth medium (1 x 10
6
 in 10 ml DMEM in a 25 
cm² flask, 3 x 10
6
 in 30 ml DMEM in a 75 cm² flask and 7 x 10
6
 in 50 ml DMEM in a 175 
cm² flask). The plate was gently rocked to evenly distribute the cells before incubation in a 
37 ºC, 5 % CO2 humidified incubator.  
 
2.2.8 Preparing frozen cultures of HEK 293 cells 
To prepare frozen cultures the cells were trypsinised after washing with PBS twice. The 
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cells were pooled together and centrifuged at 6000 rpm for 10 min. The supernatant was 
aspirated and the pellet resuspended in freezing medium (20 %,-MEM/ DMEM, 70 % FBS, 
and 10 % DMSO)(1 ml for every 1 x 10
6
 cells) 1 ml aliquots were dispensed into sterile 
cryovials and frozen slowly by placing the vials in a thick-walled styrofoam container at -
80 ºC overnight. Vials were removed from styrofoam and placed in liquid nitrogen (-196 ºC) 
for long term storage.  
 
2.2.9 Cell culture and transfection of HEK 293 cells 
HEK-293 cells were cultured as described previously in DMEM medium (Minimum 
Essential Medium,  Modification [-MEM]) supplemented with 50 mg/ml Gentamycin, 4 mM 
L-glutamine, and 10 % fetal bovine serum). Cells were plated at a density of 
2 × 10
5
 cells/1 ml DMEM medium onto each well of a 24 well tissue culture plate and 
incubated in a 5% CO2 incubator at 37 °C for 24 h. 
Cells were transiently transfected using lipofectamine 2000 (Invitrogen). The DNA 
plasmids in 100 µl of DMEM medium (without FBS, L-glutamine and antibiotics) were 
added to each well of a 24 well plate with 1 ml of medium that contained attached cells at 
approximately 50-85% confluency. In experiments that used two, three or four different 
plasmids, equal concentrations of the plasmids were added. Transient transfections was 
performed with 10 µl lipofectamine/well. Cells were left for 18- 20 h at 37 °C in a 5% 
CO2 incubator.  
Cells were exposed to various treatments 18-20 h after the start of the transfection. Control 
cells were incubated in a physiological salt solution (PSS; 140 mM, NaCl; 1.4 mM CaCl2; 
5.4 mM KCl; 1.2 mM NaH2PO4; 21 mM glucose; 26 mM NaHCO3; pH 7.4) for 10 min in a 
5% CO2 incubator at 37 °C. Activation of NMDARs was performed by incubating the cells 
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in PSS containing NMDA (1 mM) and glycine (50 µM) for 10 min. After the 10-min 
treatments at 5% CO2, and 37 °C, cells were placed in fresh media for 6 h before 
assessment of cell death. 100 µM AP5 was added to each well to block any NMDAR 
activation by low levels of glutamate or glycine in the culture media before the PSS 
treatment. The transfection was terminated by replacing the medium. To determine 
transfection efficiency, transfection was performed with GFP using a varying DNA: 
lipofectamine ratios at varying confluency of cells and hours of transfection. The cells were 
then fixed with 2 % Paraformaldehyde (PFA) for 10 min and washed twice with PBS. 
Transfection efficiency was later determined by the percentage of cells that emitted 
fluorescence intensity of cells positive for EGFP under a spinning disc confocal system 
(CARV from Digital Imaging Solutions) with an EM-CCD camera (Rolera/QI Cam 3500) 
mounted on an Olympus X71 microscope. We diverged slightly from the protocol (in result 
3.2.3) when AP5 was added to each well in all stages of before transfection, during 
transfection and  during treatment to block any NMDAR activation by low levels of 
glutamate or glycine in the culture media before the PSS treatment.  
 
2.2.10 Trypan blue exclusion assay 
Cell death was determined by trypan blue exclusion (Wagey et al., 2001a). Six hours 
following treatment, cell death was assessed both in attached cells after trypsinisation and 
floating cells in the medium and PSS by trypan blue exclusion. The percentage of the 
combined attached and floating cells in the PSS and media was determined by removing the 
PSS and media from each well and adding trypan blue (1:1 ratio). Cell counts were 
performed on a haemocytometer in 5 counting grids of 1mm
2
 (each grid corresponding to 
1 × 10
-4
) and the average number of live and dead cells was calculated as a percentage of 
cell death. All data points correspond to the mean ± SE of values performed from at least 
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three separate transfections. Statistical comparisons of cell death between groups were 
performed using a paired t-test to determine which groups were statistically different from 
each other. 
 
2.2.11 Hippocampus and Cortex Dissection 
2.2.12 Coverslip preparation 
Glass coverslips (13mm) (VWR, Lutterworth, Leicestershire, UK) were washed with 70 % 
ethanol and a final wash with PBS before being coated with poly-D-lysine (100 µg/ml in 
PBS) in a 24 well plate. These were then left overnight and washed with PBS twice before 
coated with Laminin (100 µg/ml in PBS) overnight. These were then washed with PBS 
twice just before plating. 
 
2.2.13 Dissection of the cortex and hippocampus coverslip preparation 
The pregnant female rat was killed through humane schedule 1 methods and the uterus 
removed. The embryonic yolk sac was opened up by careful slicing, taking care to avoid 
damaging the embryo. The embryo (E18) was exposed and harvested by pulling away the 
embryonic yolk sac. The head of the embryo was severed and the top of the skull was 
peeled off to reveal the brain which was then carefully removed from the skull. To culture 
cortical neurons the brain was placed dorsal side up and an incision was made between the 
two hemispheres to separate them. Each hemisphere was placed cortex side down and any 
noncortical forebrain tissue was removed. Meningeal tissue was removed while holding the 
hemisphere down. To culture hippocampal neurons, further cuts were peformed along the 
longitudinal fissure of the cerebrum cutting off the posterior to lambda region (midbrain, 
hindbrain and cerebellum). The exposed hippocampus was carefully removed using forceps 
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along the hippocampal fissure. The dissection was done in cold PBS and hippocampi were 
left in ice cold PBS until ready for dissociation. 
Dissociation was done by chopping cortex or hippocampus into small pieces and 
transferred to a 15 ml tube containing 1 ml 25 % trypLE/PBS solution and incubated for 20 
minutes at 37 °C. The trypLE was aspirated and 1 ml of warmed DMEM (as described 
previously) and titrated with a fine bore 1000 µl blue tip until all the pieces were 
dissociated. The mixture was topped up to 10 ml of DMEM and spun at 1500 rpm for 3 
minutes. The DMEM was then aspirated and 1 ml of Neurobasal Media (Neurobasal 
Medium supplemented with 2 % B27 serum free supplement 50x, 1 % Penicilin 
Streptomycin, Glutamine 300 µM final concentration and β-mercaptoethanol 25 µM final 
concentration) was added to the pellet and again titrated with a fine bore 1000 µl blue tip. 
The cells were then counted using a haemocytometer and approximately 2 x 10
5 
cells were 
plated in each coated well of a 24 well plate. The neurons are maintained in culture for 14 
days before use and fresh media was added to the wells every 3-5 days. 
  
 
2.2.14 Immunocytochemistry 
HEK 293 were cultured as described previously in 2.2.3.2 or 2.2.4.2 section with the 
exception that the 24 well plates were coated with poly-D-lysine on glass cover slips at a 
density of 1.75 × 10
5
 cells/1 ml DMEM incubated in a 5% CO2 incubator at 37 °C for 24 h. 
HEK 293 cells were transiently transfected and treated as described previously in 2.2.3.2 
section. HEK 293 cells or primary neurons (cultured as described previously in 2.2.4.2 
section) were then fixed with 4 % Paraformaldehyde (PFA) for 10 min and washed three 
times with PBS on ice. Cells were blocked in PBS containing 5% horse serum and 0.1% 
Tween-20 for 45 minutes at room temperature prior to incubation with the appropriate 
primary and secondary antibody (varying concentrations, see table in section 2.2.7). 
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Coverslips were incubated with different combinations of primary (1 hour incubation) and 
secondary (1 hour incubation) antibodies and then embedded using the ProLong Gold 
reagent (Invitrogen). The cells were visualised on a spinning disc confocal system (CARV 
from Digital Imaging Solutions) with an EM-CCD camera (Rolera/QI Cam 3500) mounted 
on an Olympus X71 microscope, using a 100 x fluoplan objective. The microscope 
confocal system was supported by Image Pro 6.0 software. To avoid potential digital 
overlap, the images in this report are single section images. 
 
2.2.15 Western Blotting 
HEK-293 cells were cultured as described previously in 2.2.3.2 section with the exception 
that cells were expended to grow in a T25 flask at a density of 1.2 × 10
6
 cells in 10 ml of 
DMEM incubated in a 5% CO2 incubator at 37 °C for 24 h. Cells were transiently 
transfected and treated as described previously in 2.2.3.2 section. After the 10 minutes 
treatment with activated or non activated PSS, the cells were then lysed for protein 
extraction on ice. Proteins from a T25 flask were collected by trypsinisation, spun down 
and washed twice with PBS. The pellet was then left in 2 ml 1/2x protease inhibitor 
(Roche) on ice for 1 hour until viscous. This was then homogenised with a fine bore 1000 
µl blue tip until dissolved and spun down at 16,000 rpm for 15 minutes. The pellet was 
washed twice with 500 µl of 1/2x protease inhibitor and spun down at 10,000 rpm for 15 
minutes. The supernatant was discarded and the pellet solubilized with buffer Px to a 1:1 
ratio (0.2 M sodium phosphate pH 7.5, 1 % Triton X-100 and supplemented with protease 
inhibitors) on ice for 1 hour. It was then spun down at 16,000 rpm for 2 minutes and the 
supernatant collected.  
The protein concentration of the protein extract was determined by Bradford’s Protein 
Assay. The Bio Rad dye was diluted 1:4 ratio of dye to water and 1 ml of diluted reagent 
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was added to 4μl of the sample to be assayed in a 1ml cuvette. The samples were mixed, 
and the colour left to develop for 5 minutes. Known protein concentrations of BSA were 
run alongside to produce a standard curve. Absorbance readings at 595 nm were obtained 
once the colour had developed, and used to calculate the protein concentration based on the 
BSA standard curve. 
Equal concentrations of protein were prepared by diluting 1:4  with 4 x NuPage sample 
buffer and denatured at 90 °C for 5 minutes. Protein samples were loaded on a 4-12 % pre-
cast NuPage gel in XCell Sure Lock mini gel system (Invitrogen). Electrophoresis was 
performed at 100 V for 1 hour in 1 x MOPS running buffer (Invitrogen). The separated 
polypeptides were transferred to 0.45 µm nitrocellulose by electroblotting in 1 x transfer 
buffer (NuPage 20x transfer buffer Invitrogen) using the Bio Rad mini system at 140V for 
1 hours and 30 minutes. The nitrocellulose paper was then blocked with a solution of 0.5 % 
blocking buffer (1X TBS, 0.1 % Tween-20 with 5 % milk) and aspirated immediately with 
SNAP i.d. (Merck Milipore) and washed three times with TBS-T (50 mM Tris Base, 150 
mM NaCl, 0.1 % Tween 20). Once blocked the blot was incubated with the necessary 
primary antibody overnight and secondary antibodies for 10 minutes (refer table in section 
2.2.7) and washed 3 times with TBS-T immediately after. The bound antibodies were 
visualized with Odyssey Licor Imaging system by placing the membrane in some buffer 
and sliding it into the machine and selecting the specific Alexa Fluor channel (700 or 800) 
depending on the antibodies used. The membrane is then scanned with a manufacturer 
standard intensity and saved. Analysis of the western was done using Image studio Lite 
(Licor) by exporting the image into the software. The western bands are then quantified by 
selecting the auto add rectangle around the bands of interest which then produced a table of 
fluorescent intensity readings. 
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2.2.16 Fraction preparation 
 
Rats were killed by decapitation and the forebrain of the animal was swiftly removed. The 
forebrains were dropped into ice-cold isolation medium (0.32M-sucrose/l mM-sodium- 
EDTA/l0 mM-Tris/ HCI, pH7.4) and chopped into small blocks with a scalpel. The blood 
and other debris were washed off the brain tissue by adding up more isolation medium and 
decanting the supernatant from the top of the minced tissue. This washing procedure was 
repeated. The chopped tissue was then homogenized in a motor driven glass Teflon 
homogeniser (clearance 0.1mm) by 6 up down strokes with a motor speed of 600 
r.p.m./min. (Citenco motor-speed 6). This homogenate was diluted with isolation medium 
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and spun at 2000rpm in a Sorval RC-5B for 5 min 4°C. The supernatant from this spin was 
centrifuged at 12,000rpm for 15 min using the Sorval RC-5B, producing the crude 
mitochondrial/synaptosomal pellet. This pellet was resuspended in 3 ml of isolation 
medium using syringe fitted with wide bore needle, diluted with 12% Ficoll/sucrose 
medium (12% (w/w) Ficoll, 0.32M-sucrose, 1mM sodium-EDTA, pH7.4) and gently 
homogenized by hand in a Potter-type homogenizer (clearance 0.375mm). The crude 
mitochondrial suspension was introduced into a centrifuge tube and above this 5ml of 7.5% 
Ficoll/sucrose medium [7.5% (w/w) Ficoll, 0.32M-sucrose, 1 mM sodium-EDTA, pH7.4] 
was carefully layered. Finally, on top of this 10ml of isolation medium was layered. This 
will form the top layer of a three step gradient.  Successive layers were added under the 
homogenate using a wide bore needle and syringe.  The tubes were centrifuged at 
26,000rpm for 45min in a 3 x 23ml in the SW28 rotor using the Beckman L7 centrifuges. 
Myelin and synaptosomes banded at the first and second interphases respectively, with the 
free mitochondria being pelleted at the bottom. The myelin layer was carefully removed 
and the synaptosomes were gently sucked off from the interphase and transfered to a 
polyethylene tube for the 12 x 50ml SS34 angle rotor for the Sorval RC-5B. The two 
fractions were pelleted at 20,000rpm for 20 min using the Sorval centrifuge. In addition to 
harvesting the myelin and synaptosomal fractions the remaining gradient medium was 
poured off. The mitochondrial pellet was resuspend in 3 ml isolation medium and the 
myelin in 2 ml of isolation medium. The synaptosome layer was carefully resuspended in 
7ml sodium resuspension medium (2.5mM Hepes, 8mMKC1, 110mM NaCl, 2.6mM 
CaCl2, 10mM glucose pH 7.4). The resuspended mitochondrial pellet might contain some 
synaptosomal contamination.  This was removed by layering the resuspended material over 
1.3M (15 ml) sucrose and pelleting the mitochondria fraction through this layer. 
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2.2.17 Colocalization Analysis 
 The slides are prepared with the relevant cells or tissue and fluorophores  as 
described in 2.2.14. Measurements of the  degree of colocalization were determined by 
observing if the fluorophores are in the same place (co-occurrence) and if there is a 
relationship between their intensities (correlation). The fluorescent images that were taken 
from each slide were converted from an RGB coloured format to 8 bit image using ImageJ. 
The background was substracted from each image and a threshold was set. A colocalization 
analysis plugin available from ImageJ was chosen and this generated various colocalisation 
coefficients for two 8 bit images or stacks. The generated coefficients were plotted as a 
scattergram that generates a colour scatter pixel plot that represents the actual colour in the 
image showing the relationship of the intensities between a pair of displayed images. A 
Pearson correlation coefficient was used to analyse degree of colocalisation or overlap 
between the pixel intensities of each set of fluorophore pairs within a region of interest 
(ROI). We then calculated the mean from at least three pairs of images and obtained a mean 
Pearson correlation coefficient.  
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2.3 Antibody Dilution 
Antibody Host Company Dilution 
Anti-Alix mouse Abcam 1:100 
Anti-FLAG rabbit Sigma Aldrich 1:1000 
Anti-NMDAR1 mouse BD Biosciences 1:1000 
Anti-EEA1 mouse BD Biosciences 1:1000 
Anti-LAMP1 mouse Enzo Life Sciences 1:1000 
Anti-PSD95 mouse Abcam 1:500 
Anti-NR2A/2B rabbit Millipore 1:250 
Anti-PSD95 rabbit Abcam 1:500 
Anti-EEA1 rabbit Abcam 1:500 
Alexa Fluor 568 Goat Anti-Mouse Life Technologies 1:1000 
Alexa Fluor 488 Donkey Anti-Rabbit Life Technologies 1:1000 
Alexa Fluor 488 Goat Anti-Mouse Life Technologies 1:1000 
IRDye 800 Goat Anti-Mouse Licor bioscience 1:10,000 
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3. Investigating the potential modulation of NMDA by Alix in Cell Death Assay: 
3.0 Introduction: 
Previous work has identified a novel dopamine receptor interacting protein, Alix 
(ALG-2 (apoptosis-linked gene 2-interacting protein X), using D1 receptor C-terminal 
domain or D3 receptor third cytoplasmic loop as 'baits' in separate yeast two-hybrid screens 
(Zhan et al., 2008). Alix is thought to be important for the stability and trafficking of 
dopamine receptors and is a ubiquitous adaptor protein that was first described for its 
capacity to bind to the calcium-binding protein, ALG-2. It is known to be involved in 
apoptosis, regulation of cell adhesion, protein sorting, adaptation to stress conditions, 
ESCRT (endosomal sorting complex required for transport) and neuronal cell death. Alix 
has been recently found within the human postsynaptic density (PSD) (Bayes et al. 2011) 
and Alix may be able to facilitate intracellular ‘cross talk’ between both dopamine and 
glutamate signalling pathways. Given that NMDARs are a central component of the PSD 
and have the capacity to trigger neuronal cell death, we hypothesized that Alix may be able 
to influence NMDA triggered cell death. Little is known about how these proteins interact 
with the NMDA receptor and their cellular functioning and further study is thus needed to 
understand this. 
It is found that a proportion of HEK cells transfected with NMDAR subunits die 
following exposure to NMDAR agonists, depending on the NMDAR subunit composition 
(Wagey et al., 2001b). To establish if the activation of Alix, is involved in NMDA induced 
cell death we evaluated the cell death percentage in HEK293 cells transfected with 
NMDAR subunits. Activation of NMDARs was performed by incubating the cells in PSS 
containing NMDA and glycine. The cell death percentage was later calculated by trypan 
blue exclusion six hours following activation. 
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In this chapter, approaches to quantify NMDAR-induced cell death were used to 
analyse the effect of Alix on NMDA receptor function. We decided to start with an 
assessment of Alix on the NMDA cell death assay in HEK293 mammalian cell line as they 
are easy to maintain and transfect. To attain this goal we did a small and large scale 
preparation of the transformed human EGFP tagged Alix, GluN1, GluN2A, mouse FLAG 
tagged Alix WT, mouse Alix NT (N-terminal regions covering amino acids (1 to 434),  
mouse  Alix CT (C-terminal regions covering amino acids (468 to 869) and mouse Alix 
DPRD (deletion of a proline rich domain in the C-terminal region of Alix). The clones were 
confirmed positive by restriction enzyme digestion and sequencing. 
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3.1 Cell Death Assay: 
3.1.1 Transfection efficiency  
 
 Transfection efficiency was determined by the percentage of cells that emitted 
green fluorescence under Fluorescence/Confocal Microscope with a range of 100-200 cells 
per transfection condition. eGFP gene expression was performed using either pEGFP-N1 
or Alix (GFP tagged in pCMVTag2C) and was analysed by direct fluorescence using a 
confocal microscope with a 20x objective. Varying ratios of cDNA and lipofectamine were 
used and the highest percentage transfection (as judged from eGFP fluorescence) was 
found from a ratio of 1:5 DNA to lipofectamine. 
 
 
Figure 3.1.1 a:  Transfection efficiency by eGFP and Alix plasmid. All data points correspond to the mean 
± SE of values. 
 
DNA : lipofectamine transfection ratio 
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Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 eGFP 0.3 ug/ul + 1 ul 
Lipofectamine 
 
7% ± 3% 3 
2 eGFP 0.3 ug/ul + 1.6 ul 
Lipofectamine 
 
20% ± 6% 3 
3 eGFP 1 ug/ul + 3 ul 
Lipofectamine 
 
29% ± 3% 3 
4 eGFP 1 ug/ul + 5 ul 
Lipofectamine 
 
39% ± 5% 3 
5 eGFP 3 ug/ul + 15 ul 
Lipofectamine 
 
80% ± 2% 3 
6 Alix 3 ug/ul + 15 ul 
Lipofectamine 
 
79% ± 3% 3 
 
Table 3.1.1 b: Percentage of eGFP after 24 hours following transfection of plasmid with lipofectamine. 
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3.2 Alix modulate NMDA-induced cell death 
 
 To quantify NMDAR-induced cell death transfection efficiency was determined at 
a 1:5 ratio of DNA:lipofectamine for a 24 hours transfection duration between 50-85% 
confluency. The effects of Alix on NMDA cell death assay was determined by following 
the protocol by Wagey et al., 2001, where the Hek293 cells were transiently transfected 
using lipofectamine with the plasmids that was previously prepared in different 
combination.  
 
 
 
Figure 3.1 a:  Modulation of NMDA cell death by Alix. The cells were activated with physiological salt 
solution (PSS) with 1 mM NMDA and 50 µM Glycine. All data points correspond to the mean ±  SE of values 
and statistical comparisons of cell death between groups were performed using a paired t-test to determine 
which groups were statistically different from each other. The bar marked with ** denotes that it is 
statistically very significant with a P value of less than 0.05. 
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Table 3.1 a: Percentage cell death after 6 hours following treatment with 1 mM NMDA/ 50 µM Glycine. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
9.6 ± 0.9 11 
2 Alix/EGFP only 
 
10.1 ± 1.5 7 
3 GluN1/GluN2A/EGFP 27.4 ± 1.4 12 
4 GluN1/GluN2A/Alix 
 
21.6 ± 1.9 9 
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Figure 3.1 b:  Modulation of NMDA cell death by Alix. The cells were treated with physiological salt solution 
(PSS) only. All data points correspond to the mean ±  SE of values and statistical comparisons of cell death 
between groups were performed  using a paired t-test to determine which groups were statistically different 
from each other. The bar marked with ** denotes that it is statistically very significant with a P value of less 
than 0.05. 
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Table 3.1 b: Percentage cell death after 6 hours following treatment with physiological salt solution (PSS) 
only. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
11.9 ± 0.7 7 
2 Alix/EGFP only 
 
12.4 ± 0.8 7 
3 GluN1/GluN2A/EGFP 11.6 ± 0.7 14 
4 GluN1/GluN2A/Alix 
 
17.3 ± 1.0 11 
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Transfection comparison 
 
Mean Difference Significance 
 
 
Control Activated  
Control Activated  -17.4426%
*
 P<0.001 
NMDA+ Alix GFP 
Activated  
-11.7297%
*
 P<0.001 
NMDA+ Alix GFP 
Not Activated  
-7.4576%
*
 P<0.001 
 
 
Alix GFP Activated  
NMDAR only 
Activated  
-16.4842%
*
 P<0.001 
NMDA+ Alix GFP 
Activated  
-10.7713%
*
 P<0.001 
NMDA+ Alix GFP 
Not Activated  
-6.4993%
*
 P = 0.001 
 
 
 
 
 
NMDAR only 
Activated  
Control Activated  17.4426%
*
 P<0.001 
Alix GFP Activated  16.4842%
*
 P<0.001 
NMDA+ Alix GFP 
Activated  
5.7129%
*
 P = 0.002 
Control Not 
Activated  
16.0221%
*
 P<0.001 
Alix GFP Not 
Activated  
14.8968%
*
 P<0.001 
NMDAR only Not 
Activated  
15.7512%
*
 P<0.001 
NMDA+ Alix GFP 
Not Activated  
9.9850%
*
 P<0.001 
 
 
 
 
 
NMDA+ Alix GFP 
Activated  
Control Activated  11.7297%
*
 P<0.001 
Alix GFP Activated  10.7713%
*
 P<0.001 
NMDAR only 
Activated  
-5.7129%
*
 P = 0.002 
Control Not 
Activated  
10.3092%
*
 P<0.001 
Alix GFP Not 
Activated  
9.1839%
*
 P<0.001 
NMDAR only Not 
Activated  
10.0383%
*
 P<0.001 
 
 
Control Not 
Activated  
NMDAR only 
Activated  
-16.0221%
*
 P<0.001 
NMDA+ Alix GFP 
Activated  
-10.3092%
*
 P<0.001 
NMDA+ Alix GFP 
Not Activated  
-6.0371%
*
 P = 0.003 
 
 
Alix WT Not 
Activated  
NMDAR only 
Activated 3 
-14.8968%
*
 P<0.001 
NMDA+ Alix GFP 
Activated  
-9.1839%
*
 P<0.001 
NMDA+ Alix GFP 
Not Activated  
-4.9118%
*
 P = 0.030 
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NMDAR only Not 
Activated  
NMDAR only 
Activated  
-15.7512%
*
 P<0.001 
NMDA+ Alix GFP 
Activated  
-10.0383%
*
 P<0.001 
NMDA+ Alix GFP 
Not Activated  
-5.7663%
*
 P<0.001 
 
 
 
 
NMDA+ Alix GFP 
Not Activated  
Control Activated  
7.4576%
*
 P<0.001 
Alix GFP Activated  
6.4993%
*
 P = 0.001 
NMDAR only 
Activated  
-9.9850%
*
 P<0.001 
Control Not 
Activated  
6.0371%
*
 P = 0.003 
Alix GFP Not 
Activated  
4.9118%
*
 P = 0.030 
NMDAR only Not 
Activated  
5.7663%
*
 P<0.001 
 
 
Table 3.1 c:  Anova Analysis table of statistically significant NMDA cell death by Alix GFP. All data points 
correspond to the mean difference of values and statistical significance of cell death between groups. Anova 
analysis was performed using Tukey post-hoc analysis to determine which groups were statistically different 
from each other. Only statistically significant pairwise comparison is displayed and the values marked with * 
denotes that it is statistically significant at the level 0.05. 
 
To assess cell death in HEK-293 cells, a trypan blue exclusion assay was performed 
6 hours following various treatments. A T-test and an ANOVA analysis using SPSS was 
performed to determine the statistical significance of the various treatments. The negative 
control culture transfected without any DNA and maintained in PSS only had a mean of 
11.9 ±0.7% cell death at 6 hours (Figure 3.1b). The negative control with lipofectamine 
only that was activated with NMDA (1 mM) and glycine (50 µM) had a mean of 9.6 ±0.9% 
cell death at 6 hours (Figure 3.1a). Paired t-test and ANOVA analysis (Table 3.1c) shows 
that the difference between the activated and non-activated negative control is considered to 
be not statistically significant. 
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In cultures that were transfected with human EGFP-Alix cDNA alone and 
maintained in PSS, cell death at 6 hours was 12.4 ± 0.8% (Figure 3.1b). In cultures that 
were transfected with human EGFP-Alix cDNA activated in PSS with NMDA (1 mM) and 
glycine (50 µM)had a mean of 10.1 ±1.5% cell death at 6 h (Figure 3.1a). Paired t-test and 
ANOVA analysis (Table 3.1c) shows that the difference between activated and non-
activated cells expressing human EGFP-Alix cDNA alone is considered to be not 
statistically significant. There was also no statistical significance between the cell death 
measured between activated or non activated cells expressing human EGFP-Alix cDNA 
alone and the negative control (without DNA). 
As a positive control, cells were transfected with GluN1/GluN2A subunits and 
those cells maintained in PSS displayed a mean of 11.6 ±0.7% cell death at 6 h (Figure 
3.1b). Whereas, cells transfected with GluN1/GluN2A subunits that were activated with 
PSS with NMDA (1 mM) and glycine (50 µM)had a mean of 27.4 ±1.4% cell death at 6 h 
(Figure 3.1a). Treatment with NMDA and glycine significantly enhanced cell death. Paired 
t-test shows that the difference between the activated and non activated positive control is 
considered to be extremely statistically significant with a P value of less than 0.0001. While 
the ANOVA analysis gave a significance value of P<0.001 (Table 3.1c). 
To determine if Alix has any cytotoxic effect on GluN1/GluN2A subunits 
transfected HEK cells, Alix was transfected with GluN1/GluN2A subunits and treated with 
PSS alone or with PSS and NMDA plus glycine and cell death was assessed 6 hours 
following the treatments. As shown in Figure 3.1a, transfecting Alix with GluN1/GluN2A 
significantly reduced the percentage of dead cells compared with cells expressing 
GluN1/GluN2A subunits and activated with NMDA. The culture transfected with Alix, 
GluN1/GluN2A subunits and activated with PSS and NMDA with glycine had a mean of 
21.6 ±1.9% cell death at 6 hours (Figure 3.1a). Paired t-test shows that the difference 
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between the activated positive control and activated cells containing Alix, GluN1, GluN2A 
is considered to be statistically significant with a P value of 0.0081 which correlate with the 
ANOVA analysis significance value of .002 (Table 3.1c).  
Non activated cells transfected with Alix and GluN1/GluN2A subunits yielded a 
mean of 17.3 ±1.0% cell death at 6 hours (Figure 3.1b). It is a higher percentage of cell 
death compared to GluN1/GluN2A subunits that were not activated. Paired t-test shows that 
the difference between the non-activated positive control and non-activated Alix, GluN1, 
GluN2A is considered to be extremely statistically significant with a P value of 0.0002 
which correlates with the ANOVA analysis significance value of P<0.001 (Table 
3.1c).There was however no statistical significance in cell death between activated and non-
activated cells expressing Alix, GluN1, GluN2A (P value of 0.0511) (Figure 3.1a and b) 
(Table 3.1c). 
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3.2.2 Coexpression of Alix with GluN1 or GluN2A alone 
To confirm that Alix is not causing a high amount of cell death without the 
overexpression of NMDAR (Since GluN2 subunits are not transported to the cell surface 
unless they associate with GluN1 subunits, (McIlhinney et al., 2003) we did a control 
experiment where we repeated the cell death assay with Alix and GluN1 or Alix with 
GluN2A alone to test if there is any significant cell death compared to the negative control 
(Figure 3.2). 
 
Figure 3.2 a:  Modulation of NMDA cell death by Alix. The cells were activated with physiological salt 
solution (PSS) with 1 mM NMDA and 50 µM Glycine. All data points correspond to the mean ±  SE of values 
and statistical comparisons of cell death between groups were performed using a paired t-test to determine 
which groups were statistically different from each other. 
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Table 3.2  a: Percentage cell death after 6 hours following treatment with 1 mM NMDA/ 50 µM Glycine. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Alix/EGFP only 
 
6.9 ± 1.0 3 
2 Alix/GluN1/ EGFP 
 
8.5 ± 0.9 3 
3 Alix/GluN2A/ EGFP 
 
7.1 ± 0.7 3 
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Figure 3.2  b:  Modulation of NMDA cell death by Alix. The cells were treated with physiological salt 
solution (PSS) only. All data points correspond to the mean ±  SE of values and statistical comparisons of cell 
death between groups were performed using a paired t-test to determine which groups were statistically 
different from each other. 
 
Table 3.2  b: Percentage cell death after 6 hours following treatment with physiological salt solution (PSS) 
only. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Alix/EGFP only 
 
7.3 ± 1.4 3 
2 Alix/GluN1/ EGFP 
 
9.3 ± 1.5 3 
3 Alix/GluN2A/ EGFP 
 
7.7 ± 1.5 3 
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 As expected we found that by transfecting Alix with GluN1 alone and Alix with 
GluN2A alone (both activated and without activation) we did not find an increase of cell 
death (all transfections yielded an average of around 10% cell death) compared to negative 
control (Figure 3.2 a and b). This differs from the observations in Figure 3.1, where Alix 
expression increased NMDAR triggered cell death in the absence of 1mM NMDA in the 
PSS. 
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3.2.3 An NMDAR antagonist, AP5 abolishes cell death in the absence or presence of 
Alix  
Next we examined if NMDAR activation is behind the increased cell death caused 
by Alix (in PSS only). Therefore, we repeated the NMDA cell death assay with AP5 to 
block NMDA triggered calcium influx to see if the increased cell death in the presence of 
Alix is caused by NMDAR activation (Figure 3.3). 
 
 
Figure 3.3 a:  The effects of 100 µM AP5 on Alix coexpression. The cells were activated with physiological 
salt solution (PSS) with 1 mM NMDA and 50 µM Glycine. All data points correspond to the mean ± SE of 
values and statistical comparisons of cell death between groups were performed using a paired t-test to 
determine which groups were statistically different from each other. 
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Table 3.3 a: Percentage cell death after 6 hours following treatment with 1 mM NMDA/ 50 µM Glycine. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
8.3 ± 1.3 3 
2 GluN1/GluN2A/EGFP  8.5 ± 0.9 3 
3 GluN1/GluN2A/Alix 
 
7.1 ± 0.7 3 
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Figure 3.3 b:  The effects of 100 µM AP5 on Alix coexpression. The cells were treated with physiological salt 
solution (PSS) only. All data points correspond to the mean ±  SE of values and statistical comparisons of cell 
death between groups were performed using a paired t-test to determine which groups were statistically 
different from each other. 
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Table 3.3 b: Percentage cell death after 6 hours following treatment with physiological salt solution (PSS) 
only. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
7.3 ± 1.4 3 
2 GluN1/GluN2A/EGFP  9.3 ± 1.5 3 
3 GluN1/GluN2A/Alix  7.7 ± 1.5 3 
 
We found that by adding AP5 to the medium before, during and after treatment 
(activated or without activation) that we were able to abolish the higher percentage of cell 
death caused by Alix and NMDAR as previously seen in Figure 3.1. Therefore, the 
increased cell death seen in the cells cotransfected with Alix requires NMDAR activation. 
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3.2.4 The effect of different NMDA concentrations on cell death in the absence and 
presence of human Alix 
After seeing the result of AP5 treatment we examined whether this was due to an 
increased sensitivity NMDARs to NMDA when coexpressed with Alix. We modulated the 
concentration of NMDA in the PSS buffer in activated assay to see if this affected the cell 
death caused by Alix (Figure 3.4). 
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Figure 3.4: The effect of different NMDA concentrations on cell death in the absence (black filled squares)  
and presence of human Alix (filled grey circles). The cells were activated with physiological salt solution 
(PSS) with varying NMDA concentration and 50 µM Glycine. Partial dose-response curves were fit to the 
data using the Hill equation under conditions where the maximum and minimium were fixed at 30 and 10 % 
respectively.  
 
 
 
 
 66 
Table 3.4: Percentage cell death after 6 hours following treatment with 1 mM NMDA/ 50 µM Glycine. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
 1 GluN1/GluN2A/Alix 
0.01mM NMDA          
18.7 ± 1.9 3 
2 GluN1/GluN2A/EGFP 
0.01mM NMDA          
9.8 ± 1.2 3 
3 GluN1/GluN2A/Alix 
0.1mM NMDA         
21.9 ± 2.0 3 
4 GluN1/GluN2A/EGFP 
0.1mM NMDA         
11.2 ± 0.8 3 
5 GluN1/GluN2A/Alix 
0.3mM NMDA           
22.5 ± 1.5 3 
6 GluN1/GluN2A/EGFP 
0.3mM NMDA           
15.0 ± 0.4 3 
7 GluN1/GluN2A/Alix 
0.7mM NMDA 
28.5 ± 0.7 3 
8 GluN1/GluN2A/EGFP 
0.7mM NMDA 
27.3 ± 0.5 3 
 
We found that by gradually increasing the NMDA concentration we also increased 
cell death caused by expression of NMDAR in the HEK293 cells (Figure 3.4 black 
squares). The same gradual increase was found by coexpression of Alix with NMDAR but 
a higher cell death percentage was observed compared to levels seen with NMDARs 
expressed alone (Figure 3.4grey circles). The addition of Alix to NMDAR caused a high 
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percentage of cell death (18.7 %) even in the presence of a low concentration of NMDA 
(10 µM) compared to the levels of cell death observed at the same concentration in cells 
expressing NMDARs alone (9.8 %). Therefore the relatively high cell death observed in 
cells expressing both Alix and NMDARs in the presence of PSS could be caused by low 
concentrations of glutamate/glycine in the culture media. Further analysis of the data was 
performed by fitting the Hill equation to the partial dose-response curves and showed that 
in the presence of Alix the NMDA EC50 for triggering NMDAR cell death decreased to 
0.11 ± 0.04 mM compared to 0.80 ± 0.02 mM for NMDAR only cells. Therefore the 
presence of Alix decreased the NMDA concentration required to trigger cell death when 
coexpressed with NMDARs. 
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3.2.5 Modulation of NMDA cell death by mouse Alix WT 
Our findings have shown that Alix is able to influence NMDAR activity in our cell 
death assay and suggest some form of functional interaction between these molecules may 
occur. We decided examine other variants of Alix in this assay. We used a mouse form of 
Alix and a number of deletion variants of the Alix mouse protein were used. Alix N-T and 
Alix C-T, which correspond to the N-terminal half and C-terminal half of the protein, 
respectively and Alix DPRD is Alix lacking the proline-rich domain. 
 
Figure 3.5: Schematic representation of Alix deletion mutants (Chatellard-Causse et al., 2002). 
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Figure 3.6 a: Modulation of NMDA cell death by mouse Alix WT. The cells were activated with 
physiological salt solution (PSS) with 1 mM NMDA and 50 µM Glycine. All data points correspond to the 
mean ± SE of values and statistical comparisons of cell death between groups were performed using a 
paired t-test to determine which groups were statistically different from each other. 
 
 
 
 
 
 
 
 
 
 
 
 70 
Table 3.6 a: Percentage cell death after 6 hours following treatment with 1 mM NMDA/ 50 µM Glycine. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
7.1 ± 0.5 3 
2 Alix WT/EGFP  
 
8.2 ± 1.0 3 
3 GluN1/GluN2A/EGFP 23.1 ± 1.1 3 
4 GluN1/GluN2A/Alix 
WT 
 
18.6 ± 1.9 3 
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Figure 3.6 b: Modulation of NMDA cell death by mouse Alix WT. The cells were treated with physiological 
salt solution (PSS) only. All data points correspond to the mean ±  SE of values and statistical comparisons of 
cell death between groups were performed using a paired t-test to determine which groups were statistically 
different from each other. 
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Table 3.6 b: Percentage cell death after 6 hours following treatment with physiological salt solution (PSS) 
only. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
9.3 ± 0.9 3 
2 Alix WT/EGFP  
 
7.4 ± 1.2 3 
3 GluN1/GluN2A/EGFP 8.2 ± 0.4 3 
4 GluN1/GluN2A/Alix 
WT 
 
15.6 ± 1.1 3 
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Transfection comparison 
 
Mean Difference Significance 
 
 
Control Activated 
NMDAR only 
Activated 
-16.02376%
*
 P<0.001 
NMDA+ Alix WT 
Activated 
-11.53522%
*
 P<0.001 
NMDA+ Alix WT 
Not Activated 
-8.52800%
*
 P = 0.001 
 
 
Alix WT Activated 
NMDAR only 
Activated 
-14.92207%
*
 P<0.001 
NMDA+ Alix WT 
Activated 
-10.43353%
*
 P<0.001 
NMDA+ Alix WT 
Not Activated 
-7.42631%
*
 P = 0.004 
 
 
 
 
 
NMDAR only 
Activated 
Control Activated 16.02376%
*
 P<0.001 
Alix WT Activated 14.92207%
*
 P<0.001 
Control Not 
Activated 
13.82659%
*
 P<0.001 
Alix WT Not 
Activated 
15.72405%
*
 P<0.001 
NMDAR only Not 
Activated 
14.94409%
*
 P<0.001 
NMDA+ Alix WT 
Not Activated 
7.49576%
*
 P = 0.004 
 
 
 
 
 
NMDA+ Alix WT 
Activated 
Control Activated 11.53522%
*
 P<0.001 
Alix WT Activated 10.43353%
*
 P<0.001 
Control Not 
Activated 
9.33804%
*
 P<0.001 
Alix WT Not 
Activated 
11.23551%
*
 P<0.001 
NMDAR only Not 
Activated 
10.45554%
*
 P<0.001 
 
 
Control Not 
Activated 
NMDAR only 
Activated 
-13.82659%
*
 P<0.001 
NMDA+ Alix WT 
Activated 
-9.33804%
*
 P<0.001 
NMDA+ Alix WT 
Not Activated  
-6.33083%
*
 P = 0.017 
 
 
Alix WT Not 
Activated  
NMDAR only 
Activated  
-15.72405%
*
 P<0.001 
NMDA+ Alix WT 
Activated  
-11.23551%
*
 P<0.001 
NMDA+ Alix WT 
Not Activated  
-8.22829%
*
 P = 0.002 
 
 
NMDAR only Not 
NMDAR only 
Activated 
-14.94409%
*
 P<0.001 
NMDA+ Alix WT -10.45554%
*
 P<0.001 
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Activated  Activated  
NMDA+ Alix WT 
Not Activated  
-7.44832%
*
 P = 0.004 
 
 
 
 
NMDA+ Alix WT 
Not Activated  
Control Activated 
8.52800%
*
 P = 0.001 
Alix WT Activated 
7.42631%
*
 P = 0.004 
NMDAR only 
Activated  
-7.49576%
*
 P = 0.004 
Control Not 
Activated  
6.33083%
*
 P = 0.017 
Alix WT Not 
Activated  
8.22829%
*
 P = 0.002 
NMDAR only Not 
Activated  
7.44832%
*
 P = 0.004 
 
Table 3.6 c:  Anova Analysis of table of statistically significant NMDA cell death by Alix WT. All data points 
correspond to the mean difference of values and statistical significance of cell death between groups. Anova 
analysis was performed using Tukey post-hoc analysis to determine which groups were statistically different 
from each other. Only statistically significant pairwise comparison is displayed and the values marked with * 
denotes that it is statistically significant at the level 0.05. 
 
As a negative control, cells transfected without any DNA and maintained in PSS 
only had a mean of 9.3 ±0.9% cell death at 6 hours (Figure 3.6 b). The negative control 
without any DNA that was activated with PSS with NMDA (1 mM) and glycine (50 µM) 
had a mean of 7.1 ± 0.5% cell death at 6 hours (Figure 3.6 a). Paired t-test and ANOVA 
analysis (Table 3.6c) shows that the difference between the negative control activated and 
not activated is considered to be not statistically significant. 
In cultures that were transfected with mouse AlixWT subunits alone and maintained 
in PSS, cell death at 6 hours was 7.4 ± 1.2% (Figure 3.6 b). In cultures that were transfected 
with AlixWT subunit alone activated in PSS with NMDA (1 mM) and glycine (50 µM)had 
a mean of 8.2 ±1.0% cell death at 6hours (Figure 3.6 a). Paired t-test and ANOVA analysis 
(Table 3.6c) shows that the difference between Alix alone activated and not activated is 
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considered to be not statistically significant. There was also no statistical significance in 
cell death between activated or non activated cells expressing Alix alone and the activated 
or non activated negative control (without DNA).   
The positive control culture transfected with GluN1/GluN2A subunits and 
maintained in PSS only had a mean of 8.2 ± 0.4% cell death at 6 hours (Figure 3.6 b). 
Whereas, the positive control expressing GluN1/GluN2A subunits that was activated with 
PSS with NMDA (1 mM) and glycine (50 µM) had a mean of 23.1 ± 1.1% cell death at 6 
hours (Figure 3.6 a). Treatment with NMDA and glycine significantly enhanced cell death. 
Paired t-test shows that the difference between the activated and non-activated positive 
control is considered to be extremely statistically significant with a P value of less than 
0.0001 which correlates with the ANOVA analysis significance value of P<0.001 (Table 
3.6c). 
To determine if mouse Alix has any cytotoxic effect on GluN1/GluN2A subunit 
transfected HEK cells, Alix was transfected with GluN1/GluN2A subunits and treated with 
PSS alone or with PSS and NMDA plus glycine and cell death was assessed 6 hours 
following the treatments. As shown in Figure 3.6 a, transfecting Alix with GluN1/GluN2A 
significantly reduced the percentage of dead cells compared with positive control 
GluN1/GluN2A subunits. The culture transfected with Alix, GluN1/GluN2A subunits and 
activated with PSS and NMDA with glycine had a mean of 18.6 ± 1.9% cell death at 6 
hours (Figure 3.6 a). Paired t-test and ANOVA analysis shows that the difference between 
the activated positive control and activated cells expressing mouse Alix, GluN1, GluN2A is 
considered to be not statistically significant.  
Alix transfected with GluN1/GluN2A subunits and not activated (PSS alone) also 
yielded a surprising result with a mean of 15.6 ± 1.1% cell death at 6 hours (Figure 3.6 b). 
It is a higher percent of cell death compared to cells expressing GluN1/GluN2A subunits 
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that were not activated. Paired t-test shows that the difference in cell death between the non 
activated positive control and non activated cells expressing Alix, GluN1 and GluN2A 
together is considered to be extremely statistically significant which correlate with the 
ANOVA analysis significance value of P<0.001 (Table 3.6c). There was however no 
statistical significance in cell death in activated or non-activated cells expressing Alix, 
GluN1, GluN2A (P value of 0.2361). These results are similar to those observed for the 
EGFP tagged human Alix used in earlier cell death experiments (Figure 3.1a and b). 
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3.2.6 Modulation of NMDA cell death by mouse Alix CT 
 
Figure 3.7 a: Modulation of NMDA cell death by mouse Alix CT. The cells were activated with physiological 
salt solution (PSS) with 1 mM NMDA and 50 µM Glycine. All data points correspond to the mean ±  SE of 
values and statistical comparisons of cell death between groups were performed using a paired t-test to 
determine which groups were statistically different from each other. 
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Table 3.7 a: Percentage cell death after 6 hours following treatment with 1 mM NMDA/ 50 µM Glycine. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
10.2 ± 0.3 3 
2 Alix CT/EGFP  
 
14.2 ± 1.9 3 
3 GluN1/GluN2A/EGFP 26.8 ± 1.7 3 
4 GluN1/GluN2A/Alix 
CT 
 
16.7 ± 0.5 3 
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Figure 3.7 b: Modulation of NMDA cell death by Alix CT. The cells were treated with physiological salt 
solution (PSS) only. All data points correspond to the mean ±  SE of values and statistical comparisons of cell 
death between groups were performed  using a paired t-test to determine which groups were statistically 
different from each other. 
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Table 3.7 b: Percentage cell death after 6 hours following treatment with physiological salt solution (PSS) 
only. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
9.5 ± 0.4 3 
2 Alix CT/EGFP  
 
9.1 ± 0.9 3 
3 GluN1/GluN2A/EGFP 11.0 ± 1.1 3 
4 GluN1/GluN2A/Alix 
CT 
 
15.9 ± 0.3 3 
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Transfection comparison 
 
Mean Difference Significance 
 
 
Control Activated 
NMDAR only 
Activated 
-16.56591%
*
 P<0.001 
NMDA+ Alix CT 
Activated 
-6.44449%
*
 P = 0.002 
NMDA+ Alix CT 
Not Activated 
-5.65768%
*
 P = 0.006 
 
 
Alix CT Activated 
NMDAR only 
Activated 
-14.52863%
*
 P<0.001 
NMDA+ Alix CT 
Activated 
-4.40721%
*
 P = 0.040 
 
 
 
 
 
NMDAR only 
Activated 
Control Activated 16.56591%
*
 P<0.001 
Alix CT Activated 14.52863%
*
 P<0.001 
NMDA+ Alix CT 
Activated 
10.12142%
*
 P<0.001 
Control Not 
Activated 
17.32639%
*
 P<0.001 
Alix CT Not 
Activated 
17.70731%
*
 P<0.001 
NMDAR only Not 
Activated 
15.81505%
*
 P<0.001 
NMDA+ Alix CT 
Not Activated 
10.90823%
*
 P<0.001 
 
 
 
 
 
NMDA+ Alix CT 
Activated 
Control Activated 6.44449%
*
 P = 0.002 
Alix CT Activated 4.40721%
*
 P = 0.040 
NMDAR only 
Activated 
-10.12142%
*
 P<0.001 
Control Not 
Activated 
7.20497%
*
 P = 0.001 
Alix CT Not 
Activated 
7.58589%
*
 P<0.001 
NMDAR only Not 
Activated 
5.69363%
*
 P = 0.005 
 
 
Control Not 
Activated 
NMDAR only 
Activated 
-17.32639%
*
 P<0.001 
NMDA+ Alix CT 
Activated 
-7.20497%
*
 P = 0.001 
NMDA+ Alix CT 
Not Activated 
-6.41816%
*
 P = 0.002 
 
 
Alix CT Not 
Activated 
NMDAR only 
Activated 
-17.70731%
*
 P<0.001 
NMDA+ Alix CT 
Activated 
-7.58589%
*
 P<0.001 
NMDA+ Alix CT 
Not Activated 
-6.79908%
*
 P = 0.001 
 NMDAR only -15.81505%
*
 P<0.001 
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NMDAR only Not 
Activated 
Activated 3 
NMDA+ Alix CT 
Activated 
-5.69363%
*
 P = 0.005 
NMDA+ Alix CT 
Not Activated 
-4.90682%
*
 P = 0.018 
 
 
 
 
NMDA+ Alix CT 
Not Activated 
Control Activated 
5.65768%
*
 P = 0.006 
NMDAR only 
Activated 
-10.90823%
*
 P<0.001 
Control Not 
Activated 
6.41816%
*
 P = 0.002 
Alix CT Not 
Activated 
6.79908%
*
 P = 0.001 
NMDAR only Not 
Activated  
4.90682%
*
 P = 0.018 
 
Table 3.7 c:  Anova Analysis of table of statistically significant NMDA cell death by Alix CT. All data points 
correspond to the mean difference of values and statistical significance of cell death between groups. Anova 
analysis was performed using Tukey post-hoc analysis to determine which groups were statistically different 
from each other. Only statistically significant pairwise comparison is displayed and the values marked with * 
denotes that it is statistically significant at the level 0.05. 
 
The negative control culture transfected without any DNA and maintained in PSS 
only had a mean of 9.5 ± 0.4% cell death at 6 hours (Figure 3.7 b). The negative control 
without any DNA that was activated with PSS with NMDA (1 mM) and glycine (50 µM) 
had a mean of 10.2 ± 0.3% cell death at 6 hours (Figure 3.7 a). Paired t-test and ANOVA 
analysis shows that the difference between the negative control activated and not activated 
is considered to be not statistically significant. 
In cultures that were transfected with Alix CT subunits alone and maintained in 
PSS, cell death at 6 hours was 9.1 ± 0.9% (Figure 3.7 b). In cultures that were transfected 
with Alix CT subunit alone activated in PSS with NMDA (1 mM) and glycine (50 µM) had 
a mean of 14.2 ± 1.9% cell death at 6 hours (Figure 3.7 a). 
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The positive control culture transfected with GluN1/GluN2A subunits and 
maintained in PSS only had a mean of 11.0 ± 1.1% cell death at 6 hours (Figure 3.7 b). 
Whereas, the positive control GluN1/GluN2A subunits that was activated with PSS with 
NMDA (1 mM) and glycine (50 µM) had a mean of 26.8 ± 1.7% cell death at 6 hours 
(Figure 3.7 a). Treatment with NMDA and glycine significantly enhanced cell death. Paired 
t-test shows that the difference between the activated and non-activated positive control is 
considered to be extremely statistically significant with a P value of less than 0.0001 which 
correlates with the ANOVA analysis significance value of P<0.001 (Table 3.7c). 
Transfecting Alix CT with GluN1/GluN2A significantly reduced the percentage of 
dead cells compared with positive control GluN1/GluN2A subunits. The culture transfected 
with Alix CT, GluN1/GluN2A subunits and activated with PSS and NMDA with glycine 
had a mean of 16.7 ± 0.5% cell death at 6 hours (Figure 3.7 a). Paired t-test shows that the 
difference between the activated positive control and activated cells expressing Alix CT, 
GluN1 and GluN2A is considered to be statistically significant with a P value of 0.0432 
which correlates with the ANOVA analysis significance value of P<0.001 (Table 3.7c).  
Non activated Alix CT transfected with GluN1/GluN2A subunits (PSS alone) 
yielded a mean cell death of 15.9 ± 0.3% cell death at 6 hours (Figure 3.7 b). It is a higher 
percent of cell death compared to GluN1/GluN2A subunits that were not activated. Paired 
t-test shows that the difference between the non activated positive control and non activated 
cells expressing mouse Alix CT, GluN1, GluN2A is considered to be statistically 
significant with a P value of 0.0277 which correlate with the ANOVA analysis sig value of 
.018 (Table 3.7c).There was however a statistical significance in the T-test in cell death 
between activated and non-activated cells expressing Alix CT, GluN1, GluN2A (P value of 
0.0471) but no statistical significance in the ANOVA analysis. Thus the Alix-CT mutant 
containing only the C-terminal region of Alix is able to replicate the enhanced cell death 
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seen with the full length human (Figure 3.1) and mouse Alix variants (Figure 3.6) in the 
absence of NMDA/glycine. 
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3.2.7 Modulation of NMDA cell death by mouse Alix NT 
 
Figure 3.8 a: Modulation of NMDA cell death by mouse Alix NT. The cells were activated with physiological 
salt solution (PSS) with 1 mM NMDA and 50 µM Glycine. All data points correspond to the mean ±  SE of 
values and statistical comparisons of cell death between groups were performed using a paired t-test to 
determine which groups were statistically different from each other. 
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Table 3.8 a: Percentage cell death after 6 hours following treatment with 1 mM NMDA/ 50 µM Glycine. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
10.6 ± 0.3 3 
2 Alix NT/EGFP  
 
11.4 ± 0.7 3 
3 GluN1/GluN2A/EGFP 26.4 ± 0.5 3 
4 GluN1/GluN2A/Alix 
NT 
 
13.2 ± 0.9 3 
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Figure 3.8 b: Modulation of NMDA cell death by Alix NT. The cells were treated with physiological salt 
solution (PSS) only. All data points correspond to the mean ±  SE of values and statistical comparisons of cell 
death between groups were performed using a paired t-test to determine which groups were statistically 
different from each other. 
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Table 3.8 b: Percentage cell death after 6 hours following treatment with physiological salt solution (PSS) 
only. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
11.0 ± 0.4 3 
2 Alix NT/EGFP  
 
9.9 ± 0.5 3 
3 GluN1/GluN2A/EGFP 10.3 ± 0.4 3 
4 GluN1/GluN2A/Alix 
NT 
 
11.3 ± 0.3 3 
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Transfection comparison 
 
Mean Difference Significance 
 
Control Activated 
NMDAR only 
Activated 
-15.84100%
*
 P<0.001 
NMDA+ Alix NT 
Activated 
-2.60646%
*
 P = 0.041 
 
Alix NT Activated 
Positive Control 
Activated 
-15.03170%
*
 P<0.001 
 
 
 
 
 
NMDAR only 
Activated 
Negative Control 
Activated 
15.84100%
*
 P<0.001 
Alix NT Activated 15.03170%
*
 P<0.001 
NMDA+ Alix NT 
Activated 
13.23454%
*
 P<0.001 
Control Not 
Activated  
15.42169%
*
 P<0.001 
Alix NT Not 
Activated  
16.53079%
*
 P<0.001 
NMDAR only Not 
Activated 
16.06126%
*
 P<0.001 
NMDA+ Alix NT 
Not Activated 
15.12686%
*
 P<0.001 
 
 
 
NMDA+ Alix NT 
Activated  
Control Activated 2.60646%
*
 P = 0.041 
NMDAR only 
Activated 
-13.23454%
*
 P<0.001 
Alix NT Not 
Activated 
3.29625%
*
 P = 0.007 
NMDAR only Not 
Activated 
2.82672%
*
 P = 0.023 
Control Not 
Activated 
NMDAR only 
Activated 
-15.42169%
*
 P<0.001 
 
Alix NT Not 
Activated 
NMDAR only 
Activated 
-16.53079%
*
 P<0.001 
NMDA+ Alix NT 
Activated 
-3.29625%
*
 P = 0.007 
 
NMDAR only Not 
Activated 
NMDAR only 
Activated 
-16.06126%
*
 P<0.001 
NMDA+ Alix NT 
Activated 
-2.82672%
*
 P = 0.023 
NMDA+ Alix NT 
Not Activated 
NMDAR only 
Activated -15.12686%
*
 P<0.001 
 
Table 3.8 c:  Anova Analysis of table of statistically significant NMDA cell death by Alix NT. All data points 
correspond to the mean difference of values and statistical significance of cell death between groups. Anova 
analysis was performed using Tukey post-hoc analysis to determine which groups were statistically different 
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from each other. Only statistically significant pairwise comparison is displayed and the values marked with * 
denotes that it is statistically significant at the level 0.05. 
 
 The negative control culture transfected without any DNA and maintained in PSS 
only had a mean of 11.0 ± 0.4% cell death at 6 hours (Figure 3.8 b). The negative control 
without any DNA that was activated with PSS with NMDA (1 mM) and glycine (50 µM) 
had a mean of 10.6 ± 0.3% cell death at 6 hours (Figure 3.8 a). Paired t-test and ANOVA 
analysis shows that the difference between the activated and non activated negative control 
is considered to be not statistically significant. 
In cultures that were transfected with Alix NT subunits alone and maintained in 
PSS, cell death at 6 hours was 9.9 ± 0.5% (Figure 3.8 b). In cultures that were transfected 
with Alix NT subunit alone activated in PSS with NMDA (1 mM) and glycine (50 µM) had 
a mean of 11.4 ± 0.7% cell death at 6 hours (Figure 3.8 a). Paired t-test and ANOVA 
analysis shows that the difference between Alix NT alone activated and not activated is 
considered to be not statistically significant. There was also no statistical significance in 
cell death between cells expressing Alix NT alone and the negative control (without DNA) 
regardless if they were activated or not.  
The positive control culture transfected with GluN1/GluN2A subunits and 
maintained in PSS only had a mean of 10.3 ± 0.4% cell death at 6 hours (Figure 3.8 b). 
Whereas, the positive control of cells expressing GluN1/GluN2A subunits that was 
activated with PSS with NMDA (1 mM) and glycine (50 µM) had a mean of 26.4 ± 0.5% 
cell death at 6 hours (Figure 3.8 a). Treatment with NMDA and glycine significantly 
enhanced cell death. Paired t-test shows that the difference between the positive control 
activated and not activated is considered to be extremely statistically significant with a P 
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value of less than 0.0001 which correlates with the ANOVA analysis significance value of 
P<0.001 (Table 3.8c). 
Transfecting Alix NT with GluN1/GluN2A significantly reduced the percentage of 
dead cells compared with positive control GluN1/GluN2A subunits. The culture transfected 
with Alix NT, GluN1/GluN2A subunits and activated with PSS and NMDA with glycine 
had a mean of 13.2 ± 0.9% cell death at 6 h (Figure 3.8 a).Paired t-test shows that the 
difference between the activated positive control and activated cells expressing Alix NT, 
GluN1, GluN2A is considered to be very statistically significant with a P value of 0.0056 
which correlates with the ANOVA analysis significance value of P<0.001 (Table 3.7c).  
Non-activated Alix NT transfected with GluN1/GluN2A subunits (PSS alone) 
resulted in a mean cell death of 11.3 ± 0.3% cell death at 6 h (Figure 3.8 b). It is a similar 
percent of cell death compared to GluN1/GluN2A subunits that were not activated. Paired 
t-test and ANOVA analysis shows that the difference between the non-activated positive 
control and non-activated cells containing AlixNT, GluN1, GluN2A was considered to be 
not statistically significant. Thus this suggests that the N-terminal region of Alix is not 
responsible for increasing NMDAR triggered cell death in the absence of NMDA/glycine 
(Figure 3.8 b). but surprisingly is able to reduce NMDAR triggered cell death to levels 
similar to negative controls (Figure 3.8 a). 
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3.2.8 Modulation of NMDA cell death by mouse Alix DPRD 
 
Figure 3.9 a: Modulation of NMDA cell death by mouse Alix DPRD. The cells were activated with 
physiological salt solution (PSS) with 1 mM NMDA and 50 µM Glycine. All data points correspond to the 
mean ± SE of values and statistical comparisons of cell death between groups were performed using a 
paired t-test to determine which groups were statistically different from each other. 
 
 
 
 
 
 
 
 
 
 
 93 
 
Table 3.9 a: Percentage cell death after 6 hours following treatment with 1 mM NMDA/ 50 µM Glycine. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
8.8 ± 1.0 3 
2 Alix DPRD/EGFP  
 
10.3 ± 0.5 3 
3 GluN1/GluN2A/EGFP 28.0 ± 0.3 3 
4 GluN1/GluN2A/Alix 
DPRD 
 
20.4 ± 0.6 3 
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Figure 3.9 b: Modulation of NMDA cell death by Alix DPRD. The cells were treated with physiological salt 
solution (PSS) only. All data points correspond to the mean ±  SE of values and statistical comparisons of cell 
death between groups were performed  using a paired t-test to determine which groups were statistically 
different from each other. 
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Table 3.9 b: Percentage cell death after 6 hours following treatment with physiological salt solution (PSS) 
only. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
9.5 ± 1.0 3 
2 Alix DPRD/EGFP  
 
10.4 ± 1.2 3 
3 GluN1/GluN2A/EGFP 10.0 ± 0.5 3 
4 GluN1/GluN2A/Alix 
DPRD 
 
17.5 ± 0.2 3 
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Transfection comparison 
 
Mean Difference Significance 
 
 
Control Activated 
NMDAR only 
Activated 
-19.24538%
*
 P<0.001 
NMDA+ Alix 
DPRD Activated 
-11.58024%
*
 P<0.001 
NMDA+ Alix 
DPRD Not 
Activated 
-8.75617%
*
 P<0.001 
 
 
Alix DPRD 
Activated 
NMDAR only 
Activated 
-17.70330%
*
 P<0.001 
NMDA+ Alix 
DPRD Activated 
-10.03816%
*
 P<0.001 
NMDA+ Alix 
DPRD Not 
Activated 
-7.21409%
*
 P<0.001 
 
 
 
 
 
NMDAR only 
Activated 
Control Activated 19.24538%
*
 P<0.001 
Alix DPRD 
Activated 
17.70330%
*
 P<0.001 
NMDA+ Alix 
DPRD Activated 
7.66514%
*
 P<0.001 
Control Not 
Activated 
18.52615%
*
 P<0.001 
Alix DPRD Not 
Activated 
17.66938%
*
 P<0.001 
NMDAR only Not 
Activated 
18.02639%
*
 P<0.001 
NMDA+ Alix 
DPRD Not 
Activated 
10.48921%
*
 P<0.001 
 
 
 
 
 
NMDA+ Alix 
DPRD Activated 
Control Activated 11.58024%
*
 P<0.001 
Alix DPRD 
Activated 
10.03816%
*
 P<0.001 
NMDAR only 
Activated 
-7.66514%
*
 P<0.001 
Control Not 
Activated 
10.86101%
*
 P<0.001 
Alix DPRD Not 
Activated 
10.00424%
*
 P<0.001 
NMDAR only Not 
Activated 
10.36125%
*
 P<0.001 
 
 
Control Not 
Activated 
NMDAR only 
Activated 
-18.52615%
*
 P<0.001 
NMDA+ Alix 
DPRD Activated 
-10.86101%
*
 P<0.001 
NMDA+ Alix 
DPRD Not 
-8.03694%
*
 P<0.001 
 97 
Activated 
 
 
Alix DPRD Not 
Activated 
NMDAR only 
Activated 
-17.66938%
*
 P<0.001 
NMDA+ Alix 
DPRD Activated 
-10.00424%
*
 P<0.001 
NMDA+ Alix 
DPRD Not 
Activated 
-7.18017%
*
 P<0.001 
 
 
NMDAR only Not 
Activated 
NMDAR only 
Activated 
-18.02639%
*
 P<0.001 
NMDA+ Alix 
DPRD Activated 
-10.36125%
*
 P<0.001 
NMDA+ Alix 
DPRD Not 
Activated 
-7.53718%
*
 P<0.001 
 
 
 
 
NMDA+ Alix 
DPRD Not 
Activated 
Control Activated 
8.75617%
*
 P<0.001 
Alix DPRD 
Activated 7.21409%
*
 P<0.001 
NMDAR only 
Activated 
-10.48921%
*
 P<0.001 
Control Not 
Activated 
8.03694%
*
 P<0.001 
Alix DPRD Not 
Activated 
7.18017%
*
 P<0.001 
NMDAR only Not 
Activated 
7.53718%
*
 P<0.001 
 
Table 3.9 c:  Anova Analysis of table of statistically significant NMDA cell death by Alix DPRD. All data 
points correspond to the mean difference of values and statistical significance of cell death between groups. 
Anova analysis was performed using Tukey post-hoc analysis to determine which groups were statistically 
different from each other. Only statistically significant pairwise comparison is displayed and the values 
marked with * denotes that it is statistically significant at the level 0.05. 
 
The negative control culture transfected without any DNA and maintained in PSS only had 
a mean of 9.5 ± 1.0% cell death at 6 hours (Figure 3.9 b). The negative control without any 
DNA that was activated with PSS with NMDA (1 mM) and glycine (50 µM) had a mean of 
8.8 ± 1.0% cell death at 6 hours (Figure 3.9 a). Paired t-test and ANOVA analysis shows 
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that the difference between the negative control activated and not activated is considered to 
be not statistically significant. 
In cultures that were transfected with mouse Alix DPRD subunits alone and 
maintained in PSS, cell death at 6 hours was 10.4 ± 1.2% (Figure 3.9 b). In cultures that 
were transfected with Alix DPRD subunit alone activated in PSS with NMDA (1 mM) and 
glycine (50 µM) had a mean of 10.3 ± 0.5% cell death at 6 hours (Figure 3.9 a). Paired t-
test and ANOVA analysis shows that the difference between cells expressing mouse Alix 
DPRD alone activated and not activated is considered to be not statistically significant. 
There was also no statistical significance between the cell death observed in cells 
expressing Alix DPRD alone and negative control (without DNA) regardless if it was 
activated or not.   
The positive control culture transfected with GluN1/GluN2A subunits and 
maintained in PSS only had a mean of 10.0 ± 0.5% cell death at 6 hours (Figure 3.9 b). 
Whereas, the positive control GluN1/GluN2A subunits that was activated with PSS with 
NMDA (1 mM) and glycine (50 µM) had a mean of 28.0 ± 0.3% cell death at 6 hours 
(Figure 3.9 a). Treatment with NMDA and glycine significantly enhanced cell death. Paired 
t-test shows that the difference between the positive control activated and not activated is 
considered to be extremely statistically significant with a P value of less than 0.0001 which 
correlates with the ANOVA analysis significance value of P<0.001 (Table 3.9c). 
The cultures transfected with mouse Alix DPRD, GluN1/GluN2A subunits and 
activated with PSS and NMDA with glycine had a mean of 20.4 ± 0.6% cell death at 6 
hours (Figure 3.9 a). The paired t-test shows that the difference between the positive control 
activated and cells expressing Alix DPRD, GluN1 and GluN2A activated is considered to 
be very statistically significant with a P value of 0.0092 which correlates with the ANOVA 
analysis significance value of P<0.001 (Table 3.9c). 
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Cells expressing mouse Alix DPRD transfected with GluN1/GluN2A subunits and 
not activated (PSS alone) also yielded a mean of 17.5 ± 0.2% cell death at 6 hours (Figure 
3.9 b). It is a higher percent of cell death compared to GluN1/GluN2A subunits that were 
not activated. Paired t-test shows that the difference between the positive control not 
activated and cells expressing mouse Alix DPRD, GluN1, GluN2A not activated is 
considered to be very statistically significant with a P value of 0.0073 which also correlates 
with the ANOVA analysis significance value of P<0.001 (Table 3.9c).There is also a T-test 
statistical significance in cell death between activated and non-activated cells expressing 
mouse Alix DPRD, GluN1 and GluN2A (P value of 0.0260) but no significance in the 
ANOVA analysis. Therefore these findings are similar to those seen with the full length 
human and mouse Alix. 
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3.2.9 Modulation of NMDA cell death by mouse Alix NT + CT coexpression 
 Since the Alix-CT mutant replicates some of the observations seen with full length 
human and mouse Alix, we wondered whether the coexpression of both mouse Alix NT 
and Alix CT mutants would fully replicate the observations seen with full length Alix. 
Experiments were performed in the presence of both Alix NT and Alix CT cotransfected 
together. 
 
 
Figure 3.10 a: Modulation of NMDA cell death by mouse Alix NT + CT. The cells were activated with 
physiological salt solution (PSS) with 1 mM NMDA and 50 µM Glycine. All data points correspond to the 
mean ± SE of values and statistical comparisons of cell death between groups were performed using a 
paired t-test to determine which groups were statistically different from each other. 
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Table 3.10 a: Percentage cell death after 6 hours following treatment with 1 mM NMDA/ 50 µM Glycine. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
10.0 ± 0.1 3 
2 Alix NT+ CT /EGFP  
 
10.4 ± 0.6 3 
3 GluN1/GluN2A/EGFP 28.1 ± 0.7 3 
4 GluN1/GluN2A/Alix 
NT+ CT 
 
17.8 ± 1.1 3 
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Figure 3.10 b: Modulation of NMDA cell death by mouse Alix NT + CT. The cells were treated with 
physiological salt solution (PSS) only. All data points correspond to the mean ±  SE of values and statistical 
comparisons of cell death between groups were performed using a paired t-test to determine which groups 
were statistically different from each other. 
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Table 3.10 b: Percentage cell death after 6 hours following treatment with physiological salt solution (PSS) 
only. 
 
Column Transfection Percentage cell 
death ± SEM (%) 
Sample size (n) 
1 Lipofectamine only 
 
 10.1 ± 0.4 3 
2 Alix NT+ CT /EGFP  
 
10.6 ± 0.9 3 
3 GluN1/GluN2A/EGFP 9.4 ± 0.9 3 
4 GluN1/GluN2A/Alix 
NT+ CT 
 
16.3 ± 0.4 3 
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Transfection comparison 
 
Mean Difference Significance 
 
 
Control Activated 
NMDAR only 
Activated  
-18.07109%
*
 
P<0.001 
NMDA+ Alix 
CTNT Activated 
-7.81250%
*
 
P<0.001 
NMDA+ Alix 
CTNT Not 
Activated 
-6.27950%
*
 P<0.001 
 
 
Alix CTNT 
Activated 
NMDAR only 
Activated 
-17.65998%
*
 
P<0.001 
NMDA+ Alix 
CTNT Activated 
-7.40139%
*
 
P<0.001 
NMDA+ Alix 
CTNT Not 
Activated 
-5.86838%
*
 
P<0.001 
 
 
 
 
 
NMDAR only 
Activated 
Control Activated 18.07109%
*
 P<0.001 
Alix CTNT 
Activated 
17.65998%
*
 
P<0.001 
NMDA+ Alix 
CTNT Activated 
10.25859%
*
 
P<0.001 
Control Not 
Activated 
17.98095%
*
 
P<0.001 
Alix CTNT Not 
Activated 
17.47326%
*
 
P<0.001 
NMDAR only Not 
Activated 
18.71470%
*
 
P<0.001 
NMDA+ Alix 
CTNT Not 
Activated 
11.79159%
*
 
P<0.001 
 
 
 
 
 
NMDA+ Alix 
CTNT Activated 
Control Activated 7.81250%
*
 P<0.001 
Alix CTNT 
Activated 
7.40139%
*
 
P<0.001 
NMDAR only 
Activated 
-10.25859%
*
 
P<0.001 
Control Not 
Activated 
7.72236%
*
 
P<0.001 
Alix CTNT Not 
Activated 
7.21467%
*
 
P<0.001 
NMDAR only Not 
Activated 
8.45611%
*
 
P<0.001 
 
 
Control Not 
Activated 
NMDAR only 
Activated 
-17.98095%
*
 
P<0.001 
NMDA+ Alix 
CTNT Activated 
-7.72236%
*
 
P<0.001 
NMDA+ Alix 
CTNT Not 
-6.18935%
*
 
P<0.001 
 105 
Activated 
 
 
Alix CTNT Not 
Activated 
NMDAR only 
Activated 
-17.47326%
*
 
P<0.001 
NMDA+ Alix 
CTNT Activated 
-7.21467%
*
 
P<0.001 
NMDA+ Alix 
CTNT Not 
Activated 
-5.68166%
*
 P = 0.001 
 
 
NMDAR only Not 
Activated 
NMDAR only 
Activated 
-18.71470%
*
 
P<0.001 
NMDA+ Alix 
CTNT Activated 
-8.45611%
*
 
P<0.001 
NMDA+ Alix 
CTNT Not 
Activated 
-6.92311%
*
 
P<0.001 
 
 
 
 
NMDA+ Alix 
CTNT Not 
Activated 
Control Activated 
6.27950%
*
 
P<0.001 
Alix CTNT 
Activated 5.86838%
*
 
P<0.001 
NMDAR only 
Activated 
-11.79159%
*
 
P<0.001 
Control Not 
Activated 
6.18935%
*
 
P<0.001 
Alix CTNT Not 
Activated 
5.68166%
*
 P = 0.001 
NMDAR only Not 
Activated 
6.92311%
*
 P<0.001 
 
Table 3.10 c:  Anova Analysis of table of statistically significant NMDA cell death by Alix CTNT. All data 
points correspond to the mean difference of values and statistical significance of cell death between groups. 
Anova analysis was performed using Tukey post-hoc analysis to determine which groups were statistically 
different from each other. The values marked with * denotes that it is statistically significant at the level 0.05. 
 
The negative control culture transfected without any DNA and maintained in PSS 
only had a mean of 10.1 ± 0.4% cell death at 6 hours (Figure 3.10 b). The negative control 
without any DNA that was activated with PSS with NMDA (1 mM) and glycine (50 µM) 
had a mean of 10.0 ± 0.1% cell death at 6 hours (Figure 3.10 a). Paired t-test and ANOVA 
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analysis shows that the difference between the negative control activated and not activated 
is considered to be not statistically significant. 
In cultures that were transfected with mouse Alix NT + CT subunits alone and 
maintained in PSS, cell death at 6 hours was 10.6 ± 0.9% (Figure 3.10 b). In cultures that 
were transfected with mouse Alix NT + CT subunit alone activated in PSS with NMDA 
(1 mM) and glycine (50 µM) had a mean of 10.4 ± 0.6% cell death at 6 hours (Figure 3.10 
a). Paired t-test and ANOVA analysis shows that the difference between mouse Alix NT + 
CT alone activated and not activated is considered to be not statistically significant. There 
was also no statistical significance between cell death observed in cells expressing mouse 
Alix NT + CT and the negative control (without DNA) regardless if they were activated or 
not.  
The positive control culture transfected with GluN1/GluN2A subunits and 
maintained in PSS only had a mean of 9.4 ± 0.9% cell death at 6 hours (Figure 3.10 b). 
Whereas, the positive control GluN1/GluN2A subunits that was activated with PSS with 
NMDA (1 mM) and glycine (50 µM) had a mean of 28.1 ± 0.7% cell death at 6 hours 
(Figure 3.10 a). Treatment with NMDA and glycine significantly enhanced cell death. 
Paired t-test shows that the difference between the positive control activated and not 
activated is considered to be extremely statistically significant with a P value of less than 
0.0001 which correlates with the ANOVA analysis significance value of P<0.001 (Table 
3.10c). 
The culture transfected with mouse Alix NT + CT, GluN1/GluN2A subunits and 
activated with PSS and NMDA with glycine had a mean of 17.8 ± 1.1% cell death at 6 
hours (Figure 3.10 a). Paired t-test shows that the difference between the positive control 
activated and mouse Alix NT + CT, GluN1, GluN2A activated is considered to be 
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statistically significant with a P value of 0.0163 which correlates with the ANOVA analysis 
significance value of P<0.001 (Table 3.10c).  
Cells expressing mouse Alix NT + CT transfected with GluN1/GluN2A subunits 
and not activated (PSS alone) also yielded a mean cell death  of 16.3 ± 0.4% cell death at 6 
hours (Figure 3.10 b). It is a higher percentage of cell death compared to GluN1/GluN2A 
subunits that were not activated. Paired t-test shows that the difference between the positive 
control not activated and cells expressing AlixNT + CT, GluN1, GluN2A not activated is 
considered to be very statistically significant with a P value of 0.0079 which also correlates 
with the ANOVA analysis significance value of P<0.001 (Table 3.10c). There was however 
no statistical significance in cell death between activated and non-activated cells expressing 
mouse Alix NT + CT, GluN1, GluN2A ( P value of 0.3681) in both the T-test and ANOVA 
analysis. Therefore the results of the Alix NT +Alix CT coexpressed show similar results to 
the effects seen with Alix CT transfected alone. 
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3.3 Summary 
 We speculate that Alix may affect NMDAR triggered cell, where transfecting Alix 
with GluN1/GluN2A and activation with NMDA/glycine significantly reduces the 
percentage of dead cells compared with the activated positive control (Figure 3.1). 
However in the absence of NMDAR activation, Alix + NMDAR expressing cells displayed 
a significantly higher level of cell death compared to other non activated (PSS only) 
controls. We tried to validate our findings by doing a number of control experiments such 
as repeating the cell death assay with Alix and GluN1 or Alix with GluN2A alone. Here we 
found that there was no significant cell death compared to the negative control (Figure 3.2). 
This also acted as a control for any cell death specific effects which may be caused by 
different cDNA plasmid vectors. We also repeated the NMDA cell death assay with AP5 to 
block NMDA triggered calcium influx to see if Alix increased cell death requires NMDAR 
activation (Figure 3.3) and found that we abolish the high percentage of cell death caused 
by Alix and NMDAR. We then tried to modulate the concentration of NMDA (10 µM, 100 
µM, 300 µM and 700 µM) in the PSS buffer in activated assay to see if this affected the 
cell death caused by Alix (Figure 3.4). We observed that by gradually increasing the 
NMDA concentration, we also increased cell death caused by activation of NMDARs. 
However, the addition of Alix in cells expressing NMDARs seems to cause a high amount 
of cell death even at a low concentration of NMDA (10 µM) (Figure 3.4grey circles) 
compared to the cell death seen with NMDAR alone at 10 µM NMDA(Figure 3.4 black 
squares). This suggests that low concentrations of glutamate and glycine in the cell media 
could cause a high level of cell death when we express Alix with NMDAR and be 
responsible for the higher levels of cell death seen in the non activated (PSS only) cell 
death assay. The NMDA EC50s calculated from the partial dose-response curves also 
supported this observation. We found that all of the Alix mouse variants used (Figure 3.6, 
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3.7, 3.8 and 3.9), generally showed a similar pattern of cell death, where Alix with 
NMDAR transfection significantly reduces the toxicity associated with NMDA receptor 
stimulation when activated, but seems to enhance cell death when not activated, as seen by 
the human Alix variant (Figure 3.1) except the Alix NT variant (Figure 3.8). This finding is 
quite interesting as it pinpoints the cause of the increased cell death in the absence of 
activation when Alix is expressed with NMDAR to the C terminal region of the protein.  
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4. Investigating the protein expression of recombinant Alix and GluN1 in 
cotransfected HEK293 cells and brain lysates/neuronal fractions: 
4.1 Introduction: 
In the previous chapter our data indicated that recombinant human Alix transfected 
together with GluN1/GluN2A NMDAR subunits influences NMDAR cell death. From 
Figure 3.1 a, transfecting Alix with GluN1/GluN2A significantly reduced the percentage of 
dead cells compared with cells expressing GluN1/GluN2A subunits and activated with 
NMDA. These data indicate that recombinant Alix, GluN1/GluN2A transfection 
significantly reduced the toxicity associated with NMDA receptor activation compared to 
GluN1/GluN2A only cells but enhanced the basal level of cell death when not activated by 
NMDA. However, the level of cell death in the presence of Alix was similar in activated 
(NMDA+glycine) or non activated (PSS only) conditions. 
In this chapter we examined the specificity of antibodies raised against Alix and 
GluN1 on recombinant protein expressed in HEK293 cells and once we confirmed their 
specificity examined the protein expression of endogenous Alix and GluN1 in rat brain 
lysates and neuronal fractions. We also observed if there was any correlation between the 
modulation of NMDAR activity by Alix in the cell death assay and protein expression 
levels of Alix and GluN1 subunits. The protein expression of Alix and GluN1 was 
evaluated by transient transfection of HEK 293 cells with Alix and GluN1/ GluN2A 
subunit cDNAs in different combinations following Table 3.1 a, b and then lysed for 
protein extraction and western blotting.  
We also substantiated the presence of Alix expression in the brain which we alluded 
to in the introduction. This was done by detection of Alix in whole rat adult and embryo 
brain lysates and subcellular neuronal fractions such as synaptosomes, light membrane and 
mitochondria. 
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4.2 Western Blotting Analysis Alix Modification of NMDA 
Full length expression of Alix (96kDa) was confirmed using a mouse anti-Alix 
antibody in both the Alix alone and Alix and GluN1/GluN2A subunit cotransfections in 
both activated and non activated HEK293 cells (Figure 4.1a and b). The protein bands 
showed little degradation and no signal was detected in cell lysates from the lipofectamine 
only negative control. Both lipofectamine only controls maintained in PSS only or 
activated with NMDA (1 mM) and glycine (50 µM) had a mean protein expression of 0.08 
± 0.05 or 0.09 ± 0.03 respectively. In cultures that were transfected with Alix cDNA and 
EGFP only and maintained in PSS, Alix protein expression was significantly higher (2.39 ± 
0.88)(Figure 4.1b). In cultures that were transfected with EGFP-Alix cDNA only and 
activated in PSS with NMDA (1 mM) and glycine (50 µM) had a mean protein expression 
of 3.77 ± 0.55 (Figure 4.1a). Paired T test showed that the difference between activated and 
not activated Alix only was statistically insignificant with a P value of 0.40. 
The cultures transfected with Alix, GluN1/GluN2A subunits and activated with PSS 
and NMDA with glycine had a mean protein expression of 0.99 ± 0.23 (Figure 4.1a). Non 
activated cells transfected with Alix and GluN1/GluN2A subunits yielded a mean protein 
expression of 0.84 ± 0.18 (Figure 4.1b). The results indicate that there is little difference 
between the protein expression of Alix in activated and non-activated cells expressing Alix, 
GluN1, GluN2A. Paired T test was found to be not statistically significant with a P value of 
0.61. 
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Figure 4.1: Protein expression of Alix protein in Alix/NMDAR cotransfected cells. BLUE wide range 
prestained protein ladder was used and an additional nonspecific band was detected by the Alix antibody at 
approximately 80 kD. This was used as an internal loading control and used to normalise expression levels 
within each lane. Additional controls include HEK293 cells transfected without cDNA, Alix only cells were 
transfected with 1 µg Alix and 2 µg EGFP and Alix +NMDARs cells were transfected with 1 µg Alix, 1 µg 
GluN1 and 1 µg GluN2A subunits ( as Chapter 3.2.1). Lanes: M, protein marker lane (kD), C, control, A, 
Alix only, A+N, Alix + NMDARs,. 
 
Figure 4.1a: Normalised activated Alix protein expression following transient transfection, protein extraction 
and western blotting (n = 4). Protein expression was normalised to the levels of the control protein band 
detected by the Alix antibody. 
                    ACTIVATED           NON ACTIVATED 
  235 
  130 
   93 
   70 
   53 
        M      C      A     A+N           C      A    A+N    
 
Alix 
Control band 
 113 
 
Figure 4.1b: Normalised not activated Alix protein expression following transient transfection, protein 
extraction and western blotting (n = 4). Protein expression was normalised to the levels of the control protein 
band detected by the Alix antibody. 
 
Table 4.1: Normalised Alix expression levels from Figures 4.1 a and b with all data points corresponding to 
the mean normalised expression ± SEM. 
 
 
Figure  4.1 a Transfection Normalised expression ± SEM 
Lane 1 Lipofectamine only 
 
0.09 ± 0.03 
Lane 2 Alix/EGFP only 
 
3.77 ± 0.55 
Lane 3 GluN1/GluN2A/Alix 
 
0.99 ± 0.23 
Figure 4.1 b Transfection Normalised expression ± SEM 
Lane 1 Lipofectamine only 
 
0.08 ± 0.05 
Lane 2 Alix/EGFP only 
 
2.39 ± 0.88 
 
Lane 3 GluN1/GluN2A/Alix 
 
0.84 ± 0.18 
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4.3 Western Blotting Analysis of GluN1 subunit expression in Alix cotransfected cells 
Full length expression of GluN1 (108kDa) was confirmed using a mouse anti-
NMDAR1 antibody in both the NMDAR only and Alix and GluN1/GluN2A subunit in 
both activated and non activated HEK293 cells (Figures 4.2a and b). The bands showed 
little degradation and no GluN1 signal was detected in the negative control that was 
transfected with only lipofectamine. 
Both lipofectamine only controls in the presence of PSS or NMDA (1 mM) and 
glycine (50 µM) had mean expression of 0.06 ± 0.05 or 0.15 ± 0.08 respectively (Figure 4.2 
b and a respectively). In cultures that were transfected with GluN1/GluN2A only and 
maintained in PSS, GluN1 protein expression was 1.46 ± 0.64 (Figure 4.2 b). In cultures 
that were transfected with GluN1/GluN2A only and activated in PSS with NMDA (1 mM) 
and glycine (50 µM) had a mean protein expression of 1.33 ± 0.75 (Figure 4.2 a). This 
indicates that treatment with NMDA and glycine does not affect GluN1 expression levels 
and this was supported by a paired T test with a P value of 0.90 for both activated and non 
activated GluN1/GluN2A only cultures.  
In cultures transfected with Alix, GluN1/GluN2A subunits and activated with PSS 
and NMDA with glycine had a mean GluN1 protein expression of 1.74 ± 0.42 (Figure 4.2 
a). Non activated cells transfected with Alix and GluN1/GluN2A subunits yielded a mean 
expression of 0.87 ± 0.38 (Figure 4.2 b). We found that the difference between activated 
and not activated protein expression was not considered statistically significant with a P 
value of 0.38 from the paired T-test. 
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Figure 4.2: Western Analysis of GluN1 expression when cotransfected with Alix. BLUE wide range 
prestained protein ladder was used and actin was used as the loading control. Controls are HEK293 culture 
transfected without any DNA, NMDAR only are HEK293 culture transfected with 1 µg GluN1, 1 µg GluN2A 
and 1 µg EGFP subunits and Alix +NMDARs are HEK293 culture transfected with 1 µg Alix, 1 µg GluN1 
and 1 µg GluN2A subunits (as Chapter 3.2.1). Lanes: M, protein marker lane (kD), C, control, A, Alix only, 
A+N, Alix + NMDARs. 
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Figure 4.2a: Normalised protein expression of activated GluN1  following transient transfection, protein 
extraction and western blotting (n = 3). GluN1 expressed was normalised to the actin loading control. 
 
Figure 4.2b: Normalised protein expression of non activated GluN1 following transient transfection, protein 
extraction and western blotting (n = 3). GluN1 expressed was normalised to the actin loading control. 
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Table 4.2: Normalised  protein levels of GluN1 from Figures 4.2a and b with all data points corresponding to 
the mean ± SEM. 
 
4.4 Western Blotting Analysis of Alix in Neuronal Fraction 
 
After checking the specificity of our Alix and GluN1 antibodies, we examined the 
expression of Alix in whole adult and embryo brain as well as neuronal fractions including 
synaptosomes, light membrane, myelin and mitochondria fractions. Unfortunately the 
myelin fraction which contains the insulating sheath that forms a layer around the axon of 
the neuron was too smeary to be able to detect a specific band. Full length expression of 
Alix (96kDa) was detected using a mouse anti-Alix antibody and the bands showed little 
degradation (Figure 4.3). 
  The whole brain from embryo had a mean protein expression of 0.15 ± 0.04. The 
expression of Alix in whole embryo brain seems comparatively quite low compared to the 
neuronal fractions. Whereas the whole adult brain had a slightly higher mean protein 
density of 0.29 ± 0.04. Synaptosome fractions showed the highest mean protein expression 
      Graph 4.2 a Transfection Normalised expression ±SEM 
       Lane 1 Lipofectamine only 0.15 ± 0.08 
       Lane 2 GluN1/GluN2A only 
 
1.33 ± 0.75 
       Lane 3 GluN1/GluN2A/Alix 
 
1.74 ± 0.42 
      Graph 4.2 b Transfection Normalised expression ±SEM 
       Lane 1 Lipofectamine only 
 
0.06 ± 0.05 
       Lane 2 GluN1/GluN2A only 
 
1.46 ± 0.64 
       Lane 3 GluN1/GluN2A/Alix 
 
0.87 ± 0.38 
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of 1.52 ± 0.03. The mitochondria had a mean protein expression of 0.61 ± 0.11. The light 
membrane had a mean protein expression of 0.62 ± 0.13. 
Paired T test was not statistically significant for embryo compared with whole 
adult, mitochondria and light membrane fractions with a P value of 0.22, 0.096 and 0.11 
respectively. However, paired T test was very statistically significant for differences 
between whole adult brain extract and the synaptosome fraction with a P value of 0.0022 as 
well as between embryo extract and synaptosome fraction with a P value of 0.0019. These 
results indicate that although Alix is expressed at relatively low levels throughout the brain. 
Alix can be found at high levels within the synaptosome fraction and suggest that they are 
predominately localised to synaptic sites within the neuron. Why this is the case we are not 
sure, but it is possible for microvesicles released into the intercellular space with some 
protein markers of exosomes such as Alix that are transferred between cells (Guescini et al, 
2010) 
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Figure 4.3: Protein expression of Alix detected in whole rat adult and embryo brain lysates and neuronal 
fractions such as synaptosome, light membrane and mitochondria. BLUE wide range prestained protein 
ladder was used and actin was used as the loading control. Lanes: M, Protein marker (kD), Syn, synaptosome 
extract, LM, Light membrane, Myl, myelin, Mito, mitochondria, Ad, adult whole brain, Em, embryo whole 
brain. 
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Figure 4.3a: Protein expression from n of 1 that was repeated 3 times against Alix from whole adult rat, 
embryo, synaptosome, light membrane and mitochondria. Protein levels were normalised using actin as a 
loading control. 
 
Column Protein sample Normalised expression ± SEM 
1 Embryo 0.15 ± 0.04 
2 Adult 
 
0.29 ± 0.04 
3 Synaptosome 
 
1.52 ± 0.03 
4 Mitochondria 
 
0.61 ± 0.11 
5 Light Membrane 
 
0.62 ± 0.13 
 
Table 4.3: Protein expression of Alix from brain lysates and neuronal fractions in Figure 4.3a with all data 
points corresponding to the mean ± SEM. 
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4.5 Western Blotting Analysis of GluN1 in Neuronal Fraction 
 
We also detected GluN1 protein expression in whole adult and embryo brain as well 
as synaptosome, light membrane, myelin and mitochondria fractions. Unfortunately like the 
Alix blot the Myelin fraction in the GluN1 blot was also too smeary to detect a distinct 
protein signal. Full length expression of GluN1 (108kDa) was detected using mouse anti-
NMDAR1 antibody and the bands showed little degradation and actin was used as the 
loading control (Figure 4.4). 
  The whole brain from embryo had a mean protein expression of 0.53 ± 0.46. The 
whole adult brain had a slightly higher mean protein expression of 0.71 ± 0.62. 
Synaptosome fractions showed a mean protein expression of 1.38 ± 0.22. The mitochondria 
fraction showed the highest expression with a mean protein expression of 1.97 ± 0.28. The 
light membrane had a mean protein expression of 0.40 ± 0.15 (Figure 4.4). Paired T test 
was not statistically significant for embryo compared with whole adult, synaptosome and 
light membrane fractions with a P value of 0.22, 0.12 and 0.72 respectively. However, 
paired T test was statistically significant for differences between embryo extract and 
mitochondria fraction with a P value of 0.018. Conversely, paired T test was not 
statistically significant for whole adult compared with all the protein extract including 
embryo, synaptosome, mitochondria and light membrane fractions with a P value of 0.22, 
0.29, 0.07 and 0.58 respectively. These results suggest that GluN1 is expressed at a higher 
level within the mitochondria fraction in the embryo. 
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Figure 4.4: Protein expression of GluN1 in whole rat adult and embryo brain lysates and some of the neuronal 
fractions such as synaptosome, light membrane and mitochondria. BLUE wide range prestained protein 
ladder was used and Actin was used as the loading control. Lanes: Protein marker (kD), Syn, synaptosome 
extract, LM, Light membrane, Myl, myelin, Mito, mitochondria, Ad, adult whole brain, Em, embryo whole 
brain. 
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Figure 4.4a: Protein expression from n of 1 that was repeated 3 times against GluN1 from rat adult brain, 
embryo, synaptosome, light membrane and mitochondria. Protein levels were normalised to actin. 
 
Column Protein sample Normalised expression ± SEM  
1 Embryo 0.53 ± 0.46 
2 Adult 
 
0.71 ± 0.62 
3 Synaptosome 
 
1.38 ± 0.22 
4 Mitochondria 
 
1.97 ± 0.28 
5 Light Membrane 
 
0.40 ± 0.15 
 
Table 4.4: Protein expression levels from Figure 4.4a with all data points corresponding to the mean ± SEM. 
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4.6 Summary 
 
The analysis of Alix protein expression in NMDAR modification was performed 
and we established that both lipofectamine only controls maintained in PSS only or 
activated with NMDA (1 mM) and glycine (50 µM) had a mean protein expression of 0.08 
± 0.05 or 0.09 ± 0.03 respectively. Alix protein expression in Alix cDNA only and 
maintained in PSS was 2.39 ± 0.88 (Figure 4.1b) whereas Alix cDNA only and activated 
had a mean protein expression of 3.77 ± 0.55 (Figure 4.1a). Paired T test showed that the 
difference between activated and not activated for Alix only was statistically insignificant 
with a P value of 0.40. Alix and GluN1/GluN2A that was activated had a mean protein 
expression of 0.99 ± 0.23 (Figure 4.1a) while non activated of Alix and GluN1/GluN2A 
yielded a mean protein expression of 0.84 ± 0.18 (Figure 4.1b). Paired T test was found to 
be not statistically significant with a P value of 0.61 which indicate that there is little 
difference between both conditions. 
We also analysed GluN1 subunit expression in Alix cotransfected cells. We 
established that lipofectamine only controls in the presence of PSS or NMDA (1 mM) and 
glycine (50 µM) had mean expression of 0.06 ± 0.05 or 0.15 ± 0.08 respectively (Figure 4.2 
b and a respectively). Protein expression of GluN1/GluN2A only and maintained in PSS 
was 1.46 ± 0.64 (Figure 4.2 b) while protein expression of GluN1/GluN2A only and 
activated was 1.33 ± 0.75 (Figure 4.2 a). Paired T test was found to be not statistically 
significant with a P value of 0.90 for both activated and non activated GluN1/GluN2A only 
cultures. Protein expression of Alix, GluN1/GluN2A subunits and activated was 1.74 ± 
0.42 (Figure 4.2 a) while protein expression of Alix and GluN1/GluN2A and maintained in 
PSS was 0.87 ± 0.38 (Figure 4.2 b). The difference was not considered statistically 
significant with a P value of 0.38 from the paired T-test. 
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We then examined the expression of Alix in whole adult and embryo brain as well 
as neuronal fractions including synaptosomes, light membrane, myelin and mitochondria 
fractions. We ascertained that the mean protein expression of whole embryo, whole adult, 
synaptosome, mitochondria and light membrane was each 0.15 ± 0.04, 0.29 ± 0.04, 1.52 ± 
0.03, 0.61 ± 0.11 and 0.62 ± 0.13 respectively. Paired T test was not statistically significant 
for embryo compared with whole adult, mitochondria and light membrane fractions with a 
P value of 0.22, 0.096 and 0.11 respectively. However, paired T test was very statistically 
significant for differences between whole adult brain extract and the synaptosome fraction 
with a P value of 0.0022 as well as between embryo extract and synaptosome fraction with 
a P value of 0.0019. The results points to the fact that Alix might be expressed at higher 
level within the synaptosome fraction. 
We also detected GluN1 protein expression in embryo brain, whole adult, 
synaptosome, mitochondria and light membrane fractions. Each had a mean protein 
expression of 0.53 ± 0.46, 0.71 ± 0.62, 1.38 ± 0.22, 1.97 ± 0.28 and 0.40 ± 0.15 
respectively (Figure 4.4). Paired T test was not statistically significant for embryo 
compared with whole adult, synaptosome and light membrane fractions with a P value of 
0.22, 0.12 and 0.72 respectively, however, paired T test was statistically significant for 
differences between embryo extract and mitochondria fraction with a P value of 0.018. 
Conversely, paired T test was not statistically significant for whole adult compared with all 
the protein extract including embryo, synaptosome, mitochodria and light membrane 
fractions with a P value of 0.22, 0.29, 0.07 and 0.58 respectively. These results suggest that 
GluN1 is expressed at relatively low levels throughout the whole brain extracts but is 
expressed at a higher level within the mitochondria fraction in the embryo. Relatively high 
levels of GluN1 (compared to whole brain extracts) where detected but the differences 
were not shown to be statistically significant. 
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5. Investigating Alix localization in cotransfected HEK293 cells: 
5.1 Introduction: 
 Fluorescence microscopy is a powerful tool because in its simplest application, 
fluorescence can be used to mark the presence or location of proteins (Giepmans et al., 
2006). For instance, a fluorescently-labelled protein can be localized to sub-cellular 
compartments, such as the dendrites or axons of neurons, or intracellular compartments, 
such as the endoplasmic reticulum or nucleus (Taraska and Zagotta, 2010). If two proteins 
interact in a complex, they both should be localized to the same region of a cell for 
example when two differently labelled proteins overlap, then the proteins are likely in the 
same subcellular neighbourhood (Patel et al., 2007).  
 In the previous chapter, Western blot analysis displayed the presence of Alix 
protein in both transiently transfected HEK293 cells as well as in crude protein extracts 
from rat embryo and adult brain. Our Western blot analysis indicated that lower 
concentrations of protein were detected when recombinant human Alix was transfected in 
HEK293 cells together with GluN1/GluN2A NMDAR subunits than in cells expressing 
Alix alone in both activated and non activated cells (Figure 4.1). Whereas, these changes 
were not observed for GluN1 expression under similar conditions (Figure 4.2). 
 In this chapter, we investigated firstly the cellular localisation of fluorescently 
labelled Alix in transfected HEK293 cells using fluorescent microscopy and 
immunocytochemistry. 
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5.2 Localisation of Alix in HEK293 cells  
 To determine the localisation of Alix in the HEK293 cells we transfected the cells 
following the protocol previously described in chapter 2.2.5, fixed and stained the cells 
with the appropriate antibodies or markers (chapter 3.2.1) before visualization under 
fluorescent microscopy. This will allow us to identify the presence of fluorescently labelled 
Alix and examine its cellular distribution and whether NMDAR activation induces any 
change in Alix cellular localisation. 
 
5.2.1 Expression of Alix within the cytoplasm 
 Alix expression was examined in the presence of Hoechst dye, which is known to 
specifically stain for the nucleus by binding to DNA in live or fixed cells  (Bonde et al., 
2002). Alix expression was detected by GFP fluorescence was detected as a blue signal 
from the Hoechst dye (Figures 5.1 and 5.3). 
Fluorescence images of Alix in HEK293 cells (Figures 5.1 and 5.3) revealed overall 
heterogeneous fluorescence within the cytoplasm and as expected Hoechst stained mainly 
in the nuclei. From the images there was little overlap between Alix and Hoechst signals. 
However, to confirm this we performed a Colocalization Scatter Plot (Figures 5.2 and 5.4). 
In the Scatter plot, pure blue and pure green pixels are coloured as such to correspond to 
Hoechst and Alix respectively. The degree of colocalization is determined by dispersion of 
the pixels in the plot, where the pixels tend to cluster more towards the axes of the plot in 
poorly colocalized staining. Whereas, if colocalized pixels are present, they appear as 
purple pixels and cluster towards the middle of the plot depending on the degree of 
colocalization (Sedarat et al., 2004). Colour scatter plots of Alix and Hoechst in HEK293 
cells revealed a mostly uncorrelated plot that is more clustered towards the x and y-axes 
and further proven by a low Pearson’s correlation value below 0.100 (n=3). 
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Figure 5.1 Intracellular distribution of Alix in three HEK293 cells transiently transfected with EGFP tagged 
Alix, following fixation and permeabilisation and treatment with Hoechst. Green fluorescence denotes Alix 
expression while blue corresponds to Hoechst stained nuclei. Fluorescence images of Alix transfected 
HEK293 cells (Panel A) reveal fluorescence within the cytoplasm of the cells but little expression within the 
nucleus. Panel B shows nuclear labelling with Hoescht and Panel C shows the merged image of Panel A and 
B. Scale Bar: 10 μm. 
A B 
C 
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Figure 5.2 Colocalisation analysis from images shown in Figure 5.1. Green pixels denotes Alix  expression 
while blue pixels corresponds to Hoechst. The Pearson’s Correlation value that denotes the degree of overlap 
between the pixels within this image pair, calculated a minimal overlap of 0.097. 
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Figure 5.3 Intracellular distribution of Alix in a larger cluster of HEK293 cells transiently transfected with 
EGFP tagged Alix, following fixation and permeabilisation and treatment with Hoechst. Green fluorescence 
denotes Alix expression while blue corresponds to Hoechst stained nuclei. Fluorescence images of Alix 
transfected HEK293 cells (Panel A) reveal fluorescence within the cytoplasm of the cells but little expression 
within the nucleus. Panel B shows nuclear labelling with Hoescht and Panel C shows the merged image of 
Panel A and B. Scale Bar: 10 μm. 
 
A B 
C 
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Figure 5.4 Colocalisation analysis from images shown in Figure 5.3. Green pixels denotes Alix  expression 
while blue pixels corresponds to Hoechst signals. The Pearson’s Correlation value that denotes the degree of 
overlap between pixels within this image pair, calculated a minimal overlap of -0.217. 
  
 
 
 
 
 
 
 
 
 132 
5.2.2 Alix distribution and cellular endosome marker localisation 
 There is evidence that Alix has plays some involvement in ESCRT (endosomal 
sorting complex required for transport) (Trioulier et al., 2004; Ohkouchi et al., 2004) and 
given the Alix staining observed in Figure 5.1 and 5.3, we wanted to observe if there was 
any correlation between Alix expression and the endosome marker EEA1. We transiently 
transfected Alix, fixed and permeabilised the transfected cells and treated with primary 
antibodies against EEA1 and stained with Hoechst (Figure 5.5 and 5.7). 
 As before, fluorescence images of Alix revealed green fluorescence within the 
cytoplasm of the cells and as expected Hoechst stained mainly the nuclei. Staining with 
EEA1 revealed a punctate pattern consistent with cytoplasmic distribution within  
endosomes (Wilson et al., 2000). From the images there was little overlap between Alix 
and EEA1 signals. However, to confirm this we performed a Colocalization Scatter Plot 
(Figures 5.6 and 5.8). In the Scatter plot, pure red and pure green are coloured as such to 
correspond to EEA1 and Alix respectively. The degree of colocalization is determined by 
dispersion of the pixels in the plot. The colour Scatter plot of Alix and EEA1 in HEK293 
cells revealed more variable correlation plots (Figures 5.6 and 5.8) with varying degrees of 
scatter pattern spread all over within the correlation plots. The mean Pearson’s Correlation 
value of 0.252 (n =3) indicates that the correlation between both Alix and EEA1 expression 
patterns is weak. 
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Figure 5.5 Intracellular distribution of Alix in a group of isolated HEK293 cells transiently transfected with 
EGFP tagged Alix, following fixation and permeabilisation, exposure to primary antibodies against EEA1 
and treatment with Hoechst. Green fluorescence images of Alix transfected HEK293 cells (Panel A) reveal 
expression within the cell cytoplasm. Expression of EEA1 (Panel B) reveals a punctuate staining pattern 
consistent with cytoplasmic distribution of endosomes. Panel C shows nuclear labelling with Hoescht and 
Panel D shows the merged image of Panel A, B and C. Green expression denotes Alix fluorescence, red as 
EEA1 and blue corresponds to Hoechst stained nuclei. Scale Bar: 10 μM. 
A 
D 
B 
C 
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Figure 5.6 Colocalisation analysis from images shown in Figure 5.5. Green pixels denotes Alix, while red 
pixels corresponds to EEA1. The Pearson’s Correlation value that denotes the degree of overlap between the 
pixels within this image pair, calculated a minimal overlap of 0.487. 
 
 
 
 
 135 
      
      
Figure 5.7 Intracellular distribution of Alix in a cluster of HEK293 cells transiently transfected with EGFP 
tagged Alix, following fixation and permeabilisation, exposure to primary antibodies against EEA1 and 
treatment with Hoechst. Green fluorescence images of Alix transfected HEK293 cells (Panel A) reveal 
expression within the cell cytoplasm. Expression of EEA1 (Panel B) reveals a punctuate staining pattern 
consistent with cytoplasmic distribution of endosomes. Panel C shows nuclear labelling with Hoescht and 
Panel D shows the merged image of Panel A, B and C. Green expression denotes Alix fluorescence, red as 
EEA1 and blue corresponds to Hoechst stained nuclei. Scale Bar: 10 μm. 
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 Figure 5.8 Colocalisation analysis from images shown in Figure 5.7. Green pixels denotes Alix, while red 
pixels corresponds to EEA1. The Pearson’s Correlation value that denotes the degree of overlap between the 
pixels within this image pair, calculated a minimal overlap of 0.163. 
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5.2.3 Alix distribution and the cytoskeleton 
 In view of our finding of Alix’s cytoplasmic localization within HEK293 cells 
(Figure 5.1 and 5.3), we examined if Alix is associated with the cytoskeleton. In order to 
investigate this we transiently transfected EGFP tagged Alix and stained the cells with 
phalloidin and Hoechst. Phalloidin staining is known display a cytoskeletal staining pattern 
consistent with F actin distribution (Pu et al., 2011). 
 Staining with phalloidin revealed a cytoskeletal staining pattern (Figures 5.9 and 
5.11). From visual inspection of the images, there was no clear overlap btween Alix and 
phalloidin signals. However, to confirm this we did a Colocalization Scatter Plot (Figures 
5.10 and 5.12). In the scatter plot, pure red and pure green are coloured as such to 
correspond to phalloidin and Alix respectively. Degree of colocalization is determined by 
dispersion of the pixels in the plot. The Colour Scatter plot of Alix and Phalloidin in 
HEK293 cells revealed varying degrees of scatter pattern spread all over the plot similar to 
that seen with EEA1 (Figures 5.6 and 5.8). The mean Pearson’s Correlation value of 0.251 
(n=3) indicates that the correlation is weak. 
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Figure 5.9 Intracellular distribution of Alix in a group of isolated HEK293 cells transiently transfected with 
EGFP tagged Alix, following fixation and permeabilisation, exposure to fluorescently conjugated peptides 
against phalloidin and treatment with Hoechst. Green fluorescence images of Alix transfected HEK293 cells 
(Panel A) reveal expression within the cell cytoplasm. Staining with Phalloidin (Panel B) revealed a 
cytoskeletal staining pattern consistent with F actin distribution. Panel C shows nuclear labelling with 
Hoescht and Panel D shows the merged image of Panel A, B and C. Green denotes Alix fluorescence, red as 
Phalloidin and blue corresponds to Hoechst stained nuclei. Scale Bar: 10 μM. 
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Figure 5.10 Colocalisation analysis from images shown in Figure 5.9. Green pixels denotes Alix, while red 
pixels corresponds to phalloidin. The Pearson’s Correlation value that denotes the degree of overlap between 
the pixels within this image pair, calculated a minimal overlap of 0.335. 
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Figure 5.11 Intracellular distribution of Alix in a cluster of HEK293 cells transiently transfected with EGFP 
tagged Alix, following fixation and permeabilisation, exposure to fluorescently conjugated peptides against 
phalloidin and treatment with Hoechst. Green fluorescence images of Alix transfected HEK293 cells (Panel 
A) reveal expression within the cell cytoplasm. Staining with Phalloidin (Panel B) revealed a cytoskeletal 
staining pattern consistent with F actin distribution. Panel C shows nuclear labelling with Hoescht and Panel 
D shows the merged image of Panel A, B and C. Green denotes Alix fluorescence, red as phalloidin and blue 
corresponds to Hoechst stained nuclei. Scale Bar: 10 μM. 
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Figure 5.12 Colocalisation analysis from images shown in Figure 5.11. Green pixels denotes Alix, while red 
pixels corresponds to phalloidin. The Pearson’s Correlation value that denotes the degree of overlap between 
the pixels within this image pair, calculated a minimal overlap of 0.172. 
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5.3 Localisation of Alix in NMDAR activated HEK293 cells  
 To assess if there is any association of two proteins in a cellular environment, co-
localization microscopy of fluorescently tagged proteins is a widely used method to support 
a molecular interaction (Taraska and Zagotta, 2010). Here we wanted to see if there is any 
difference between the association level seen between Alix and NMDAR when the cells are 
activated or not following the similar conditions used in the NMDAR cell death assay 
described in section 3.2.1. Earlier sections (5.1 and 5.2) have determined the localisation 
and correlation of Alix in HEK293 cells relative to subcellular (Hoescht and phalloidin) 
and endosomal markers (EEA1). Using immunocytochemistry we determined Alix 
localisation when it is cotransfected with NMDAR subunits and if there is any change in 
expression when NMDARs are activated with 1 mM NMDA or only exposed to PSS. 
 
5.3.1 Activated NMDARs and Alix localization 
 Fluorescence images of EGFP tagged Alix revealed a green fluorescence within the 
cytoplasm of the cells and GluN1 restricted to the cytoplasm as well as the cell membrane 
(5.13 and 5.15). Visual inspection of the images reveals a partial overlap between Alix and 
GluN1 expression. However, to confirm this we did a Colocalization Scatter Plot. In the 
scatter plot, pure red and pure green are coloured as such to correspond to GluN1 and Alix 
respectively. The degree of colocalization is determined by dispersion of the pixels within 
the plot. The Colour Scatter plot of Alix and GluN1 in HEK293 cells (Figures 5.14 and 
5.16) revealed a varied correlation plot demonstrated by varying degrees of scatter pattern 
spread all over the plot. However, the analysis suggests some degree of correlation between 
Alix and GluN1 expression and with a mean Pearson’s Correlation value of 0.5 (n=20) 
there is a statistically moderate correlation. 
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Figure 5.13 Intracellular distribution of Alix in a group of isolated HEK293 cells transiently transfected with 
EGFP tagged Alix and GluN1+GluN2A, following fixation and permeabilisation and exposure to primary 
antibodies against GluN1. Green denotes Alix fluorescence, while red is GluN1. Green fluorescence images 
of Alix transfected HEK293 cells (Panel A) reveal expression within the cell cytoplasm. Staining with GluN1 
(Panel B) revealed a distribution of strong fluorescence in the plasma membrane. Panel C shows the merged 
image of Panel A and B. Scale Bar: 10 μm. 
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Figure 5.14 Colocalisation analysis from images shown in Figure 5.13. Green pixels denotes Alix, while red 
pixels corresponds to GluN1. The Pearson’s Correlation value that denotes the degree of overlap between the 
pixels within this image pair, calculated a minimal overlap of 0.852. 
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Figure 5.15 Intracellular distribution of Alix in a group of clustered HEK293 cells transiently transfected with 
EGFP tagged Alix and GluN1+ GluN2A, following fixation and permeabilisation and exposure to primary 
antibodies against GluN1. Green denotes Alix fluorescence, while red is GluN1. Green fluorescence images 
of Alix transfected HEK293 cells (Panel A) reveal expression within the cell cytoplasm. Staining with GluN1 
(Panel B) revealed a distribution of strong fluorescence in the plasma membrane. Panel C shows the merged 
image of Panel A and B. Scale Bar: 10 μm. 
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Figure 5.16 Colocalisation analysis from images shown in Figure 5.15. Green pixels denotes Alix, while red 
pixels corresponds to GluN1. The Pearson’s Correlation value that denotes the degree of overlap between the 
pixels within this image pair, calculated a minimal overlap of 0.249. 
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5.3.2 Nonactivated NMDAR and Alix localization 
 Fluorescence images of Alix and GluN1 expression in non activated cells were 
similar to the activated cells in section 5.3.1. In the Colocalization Scatter Plot, pure red 
and pure green are coloured as such to correspond to GluN1 and Alix respectively. The 
Colour Scatter plot of Alix and GluN1 in HEK293 cells showed a variable scatter pattern 
but some degree of colocalisation. This was demonstrated by a mean Pearson’s Correlation 
value of 0.44 (n=20) which suggests a statistically a moderate correlation and close to the 
value obtained for activated cells (section 5.3.1). Paired t-test shows that the difference 
between the activated and non activated correlation plot is considered to be not statistically 
significant with a P value of 0.499. These observations suggest there is little change in Alix 
localization following NMDAR coexpression or NMDAR activation. 
 The reason for the relatively high correlation rate observed here compared to earlier 
comparisons (sections 5.1 and 5.2) could be due to the fact that both Alix and GluN1 
protein are overexpressed (via plasmid cDNA expression) in the transiently transfected 
HEK293 cells and this may not fully replicate endogenous expression. 
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Figure 5.17 Intracellular distribution of Alix in a group of non activated HEK293 cells transiently transfected 
with EGFP tagged Alix and GluN1+ GluN2A, following fixation and permeabilisation and exposure to 
primary antibodies against GluN1. Green denotes Alix fluorescence, while red is GluN1. Green fluorescence 
images of Alix transfected HEK293 cells (Panel A) reveal expression within the cell cytoplasm. Staining with 
GluN1 (Panel B) revealed a distribution of strong fluorescence in the plasma membrane. Panel C shows the 
merged image of Panel A and B. Scale Bar: 10 μm. 
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Figure 5.18 Colocalisation analysis from images shown in Figure 5.17. Green pixels denotes Alix, while red 
pixels corresponds to GluN1. The Pearson’s Correlation value that denotes the degree of overlap between the 
pixels within this image pair, calculated a minimal overlap of 0.894. 
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Figure 5.19 Intracellular distribution of Alix in a group of non activated HEK293 cells transiently transfected 
with EGFP tagged Alix and GluN1+GluN2A, following fixation and permeabilisation and exposure to 
primary antibodies against GluN1. Green denotes Alix fluorescence, while red is GluN1. Green fluorescence 
images of Alix transfected HEK293 cells (Panel A) reveal expression within the cell cytoplasm. Staining with 
GluN1 (Panel B) revealed a distribution of strong fluorescence in the plasma membrane. Panel C shows the 
merged image of Panel A and B. Scale Bar: 10 μm. 
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Figure 5.20 Colocalisation analysis from images shown in Figure 5.19. Green pixels denotes Alix, while red 
pixels corresponds to GluN1. The Pearson’s Correlation value that denotes the degree of overlap between the 
pixels within this image pair, calculated a minimal overlap of 0.383. 
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5.4 Summary  
 From the images that we analysed, there was little overlap between Alix and 
Hoechst (Figures 5.1 and 5.3), Alix and EEA1 (Figures 5.5 and 5.7) and Alix and 
phalloidin (Figures 5.9 and 5.11). This  was further proven by a low Pearson’s correlation 
value of  0.100 (n=3) for Alix and Hoechst, 0.252 (n =3) for Alix and EEA1 and 0.251 
(n=3) for Alix and phalloidin. Therefore there is little expression of Alix within the nucleus 
and little association with cytoskeletal proteins or the endosomal protein EEA1 in HEK293 
cells.  
 However, our analysis suggests there is a moderate degree of correlation between 
Alix and GluN1 expression when activated with a mean Pearson’s Correlation value of 0.5 
(n=20) (Figure 5.13 and 5.15). There is a also a moderate degree of correlation between 
Alix and GluN1 expression when not activated with a mean Pearson’s Correlation value of 
0.44 (n=20)(Figure 5.17 and 5.19). A paired t-test showed no statistically significant 
difference between the activated and non activated correlation plots with a P value of 
0.499. These observations suggest there is little change in Alix localization with GluN1 
following NMDAR activation or non activation. However, as these recombinant proteins 
are expressed in a heterologous expression system, using plasmid vectors optimized for 
protein overexpression. The relatively high correlation detected between Alix and GluN1 
expression in HEK293 cells could be due to excessive expression within the cell. In 
addition the HEK293 cells may not fully replicate the endogenous neuronal environment 
necessary for correct Alix localisation and thus may not be the ideal model system to 
examine Alix localization in this manner. Thus in order to investigate this further we 
decided to ascertain the correlation and expression of endogenous Alix in cultured primary 
neurons from rat hippocampus and cortex in the next chapters. 
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6.1 Localisation of Alix in primary cortical and hippocampal neurons 
There is little information in the literature describing native Alix expression within 
neurons and we decided to ascertain the correlation and expression of basal Alix in cultured 
hippocampal and cortical primary neurons. We decided to use cultures that are 14 days old 
as neurons are reported with mature synapse from day 10 onwards in cultures (Grabrucker, 
A. 2009). We followed the immunocytochemistry protocols used for HEK293 cells 
previously described in chapter 5.  
 
6.1.1 Expression of Alix within the cytoplasm of cortical neurons and hippocampal 
neurons 
Fluorescence images of endogenous Alix expression revealed a punctate 
fluorescence within the cytoplasm of the cells with Hoechst staining the cell nuclei (Figures 
6.1 and 6.3). There does not seem to be any overlap between Alix and Hoechst signals and 
to confirm with this we performed a Colocalization Scatter Plot. In the scatter plot, pure 
blue and pure red are coloured as such to correspond to Hoechst and Alix respectively. 
Colour scatter plot of Alix and Hoechst in the cortical neurons revealed a mostly 
uncorrelated plot seen by a scatter plot that is more clustered towards the x and y-axes and 
further proven by a low mean Pearson’s correlation value of -0.133 (n=3) (Figures 6.2). 
The Colour scatter plot of Alix and Hoechst in the hippocampal neurons also revealed a 
mostly uncorrelated plot seen by a scatter plot that is more clustered towards the x and y-
axes and further proven by a low mean Pearson’s correlation value of -0.004 (n = 3) 
(Figure 6.4). 
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Figure 6.1 Intracellular distribution of endogenous Alix in primary cortical neuronal cultures stained with 
Hoechst. Fluorescence images of Alix reveal mostly a punctate fluorescence pattern within the cell 
cytoplasm. Red denotes Alix fluorescence while blue corresponds to Hoechst stained nuclei. Scale Bar: 10 
μm. 
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Figure 6.2 Colocalisation analysis from images shown in Figure 6.1. Red pixels denotes Alix while blue 
pixels corresponds to Hoechst. The Pearson’s Correlation value that denotes the degree of overlap between 
the image pair calculated a minimal overlap of -0.354. 
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Figure 6.3 Intracellular distribution of endogenous Alix in primary hippocampal neuronal cultures stained 
with Hoechst. Fluorescence images of Alix reveal mostly a punctate fluorescence pattern within the cell 
cytoplasm. Red denotes Alix fluorescence while blue corresponds to Hoechst stained nuclei. Scale Bar: 10 
μm. 
A 
C 
B 
 157 
 
Figure 6.4 Colocalisation analysis from images shown in Figure 6.3. Red pixels denotes Alix while blue 
pixels corresponds to Hoechst. The Pearson’s Correlation value that denotes the degree of overlap between 
the image pair calculated a minimal overlap of 0.185. 
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6.2.1 Endogenous Alix distribution in cortical and hippocampal neurons and the 
localization of the cellular endosome marker, EEA1 
Previously we observed a weak correlation between Alix and EEA1 expression in 
HEK293 cells (Figure 5.5 and 5.7). We further investigated this by examining if there was 
any correlation between endogenous expression of Alix and the endosome marker EEA1 in 
primary cortical and hippocampal neurons. As before we fixed, permeabilised and treated 
the cells with primary and secondary antibodies against Alix and EEA1 and stained for 
nuclei with Hoechst. 
The fluorescence images of endogenous Alix expression (Figures 6.5 and 6.7) 
revealed a sparse punctate fluorescence within the cell cytoplasm with Hoechst clearly 
showing the cell nuclei. Endogenous EEA1 expression revealed also a punctate staining 
pattern but was more evenly distributed throughout the cytoplasm compared to Alix. From 
the merged images it was difficult to clearly identify colocalisation between Alix and 
EEA1 expression. However, to confirm this we performed a Colocalization Scatter Plot. In 
the Scatter plot, pure red and pure green pixels correspond to Alix and EEA1 respectively. 
Colour scatter plot of Alix and EEA1 revealed a more varied correlation plot seen by 
varying degrees of scatter pattern spread all over the plot (Figures 6.6 and 6.8). We found a 
mean Pearson’s Correlation value of 0.406 (n=3) for the cortical neurons which shows that 
there is a moderate correlation. On the other hand, with a mean Pearson’s Correlation value 
of 0.307 (n = 3) we found that there is a weak correlation for the hippocampal neurons. 
However paired t-test shows that the difference between cortical and hippocampal neurons 
is considered to be not statistically significant with a P value of 0.676. 
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Figure 6.5 Intracellular distribution of endogenous Alix in cortical neurons, following fixation and 
permeabilisation, exposure to primary antibodies against Alix and EEA1 and treatment with Hoechst. Red 
fluorescence images of endogenous Alix (Panel A) reveal a punctate expression pattern within the cell 
cytoplasm. Expression of EEA1 (Panel B) also reveals a punctate staining pattern consistent with cytoplasmic 
distribution of endosomes. Panel C shows nuclear labelling with Hoescht and Panel D shows the merged 
image of Panel A, B and C. Red denotes Alix fluorescence, green as EEA1 and blue corresponds to Hoechst 
stained nuclei. Scale Bar: 10 μm. 
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Figure 6.6 Colocalisation analysis from cortical images shown in Figure 6.5. Red pixels denotes Alix, while 
green pixels corresponds to EEA1. The Pearson’s Correlation value that denotes the degree of overlap 
between the pixels within this image pair, calculated a moderate correlation of 0.532. 
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Figure 6.7 Intracellular distribution of endogenous Alix in hippocampal neurons, following fixation and 
permeabilisation, exposure to primary antibodies against Alix and EEA1 and treatment with Hoechst. Red 
fluorescence images of endogenous Alix (Panel A) reveal a punctate expression pattern within the cell 
cytoplasm. Expression of EEA1 (Panel B) also reveals a punctate staining pattern consistent with cytoplasmic 
distribution of endosomes. Panel C shows nuclear labelling with Hoescht and Panel D shows the merged 
image of Panel A, B and C. Red denotes Alix fluorescence, green as EEA1 and blue corresponds to Hoechst 
stained nuclei. Scale Bar: 10 μm. 
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Figure 6.8 Colocalisation analysis from hippocampal images shown in Figure 6.7. Red pixels denotes Alix, 
while green pixels corresponds to EEA1. The Pearson’s Correlation value that denotes the degree of overlap 
between the pixels within this image pair, calculated a very weak correlation of 0.181. 
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6.2.2 Endogenous Alix distribution and the cytoskeleton within cortical neurons 
 In view of our finding of Alix’s weak correlation with Phalloidin in HEK293 cells 
(Figures 5.9 and 5.11), we investigated the distribution of endogenous Alix localization 
with the cytoskeleton in cortical and hippocampal neurons. Cortical and hippocampal 
neurons were stained with primary antibodies for Alix and costained with phalloidin.  
 Fluorescence images of endogenous Alix expression revealed punctate cytoplasmic 
expression but also a green background signal throughout the cytoplasm (Figures 6.9 and 
6.11). Staining with Phalloidin revealed an expected cytoskeletal staining pattern. A 
Colocalization Scatter Plot was performed to assess colocalisation between endogenous 
Alix and phalloidin signals (Figures 6.10 and 6.12). In the scatter plot, pure red and pure 
green are coloured as such to correspond to Phalloidin and Alix respectively. The Colour 
Scatter plot of Alix and Phalloidin revealed a more varied correlation plot seen by varying 
degrees of scatter pattern spread all over the plot. However, with a mean Pearson’s 
Correlation value of 0.538 (n= 3) we found that there is a moderate correlation in the 
cortical neurons. There was also a moderate correlation in the hippocampal neurons with a 
mean Pearson’s Correlation value of 0.415 (n = 3). 
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Figure 6.9 Intracellular distribution of endogenous Alix in cortical neurons, following fixation and 
permeabilisation, exposure to primary antibodies against Alix and treatment with phalloidin and Hoechst. 
Green fluorescence images of endogenous Alix (Panel A) reveal a punctate expression pattern within the cell 
cytoplasm. Phalloidin staining (Panel B) shows the cytoskeleton and is consistent with intracellular F actin 
distribution. Panel C shows nuclear labelling with Hoescht and Panel D shows the merged image of Panel A, 
B and C. Green denotes Alix fluorescence, red as phalloidin and blue corresponds to Hoechst stained nuclei. 
Scale Bar: 10 μm. 
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Figure 6.10 Colocalisation analysis of cortical neurons from images shown in Figure 6.9. Green pixels 
denotes Alix, while red pixels corresponds to phalloidin. The Pearson’s Correlation value that denotes the 
degree of overlap between the pixels within this image pair, calculated a correlation of 0.699. 
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Figure 6.11 Intracellular distribution of endogenous Alix in hippocampal neurons, following fixation and 
permeabilisation, exposure to primary antibodies against Alix and treatment with phalloidin and Hoechst. 
Green fluorescence images of endogenous Alix (Panel A) reveal a punctate expression pattern within the cell 
cytoplasm. Phalloidin staining (Panel B) shows the cytoskeleton and is consistent with intracellular F actin 
distribution. Panel C shows nuclear labelling with Hoescht and Panel D shows the merged image of Panel A, 
B and C. Green denotes Alix fluorescence, red as phalloidin and blue corresponds to Hoechst stained nuclei. 
Scale Bar: 10 μm. 
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Figure 6.12 Colocalisation analysis of hippocampal neurons from images shown in Figure 6.11. Green pixels 
denotes Alix, while red pixels corresponds to phalloidin. The Pearson’s Correlation value that denotes the 
degree of overlap between the pixels within this image pair, calculated a correlation of 0.480. 
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6.2.3 Endogenous Alix expression with NMDA receptors in cortical and hippocampal 
neurons 
 In chapter 5, we observed a moderate correlation of Alix and GluN1 expression in 
HEK293 cells (Figures 5.13 and 5.15), however given this was examined in a heterologous 
cell expression system, it is important to evaluate the endogenous expression pattern of 
these proteins within cortical and hippocampal neurons. Cortical and hippocampal neurons 
were treated with primary antibodies for Alix and GluN2A/B and respective fluorescent 
signals were visualized after exposure to fluorescently conjugated secondary antibodies.  
 Fluorescence images of Alix revealed a punctate fluorescence within the cytoplasm 
of the cortical and hippocampal neurons and GluN2A/2B shows cytoplasmic expression, 
but visually it was difficult to clearly distinguish whether the signals overlapped (Figures 
6.13 and 6.15). A Colocalization Scatter Plot was constructed using pure red and pure 
green to correspond to Alix and GluN2A/2B respectively. The Colour Scatter plot of Alix 
and GluN2A/2B revealed a more varied correlation plot seen by varying degrees of scatter 
pattern spread all over the plot (Figures 6.14 and 6.16). The mean Pearson’s Correlation 
value of 0.761 (n=3) suggested a strong correlation rate for the cortical neurons. However, 
with a mean Pearson’s Correlation value of 0.275 (n = 3) we found that there is a weak 
correlation rate for the hippocampal neurons. On the other hand, paired t-test shows that the 
difference between cortical and hippocampal neurons is considered to be not statistically 
significant with a P value of 0.183. Therefore, the difference in Alix and GluN2A/B 
correlation between the two cell types is not statistically different. 
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Figure 6.13 Intracellular distribution of Alix and GluN2A/2B in primary cortical neurons. Fluorescence 
images of Alix (Panel A) reveal a punctate fluorescence within the cytoplasm of the cells. Staining with 
GluN2A/2B (Panel B) reveals cytoplasmic staining pattern. Panel C shows nuclear labelling with Hoescht 
and Panel D shows the merged image of Panel A, B and C. Green denotes GluN2A/2B fluorescence, red as 
Alix and blue corresponds to Hoechst stained nuclei. Scale Bar: 10 μm. 
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Figure 6.14 Colocalisation analysis of cortical neurons images shown in Figure 6.13. Red pixels denotes Alix 
while green pixel corresponds to GluN2A/2B. The Pearson’s Correlation value denotes the degree of overlap 
between the pixels within the image pair calculated a very strong correlation rate of 0.770. 
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Figure 6.15 Intracellular distribution of Alix and GluN2A/2B in primary hippocampal neurons. Fluorescence 
images of Alix (Panel A) reveal a punctate fluorescence within the cytoplasm of the cells. Staining with 
GluN2A/2B (Panel B) reveals cytoplasmic staining pattern. Panel C shows nuclear labelling with Hoescht 
and Panel D shows the merged image of Panel A, B and C. Green denotes GluN2A/2B fluorescence, red as 
Alix and blue corresponds to Hoechst stained nuclei. Scale Bar: 10 μm. 
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Figure 6.16 Colocalisation analysis of hippocampal neurons images shown in Figure 6.15. Red pixels denotes 
Alix while green pixel corresponds to GluN2A/2B. The Pearson’s Correlation value denotes the degree of 
overlap between the pixels within the image pair calculated a very week correlation rate of 0.146. 
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6.2.4 Endogenous Alix with PSD 95 in cortical neurons 
Another well-characterized intracellular protein known to associate with NMDARs 
is PSD95 (Sheng, 2001) and we examined whether Alix could correlate with PSD95 
expression in cortical and hippocampal neurons. Cortical and hippocampal neurons were 
treated with primary antibodies for Alix and PSD95 and respective fluorescent signals were 
visualized after exposure to fluorescently conjugated secondary antibodies.   
Fluorescence images of Alix also revealed a dispersed punctate fluorescence pattern 
within the cytoplasm of the cells and the PSD95 signal revealed a punctate pattern that was 
spread across the cytoplasm (Figures 6.17 and 6.19). A Colocalization Scatter Plot was 
performed where pure red and pure green pixels correspond to Alix and PSD95 
respectively. The Colour Scatter plot of Alix and PSD95 revealed a more varied correlation 
plot seen by varying degrees of scatter pattern spread all over the plot (Figures 6.18 and 
6.20). The mean Pearson’s Correlation value of 0.496 (n = 3) indicated a moderate 
correlation rate for the cortical neurons. However, there was a weaker correlation in 
hippocampal neurons with a mean Pearson’s Correlation value of 0.264 (n = 3). The paired 
t-test shows that the difference between cortical and hippocampal neurons is considered 
statistically significant with a P value of 0.018. 
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Figure 6.17 Intracellular distribution of Alix and PSD95 in primary cortical neurons. Fluorescence images of 
Alix (Panel A) reveal a dispersed punctate fluorescence within the cytoplasm of the cells. Staining with 
PSD95 (Panel B) reveals a punctate cytoplasmic staining pattern. Panel C shows nuclear labelling with 
Hoescht and Panel D shows the merged image of Panel A, B and C. Green denotes PSD95 fluorescence, red 
as Alix and blue corresponds to Hoechst stained nuclei. Scale Bar: 10 μm. 
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Figure 6.18 Colocalisation analysis of cortical neurons images shown in Figure 6.17. Red pixels denotes Alix 
while green pixel corresponds to PSD95. The Pearson’s Correlation value denotes the degree of overlap 
between the pixels within the image pair calculated a moderate correlation rate of 0.503. 
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Figure 6.19 Intracellular distribution of Alix and PSD95 in primary hippocampal neurons. Fluorescence 
images of Alix (Panel A) reveal a dispersed punctate fluorescence within the cytoplasm of the cells. Staining 
with PSD95 (Panel B) reveals a punctate cytoplasmic staining pattern. Panel C shows nuclear labelling with 
Hoescht and Panel D shows the merged image of Panel A, B and C. Green denotes PSD95 fluorescence, red 
as Alix and blue corresponds to Hoechst stained nuclei. Scale Bar: 10 μm. 
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Figure 6.20 Colocalisation analysis of cortical neurons images shown in Figure 6.19. Red pixels denotes Alix 
while green pixel corresponds to PSD95. The Pearson’s Correlation value denotes the degree of overlap 
between the pixels within the image pair calculated a weak correlation rate of 0.353. 
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6.2.5 Endogenous Alix localisation with synaptophysin in cortical neurons 
Synaptophysin is a binding partner for the SNARE protein (SNAP (Soluble NSF 
Attachment Protein) Receptor), synaptobrevin and is often used as marker for synaptic 
localization (Reisinger et al., 2004) and we examined the localization of Alix with 
synaptophysin in primary cortical and hippocampal neurons. Cortical and hippocampal 
neurons were treated with primary antibodies for Alix and synaptophysin and respective 
fluorescent signals were visualized after exposure to fluorescently conjugated secondary 
antibodies. 
Fluorescence images of Alix and synaptophysin both showed a punctate pattern 
within the cell cytoplasm (Figures 6.21 and 6.23). A Colocalization Scatter Plot was 
performed using pure red and pure green pixels to correspond to Alix and synaptophysin. 
The Colour Scatter plot of Alix and synaptophysin revealed a more varied correlation plot 
seen by varying degrees of scatter pattern spread all over the plot (Figures 6.22 and 6.24). 
There was a weak correlation rate with a mean Pearson’s Correlation value of 0.31 (n = 3) 
in the cortical cultures and 0.238 (n = 3) in the hippocampal cultures. 
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Figure 6.21 Intracellular distribution of Alix and synaptophysin in primary cortical neurons. Fluorescence 
images of Alix (Panel A) reveal a dispersed punctate fluorescence within the cytoplasm of the cells. Staining 
with synaptophysin (Panel B) reveals a punctate staining pattern restricted to certain regions of the neuron. 
Panel C shows nuclear labelling with Hoescht and Panel D shows the merged image of Panel A, B and C. 
Green denotes synaptophysin fluorescence, red as Alix and blue corresponds to Hoechst stained nuclei. Scale 
Bar: 10 μm. 
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Figure 6.22 Colocalisation analysis images shown in Figure 6.21. Red pixels denotes Alix while green pixel 
corresponds to synaptophysin. The Pearson’s Correlation value denotes the degree of overlap between the 
pixels within the image pair calculated a weak correlation rate of 0.383. 
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Figure 6.23 Intracellular distribution of Alix and synaptophysin in primary cortical neurons. Fluorescence 
images of Alix (Panel A) reveal a dispersed punctate fluorescence within the cytoplasm of the cells. Staining 
with synaptophysin (Panel B) reveals a punctate staining pattern restricted to certain regions of the neuron. 
Panel C shows nuclear labelling with Hoescht and Panel D shows the merged image of Panel A, B and C. 
Green denotes synaptophysin fluorescence, red as Alix and blue corresponds to Hoechst stained nuclei. Scale 
Bar: 10 μm. 
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Figure 6.24 Colocalisation analysis images shown in Figure 6.23. Red pixels denotes Alix while green pixel 
corresponds to synaptophysin. The Pearson’s Correlation value denotes the degree of overlap between the 
pixels within the image pair calculated a week correlation rate of 0.335. 
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6.3 Summary  
Previously, we observed a weak correlation between Alix and EEA1 expression in 
HEK293 cells (Figure 5.5 and 5.7). Conversely, we observed a moderate correlation for the 
cortical neurons (0.406, n=3) but there was a weak correlation for the hippocampal neurons 
(0.307, n=3) (Figures 6.5 and 6.7). However, paired t-test shows that the difference 
between cortical and hippocampal neurons is considered to be not statistically significant 
with a P value of 0.676. 
We found that previously Alix had a weak correlation with Phalloidin in HEK293 
cells (Figures 5.9 and 5.11). However, with a mean Pearson’s Correlation value of (0.538, 
n= 3) in the cortical neurons and (0.415, n=3) in the hippocampal neurons we found that 
there is a moderate correlation for both primary cultures (Figures 6.9 and 6.11).  
 In chapter 5, we observed a moderate correlation of Alix and GluN1 expression in 
HEK293 cells (Figures 5.13 and 5.15). There seems to be also a strong correlation rate for 
the cortical neurons with a mean Pearson’s Correlation value of (0.761, n=3) but there was 
on the other hand, a weak correlation with an average Pearson’s Correlation value of 
(0.275, n=3) in the hippocampal neurons (Figures 6.13 and 6.15). Then again, paired t-test 
shows that the difference between cortical and hippocampal neurons is considered to be not 
statistically significant with a P value of 0.183. 
Next, we examined whether Alix expression could correlate with PSD95 expression 
in cortical and hippocampal neurons (Figures 6.17 and 6.19). We observed a moderate 
correlation for the cortical neurons with a mean Pearson’s correlation value of (0.496, n = 
3) but there was a weaker correlation in hippocampal neurons with a mean Pearson’s 
Correlation value of (0.264, n = 3). Interestingly, we also observed a  statistically 
significant P value of 0.018 from the paired t-test between the cortical and hippocampal 
primary cultures. 
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We then decided to examine the localization of Alix with synaptophysin in primary 
cortical and hippocampal neurons (Figures 6.21 and 6.23). We found that there was a weak 
correlation rate in both the cortical and hippocampal cultures with a mean Pearson’s 
Correlation value of 0.31 (n = 3) in the cortical culture and 0.238 (n = 3) in the 
hippocampal cultures.  
Overall, these results support previous observations from other work and indicate 
that Alix colocalises with the cytoskeletal protein, phalloidin and shows moderate 
colocalisation with postsynaptic proteins such as PSD95 but weak correlation with 
presynaptic proteins such as synaptophysin (Schmidt et al., 2003); Bayes et al., 2010). 
Although we found differing correlation rates between cortical and hippocampal cultures 
between Alix and EEA1, Alix and GluN2A/2B and Alix and PSD95, the only correlation 
difference that was statistically significant was the difference between Alix and PSD95 
localisation (Figures 6.17 and 6.19). Although this might indicate important differences in 
Alix localization between both neuronal cell types, it would need to be verified by further 
analysis of a larger sample size (for example the differences between Alix and EEA1 and 
Alix and GluN2A/B). Furthermore, we are not sure why Alix would display such cell type 
specific localisation. There is evidence that Alix containing exosomes can display cell type 
specific interactions. (Chivet et al., 2014) found that exosomes from neuroblastoma cells 
bind randomly to neurons and glial cells and could be endocytosed preferentially by glial 
cells but exosomes secreted from stimulated cortical neurons were endocytosed and bound 
to only neurons. They hypothesise that exosomes that are released by synaptic activation do 
not bind to glial cells but specifically to other neurons suggesting a novel aspect of 
interneuronal communication. Although, this would indicate specific differences in 
exosome interaction between neuronal and glial cell types, the role of Alix and the 
molecular processes underlying these specific interactions remain unclear. 
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7. Discussion: 
7.1 Discussion of modulation of NMDA receptor function by Alix in Cell Death Assay 
In order to examine whether Alix had any effect on NMDAR function, we measured 
NMDAR triggered cell death in HEK293 cells expressing human, mouse Alix or Alix 
mouse mutants with NMDARs. We used two statistical tests to analyse our results, a paired 
t-test for individual pairwise comparisons but also performed multiple comparisons across 
all eight variables within an experiment using ANOVA analysis and performed Tukey’s 
post-hoc tests to identify which pairs of data displayed statistically significant differences.  
In all cases the results from the t-test comparisons correlated with those identified 
following ANOVA and Tukey’s post-hoc test.  
Our results in this chapter show that Alix and all deletion mutants (except the Alix 
NT mutant) have an effect on NMDAR triggered cell death when assessed using either 
paired t-test comparisons and when the data from the activated and non-activated cells have 
been compared together using ANOVA and post-hoc analysis.  
Wagey et al. found that a proportion of HEK cells transfected with NMDAR 
subunits die following exposure to NMDAR agonists, depending on the NMDAR subunit 
composition. To establish if the activation of Alix could influence NMDA induced cell 
death we evaluated the cell death percentage in HEK293 cells transfected with NMDAR 
subunits. Activation of NMDARs was performed by incubating the cells in PSS containing 
NMDA and glycine. The cell death percentage was later calculated by trypan blue 
exclusion six hours following activation. 
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Figure 7.1:  Modulation of NMDA cell death by Alix in activated and non activated cells. All data points 
correspond to the mean ± SE of values and statistical comparisons of cell death between groups were 
performed using a paired t-test and ANOVA analysis to determine which groups were statistically different 
from each other.  
 We over expressed GFP tagged human Alix via lipofectamine in a HEK293 
mammalian cell line and examined its effect on NMDA receptor triggered cell death 
(Figure 3.1 ab and Figure 7.1). The result that we achieved for the positive control was in 
line with the findings of R. Wagey and C. Krieger, 2001. They reported that over activation 
of NMDA receptors leads to cell death in HEK293 cells, which have been transfected with 
recombinant NMDA receptors. Under their experimental conditions the positive control 
where cells transfected with GluN1/GluN2A subunits are activated with PSS containing 
NMDA (1 mM) and glycine (50 µM) enhanced cell death to 27.4 ± 0.7% (p =0.005) 
compared to a non activated positive control that had a basal mean cell death of 13.8 ± 
                   ACTIVATED                                 NOT ACTIVATED 
                                                  ALIX GFP 
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1.4%. They attributed the level of basal cell death to low levels of glutamate present within 
the cultures media which could stimulate functional NMDA receptors expressed in 
GluN1/GluN2A transfected cells. To alleviate the effect of this background level of 
glutamate we added the NMDAR antagonist,  AP5 to block any background NMDA 
activation before the PSS treatment. 
Our own findings revealed similar results, where we found that cells expressing 
GluN1/GluN2A subunits that were not activated (PSS only) had a mean cell death of 11.6 ± 
0.7% (Table 3.1 b). Whereas, cells expressing GluN1/GluN2A subunits that were activated 
had a mean cell death of 27.4 ± 1.4% (Table 3.1 a). Treatment with NMDA and glycine 
significantly enhanced cell death as previously reported. In agreement with the observations 
by Wagey et al., 2001, the Paired t-test and ANOVA analysis showed that the difference 
between the activated and non activated positive controls (expressing NMDARs) is 
considered to be statistically significant with a P<0.001. 
We also found that the levels of cell death observed following transfection of Alix 
alone whether it was activated or not, were not statistically different compared to the 
negative control cell lines (without DNA transfection) or to non activated positive control 
(GluN1/GluN2A transfected cells)(Table 3.1 a and 3.1 b). 
Transfecting Alix with GluN1/GluN2A and activating them with NMDA 
significantly reduced the percentage of dead cells compared with the activated positive 
control (cells only expressing GluN1/GluN2A). The culture transfected with Alix, 
GluN1/GluN2A subunits and activated NMDA with glycine had a mean cell death of 21.6 
± 1.9% (Table 3.1 a). The paired t-test and ANOVA analysis showed that the difference 
between the activated positive control (GluN1/GluN2A only) and activated Alix, GluN1, 
GluN2A combination is statistically different with a P<0.001 (marked with ** in Figure 3.1 
a).  
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An interesting finding was also seen in non activated cells transfected with Alix and 
GluN1/GluN2A subunits which yielded a mean cell death of 17.3 ± 1.0% (Table 3.1 b). 
This was a higher percentage of cell death compared to non activated GluN1/GluN2A 
transfected cells. A paired t-test and the ANOVA analysis showed that the difference 
between these two conditions is considered to be statistically different with a P<0.001 (also 
marked with ** on the right hand side of Figure 3.1 b). There was however no statistical 
significance in cell death (P value of 0.0511) between activated or non-activated cells if 
they both expressed Alix, GluN1, and GluN2A together. 
These data indicate that recombinant Alix, GluN1/GluN2A transfection 
significantly reduced the toxicity associated with NMDA receptor activation compared to 
GluN1/GluN2A only cells but enhanced the basal level of cell death when not activated by 
NMDA. Moreover the overall level of cell death in the presence of Alix coexpressed with 
NMDARs is similar in both activated or non activated cells. Why this is the case is still not 
understood, but it suggests that Alix is exerting an influence on NMDA receptor triggered 
cell death measured in these cells. 
Therefore to investigate this observation further, we then confirmed that Alix 
transfected on its own was not causing high levels of cell death in the absence of NMDAR 
expression since GluN2 subunits are not transported to the cell surface unless they associate 
with GluN1 subunits (McIlhinney et al., 2003) by doing a control experiment where we 
repeated the cell death assay with cotransfections of Alix and GluN1 or Alix with GluN2A 
and found that there was no significant change in cell death compared to the negative 
control (Table 3.2 a and 3.2 b). We then tried to modulate the concentration of NMDA (10 
µM, 100 µM, 300 µM and 700 µM) in the PSS buffer to see if this affected the cell death 
caused by Alix (Figure 3.4). In both cases, increasing the concentration of NMDA 
increased the level of cell death. However, the levels of cell death were higher in the 
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presence of Alix at low concentrations of NMDA (10-100 µM) compared to cells 
expressing only GluN1/GluN2A subunits. This further supported the view that the presence 
of Alix is reducing the NMDA concentration required to trigger maximal levels of cell 
death in our assay (>20 %) and suggests that the increased cell death in the presence of Alix 
seen in non activated cells is probably caused by low levels of glutamate and thus NMDAR 
activation within the culture media.  
Furthermore, this is supported by curve fitting the partial dose-response curves with 
the Hill equation. This revealed that the coexpression of Alix decreased the NMDA EC50 
for inducing cell death by 7 fold compared to NMDARs expressed alone. Another issue to 
consider are the NMDA EC50 values measured in the cell death assay. These differ quite 
considerably compared to those measured in other systems where recombinant NMDA 
receptor function has been recorded by oocyte electrophysiology (NMDA EC50 = 47 µM) 
(Chen et al., 2005). There are a number of reasons for this discrepancy and this has 
probably been influenced by the transfection efficiency of both GluN1 and GluN2A 
subunits within the same cell, the ability to detect changes in cell death over prolonged 
periods of time and the influence of multiple second messenger pathways needed before 
cell death is detected. Nevertheless there is common agreement that EC50 values cannot be 
easily compared across different tissue systems/assay measurements and their interpretation 
has to be used appropriately (Colquhoun,1998). Unfortunately, we have been unable to 
compare our EC50 values with other published work as most studies on NMDAR cell death 
only use a maximal agonist concentration to activate NMDARs (Wagey and Krieger, 
2001). We have only been able to measure partial dose-response curves during cell death 
measurements and further work is required to investigate this issue further using a wider 
range of NMDA concentrations and also other NMDAR agonists.We next repeated the 
NMDA cell death assay in the presence of AP5 to specifically block NMDA receptor 
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activity and the subsequent calcium influx to see if the high cell death levels induced by 
Alix in the absence of NMDA activation were directly caused by stimulation of the NMDA 
receptor (Figure 3.3 a and 3.3 b). We found that by adding AP5 to the medium before, 
during and after NMDA treatment (activated or without activation) that we abolished the 
high percentage of cell death caused by Alix and NMDAR as previously seen in Figure 3.1 
a and 3.1 b. Therefore, this suggests that our observations with Alix are specific to NMDA 
receptor function and that Alix is able to simulate a pathway downstream from the NMDA 
receptor, which triggers the cell death process in our assay. 
We know that the interaction between Alix and ALG-2 occurs through its C-
terminal proline-rich region and is known to be Ca
2+
 dependent, where Ca
2+
 binding 
to ALG-2 induces a conformational change which allows it to interact with Alix (Katoh et 
al., 2003; Strappazzon et al., 2010). Although we did not use ALG-2 in our experiments, 
our results suggest that Alix alone and NMDARs may also play a part in this process as the 
vessel that permits excessive Ca
2+
influx which then triggers a variety of processes that 
leads to apoptosis. This is also consistent with the high level of cell death caused by 
recombinant Alix, GluN1/GluN2A transfection in non activated (PSS only) cells as our low 
NMDA concentration assay suggests that in the presence of Alix the levels of cell death are 
higher than in the absence of Alix.   
The mechanism of how Alix is able to enhance receptor triggered cell death is 
unclear, but another theory can be taken from the work by (Schneider-Brachert et al., 2004) 
that reported the activation of caspase 8 by TNFR1 (tumour necrosis factor α receptor 1) in 
lymphocytes can only occur when the receptor has been endocytosed and passed on to 
MVBs. This finding started the notion of death inducing signalling endosomes. It is 
possible that the process requires NMDARs to be endocytosed and passed on to MVB 
which then starts the apoptosis process. Furthermore, there is evidence that the ESCRT 
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complex is involved in lysosomal degradation of neurotransmitter receptors and it has been 
speculated that impairment of this process may lead to neurodegeneration (Isaacs et al. 
2011).  
Deletion variants of the Alix mouse mutants were used to determine what effect 
these variants had on the cell death assay. We know that the N-terminal of Bro1 domain 
mediates localization to endosomes, and is an important functional site for Alix (Odorizzi, 
2006). The C-terminal region interacts with the majority of proteins that connect Alix to 
cellular processes. The Bro1 domain and C-terminal region are linked by a relatively 
uncharacterized sequence containing two coiled-coil domains and the whole sequence ends 
with a proline rich domain (Odorizzi, 2006). 
We found that all of the Alix mouse variants used (Figure 3.6 or Figure 7.2, Figure 
3.7 or Figure 7.3 and 3.9 or Figure 7.4), produced a similar pattern of cell death, where Alix 
coexpressed with NMDAR significantly reduced the toxicity associated with NMDA 
receptor stimulation when activated, but seems to enhance cell death when not activated, as 
seen by the human Alix variant (Figure 7.1). The only exception to this result was the Alix 
NT variant (Figure 3.8 or Figure 7.5). This finding is quite interesting as it pinpoints the 
Alix region responsible for the enhanced NMDA cell death to the C terminal domain of the 
Alix protein. The C terminal of Alix is known to interact with ALG-2 in a Ca
2+
-dependent 
manner (Ohkouchi et al., 2004) and has been linked with cytoplasmic vacuolization 
(Chatellard-Causse et al. 2002) but how this could increase cell death triggered by NMDAR 
activation is less straightforward. It is possible that this region of Alix is able to influence 
processes downstream of NMDARs (presumably in a Ca
2+
-dependent manner). It is not 
known if this is a direct interaction or via downstream signalling processes but the 
implication of these results seem to suggest a possible function linkage between these two 
proteins. 
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Figure 7.2:  Modulation of NMDA cell death by Alix WT in activated and non activated cells. All data points 
correspond to the mean ± SE of values and statistical comparisons of cell death between groups were 
performed using a paired t-test and ANOVA analysis to determine which groups were statistically different 
from each other.  
                   ACTIVATED                                 NOT ACTIVATED 
                                                  ALIX WT 
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Figure 7.3:  Modulation of NMDA cell death by Alix CT in activated and non activated cells. All data points 
correspond to the mean ± SE of values and statistical comparisons of cell death between groups were 
performed using a paired t-test and ANOVA analysis to determine which groups were statistically different 
from each other.  
                   ACTIVATED                                 NOT ACTIVATED 
                                                  ALIX CT 
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Figure 7.4:  Modulation of NMDA cell death by Alix DPRD in activated and non activated cells. All data 
points correspond to the mean ±  SE of values and statistical comparisons of cell death between groups were 
performed using a paired t-test and ANOVA analysis to determine which groups were statistically different 
from each other.  
                   ACTIVATED                                 NOT ACTIVATED 
                                                  ALIX DPRD 
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Figure 7.5:  Modulation of NMDA cell death by Alix NT in activated and non activated cells. All data points 
correspond to the mean ± SE of values and statistical comparisons of cell death between groups were 
performed using a paired t-test and ANOVA analysis to determine which groups were statistically different 
from each other.  
 
 
 
 
 
                   ACTIVATED                                 NOT ACTIVATED 
                                                  ALIX NT 
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7.2 Discussion of western blot analysis of NMDA/Alix coexpression within HEK293 
cells 
 We then examined the protein expression of Alix in our transfected HEK293 cells  
to investigate whether Alix was exerting its effect on NMDAR cell death by influencing 
protein expression. Full length expression of Alix (96kDa) was confirmed using a full 
length mouse anti-Alix antibody in both the Alix alone and Alix and GluN1/GluN2A 
subunit in both activated and non activated HEK293 cells (Figure 4.1). The bands showed 
little degradation and the negative control did not show a clear protein signal when 
transfected with only lipofectamine. 
In cultures that were transfected with only Alix cDNA and EGFP and maintained in 
PSS, mean relative Alix protein expression was 2.39 ± 0.88 (Figure 4.1b). In cultures that 
were transfected with EGFP-Alix cDNA only and activated in PSS with NMDA (1 mM) 
and glycine (50 µM) had a mean relative protein expression of 3.77 ± 0.55 (Figure 4.1a). 
Therefore it seems that NMDA/glycine treatment elevates Alix expression. But a paired T 
test showed that this difference was statistically insignificant with a P value of 0.40. 
In cells transfected with Alix, GluN1/GluN2A subunits and activated with PSS and 
NMDA with glycine had a mean relative Alix protein expression of 0.99 ± 0.23 (Figure 
4.1a). Non activated cells transfected with Alix and GluN1/GluN2A subunits yielded a 
relative mean protein expression of 0.84 ± 0.18 (Figure 4.1b). The difference here was also 
found to be not statistically significant with a P value of 0.61. 
We observed a higher protein expression of Alix in Alix only transfected cells 
compared to Alix, GluN1/GluN2A cotransfected cells when activated with NMDA. In the 
activated cells, the paired T test suggests that the differences are statistically significant 
with a P value of 0.019. However, there was a smaller (non statistically significant) change 
in Alix expression between Alix only transfected cells compared to non activated Alix, 
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GluN1/GluN2A cotransfected cells with a P value of 0.22. It is unclear why Alix 
expression levels differ here but it could be induced by general changes in protein 
expression within cells when they are activated by NMDA during the cell death assay 
rather than a specific effect on Alix expression.  
We then examined NMDA receptor expression by examining protein expression of 
GluN1 subunit (108kDa) and this was confirmed using a mouse anti-NMDAR1 antibody in 
both the NMDAR only and Alix and GluN1/GluN2A expressing cells in both activated and 
non activated HEK293 cells (Figure 4.2). 
In cultures that were transfected with GluN1/GluN2A only and maintained in PSS, 
GluN1 mean relative protein expression was 1.46 ± 0.64 (Figure 4.2b). In cultures that were 
transfected with GluN1/GluN2A only and activated in PSS with NMDA (1 mM) and 
glycine (50 µM) had a mean relative protein expression of 1.33 ± 0.75 (Figure 4.2a). 
Therefore, activation with NMDA and glycine has little effect on GluN1 protein levels and 
this was supported by a  paired T test with a P value of 0.90 for both activated and non 
activated GluN1/GluN2A only cultures. 
In cells transfected with Alix, GluN1/GluN2A subunits and activated with PSS and 
NMDA with glycine had a mean relative expression of 1.74 ± 0.42 (Figure 4.2a). Non 
activated cells transfected with Alix and GluN1/GluN2A subunits yielded a mean relative 
expression of 0.87 ± 0.38 (Figure 4.2b).  Thus, the protein expression levels of GluN1 seem 
to differ between activated and non-activated cells expressing Alix. However, this 
difference was not considered statistically significant with a P value of 0.38 (paired T-test). 
Therefore our overall conclusion is that the levels of GluN1 are not altered when these 
proteins are coexpressed and the levels of both proteins are not changed significantly before 
or after NMDA receptor activation.  
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We previously discussed that Alix is found in the human PSD (Bayes et al., 2011) 
which would lead credence for us to examine whether there is a similar expression pattern 
in rat brain. Using the antibodies described earlier, we examined Alix in whole adult and 
embryo brain protein extracts as well as Synaptosome, Light Membrane, Myelin and 
Mitochondria fractions. Unfortunately the Myelin fraction which is comprised of the 
insulating sheath around the axon of the neuron was too smeary for us to detect a distinct 
protein signal. But full length Alix expression (96kDa) was detected using mouse anti-Alix 
in all other fractions (Figure 4.3).  
We found that whole embryo brain sample had a mean relative protein expression 
of 0.15 ± 0.04 (Table 4.3). The expression of Alix in whole embryo brain seems 
comparatively quite low. Whereas the whole adult brain had a slightly higher mean relative 
protein expression of 0.29 ± 0.04 (Table 4.3). Synaptosome fractions showed the highest 
mean relative protein expression of 1.52 ± 0.03 (Table 4.3). Synaptosomes are isolated 
from the synaptic terminal of a neuron (Chicurel et al., 1993) and the high relative protein 
expression would be consistent with the findings from Bayes et al. 2011 that Alix is located 
within the human PSD. The mitochondria fraction had a mean protein expression of 0.61 ± 
0.11 (Table 4.3) and represents the energy providing organelles that are also involved in 
signalling cellular differentiation, cell cycle, cell growth and cell death (Antico Arciuch et 
al., 2012). The light membrane had a mean protein expression of 0.62 ± 0.13 (Table 4.3) 
and are comprised of the gradient centrifugation of the cell membrane (Bermejo et al., 
2014). Paired T test was not statistically significant for embryo compared with whole adult, 
mitochondria and light membrane fractions with a P value of 0.22, 0.096 and 0.11 
respectively. Paired T test showed very statistically significant for differences between 
whole adult brain extract and the synaptosome fraction with a P value of 0.0022 as well as 
between embryo extract and synaptosome fraction with a P value of 0.0019. Therefore this 
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might suggest that Alix expression is stronger in the synaptosomal fractions and would be 
consistent with its association with the PSD. We have to also consider that there is a lower 
level of expression from both the embryo and whole adult brain extract, which makes a true 
comparison with all the other fractions difficult even though we loaded the similar levels of 
protein as seen from the actin control (Figure 4.3).  
We also examined GluN1 expression in whole adult and embryo brain as well as 
Synaptosome, Light Membrane, Myelin and Mitochondria fractions. Unfortunately, like the 
Alix blot the Myelin fraction in the GluN1 blot was also too smeary for identifying a 
distinct protein signal. Full length expression of GluN1 (108kDa) was detected using a 
mouse anti-NMDAR1 antibody (Figure 4.4). 
  The whole embryo brain extract had a mean relative protein expression of 0.53 ± 
0.46 (Table 4.4). The expression of GluN1 in whole embryo brain extract seemed 
comparatively quite low. Whereas the whole adult brain extract had a comparatively higher 
mean relative protein expression of 0.71 ± 0.62 (Table 4.4). Synaptosome fractions showed 
a mean relative protein expression of 1.38 ± 0.22 (Table 4.4). The mitochondria fraction 
showed the highest expression with a mean protein expression of 1.97 ± 0.28 (Table 4.4). 
The light membrane had a mean protein expression of 0.40 ± 0.15 (Table 4.4) and is the 
isolation of gradient centrifugation of the cell membrane (Figure 4.4). Paired T test was not 
statistically significant for embryo compared with whole adult, synaptosome and light 
membrane fractions with a P value of 0.22, 0.12 and 0.72 respectively, however, paired T 
test was statistically significant for differences between embryo extract and mitochondria 
fraction with a P value of 0.018. Conversely, paired T test was not statistically significant 
for whole adult compared with all other protein extracts including embryo, synaptosome, 
mitochondria and light membrane fractions with a P value of 0.22, 0.29, 0.07 and 0.58 
respectively. These results suggest that GluN1 might be expressed at a higher level within 
 200 
the mitochondria fraction compared to other fractions/brain extracts. Again, with the low 
level of expression seen from both the embryo and whole adult brain extract a true 
comparison with all the other fractions is difficult even though we loaded the similar levels 
of protein as seen from the actin control (Figure 4.4). 
It is interesting that we see a very statistically significant difference when we 
compared Alix protein expression in whole adult brain as well as embryo brain against 
synaptosome fractions. Wang et al., 2011 theorised the possibility that synapsin is released 
from cells via exosomes and that the interior of exosomes contains cytoplasmic proteins, 
such as synapsin. They did a serial centrifugation from the cell culture supernatant of 
cultures enriched in cortical astrocytes to isolate a significant amount of exosomes that 
contain synapsin and the exosomal marker protein Alix. Therefore our findings that Alix 
expression is higher in synaptosomes compared to other cell preparations and is consistent 
with other reports that Alix is present in the PSD. 
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7.3 Discussion of Alix localization in cotransfected HEK293 cells, primary cortical and 
hippocampal cultures 
Our immunoblotting revealed strong Alix expression in GFP-Alix transfected 
HEK293 cells and in rat brain fractions and we then investigated the cellular localisation of 
Alix in HEK293 cells and primary neuronal cultures. The presence of Alix was evaluated 
by transfecting HEK293 cultures with Alix and GluN1/ GluN2A subunit in different 
combination following Table 3.1 a, b and then stained with specific antibodies. Previous 
work has shown that Alix is mainly localised in the cytoplasm and cytosol and cytoskeleton 
(Pan et al., 2008; Vito et al., 1999). Fluorescence images of Alix in HEK293 cells revealed 
overall heterogeneous fluorescence within the cytoplasm of the cells with a few green 
circular structures but little expression in the nuclei (Figure 5.1 and 5.3). Visually there 
does not seem to be any overlap between Alix and nuclear Hoechst staining and this was 
confirmed by an uncorrelated scatter plot with Alix and Hoechst pixels more clustered 
towards the axes and further proven by a low Pearson’s correlation value below 0.100 with 
a minimum n of 3.This cellular localisation is consistent with the cytoplasmic localization 
of transfected Alix in L66 fibroblasts observed in previous work (Vito et al. 1999). 
 Considering Alix is known to interact with ESCRT (endosomal sorting complex 
required for transport) (Trioulier et al., 2004; Ohkouchi et al., 2004) and the green 
structures that we observed in the previous Alix staining (figure 5.1 and 5.3) we wanted to 
observe if there was any correlation between Alix and the endosome marker EEA1 (Figure 
5.5 and 5.7). Staining with EEA1 revealed an expected punctuate staining pattern consistent 
with cytoplasmic distribution of endosomes. The colour scatter plot and mean Pearson’s 
correlation (0.252) suggested that the correlation between EEA1 and Alix staining is weak. 
 We also examined Alix colocalisation with the cytoskeleton using phalloidin 
staining (Schmit and Lambert 1990) (Figure 5.9 and 5.11). Again the colour scatter plot of 
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Alix and Phalloidin in HEK293 cells revealed a variable correlation plot and a mean 
Pearson’s Correlation value of 0.251 (n = 3) which suggests that the correlation is weak. 
However there is evidence that siRNA knockdown of Alix expression can cause 
redistribution of the actin cytoskeleton (Cabezas et al., 2005) in HeLa cells and 
coimmunopreciptation studies in HEK293 cells have shown Flag tagged Alix protein 
interaction with structural elements of the cytoskeleton (Schmidt et al. 2003) in HEK293 
cells. It is possible that the GFP tagged to the N-terminus of Alix protein (Zhan et al. 2008) 
used in this study may have affected or weakened the cytoskeletal interactions of Alix 
within the cell. Although this may suggest that the GFP tagged Alix used in this study 
could lead to spurious results, it should be noted that the Flag tagged mouse Alix construct 
used in the NMDAR cell death assay produced identical results with the GFP tagged 
human Alix construct (Figure 3.6 a and b, 3.7 a and b, 3.8 a and b and 3.9 a and b). 
 Once we determined the localisation and correlation of Alix expressed alone in the 
HEK293 cells, with EEA1 and with Phalloidin, we wanted to establish if there was any 
correlation between Alix and NMDAR expression following the same conditions as the 
NMDAR cell death assay we have established in Chapter 3.2.1. This allowed us to 
determine the intracellular distribution of Alix is when it is transfected with NMDARs and 
to examine if there is any change in expression or localisation when NMDARs are activated 
or not activated. 
 Our results suggested that there was a partial overlap between Alix and GluN1 
expression in activated (Figure 5.13 and 5.15) and non activated HEK293 cells (Figure 5.17 
and 5.19). In both cases the colour scatter plots and the mean Pearson’s correlation 
suggested a moderate correlation (0.5, n=20 and 0.44, n=20). A paired t-test showed no 
statistically significant difference between the activated and non activated correlation plots 
with a P value of 0.499. Therefore the effects of NMDAR activation have little effect on the 
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colocalisation pattern of both Alix and GluN1 within the cell. One reason for the moderate 
correlation observed between Alix and GluN1 expression could be due to the fact that Alix 
and GluN1 cDNAs are both transfected into HEK293 cells and expressed under CMV 
promoters optimized for a higher cell expression than basal expression levels. 
 All models of experiments have limitations that must be considered and with 
mammalian cell lines we have the ability to examine cells in a more controlled enviroment, 
ease of experimental replication and shortened time scale. However primary cultures are 
more complex, genetically stable and are the actual cells partaking in endogenous neuronal 
processes which makes it more likely to replicate the neuronal environment. As it is not 
possible to observe endogenous expression of Alix in HEK293 cells, we decided to 
ascertain the correlation and expression of endogenous Alix in cultured neurons from the 
hippocampus and cortex. This will allow us to establish the localisation of endogenous 
Alix, where it is distributed and if there is any change in its expression in these neurons 
from different brain regions. The hippocampus is known to play an important role in short 
and long term memory and spatial navigation (King et al., 2004) and in the cortex which is 
known to play a key role in memory and cognitive processing (Rubenstein, 2011).  
 However there are limitations with in vitro dissociated neuronal cultures in terms of 
their ability to form appropriate synaptic structures and circuitary. Furthermore the normal 
brain tissue structure is absent in these primary cultures and this may have significant 
effects on the functions of these cells. More appropriate ex vivo systems could involve 
organotypic slice culture systems, however these systems are much harder to maintain and 
visualize protein expression using immunocytochemistry (Cho et al., 2007). 
The main cell types in the CNS are neurons and glial cells, which can be identified by a 
variety of morphological and functional characteristics. We know that neurons have two 
processes with axon and dendrites and glial are star shaped cells with only one (Kriegstein, 
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1983). We did not inhibit the growth of glia in our cultures and it is possible that our 
immunocytochemistry contained a mixed population of neurons and glia. Alix is also 
expressed in exosomes released by glia (Chen et al., 2000; Guescini et al. 2010) and this is 
one of the reasons we used synaptophysin as a marker as we know that astrocytes do not 
express synaptic proteins (Sofroniew and Vinters 2010). Alternatively we could have 
detected and Alix immunofluorescence within astrocytes and their relative expression 
compared to neurons within our cultures by staining for specific glial protein markers such 
as GFAP. 
 Another important point to consider is whether the time point of synaptic marker 
visualisation in our cultured primary neurons truly represents the formation of excitatory 
synapses and the formation of a mature PSD. All neurons were examined after 14 days in 
vitro and studies suggest that at this time point synapses are beginning to mature and 
increase in number until 21 days (Graburcker et al. 2009). Furthermore, this study provided 
evidence supporting the ultrastructural maturity of synapses, localised expression of pre and 
postsynaptic proteins after 14 days in vitro and showed that the thickness of the PSD 
measured using electron microscopy remained unchanged after 14 days in vitro and 
suggests that these synapses are structurally mature at this point in culture. The endogenous 
levels of Alix in the cortical and hippocampal cultures (Figure 6.1 and 6.3) revealed a 
punctate fluorescence within the cell cytoplasm. As seen with the HEK293 cells, we found 
little colocalisation with Hoechst in the colocalisation scatter plot and a mean Pearson’s 
correlation coefficient (-0.133, n=3) for the cortical neurons and (-0.004, n=3) for the 
hippocampal neurons.  
Considering the weak correlation of Alix and EEA1 in the HEK293 cells we wanted 
to observe if there was any correlation between the basal level of Alix and the endosome 
marker EEA1 in the cortical and hippocampal cultures (Figure 6.5 and 6.7). Staining with 
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EEA1 revealed an expected punctuate staining pattern consistent with cytoplasmic 
distribution of endosomes. We found a moderate correlation of Alix and EEA1 in the 
cortex, with a Pearson’s Correlation value of 0.406 (n = 3). However, we found a weak 
correlation of Alix and EEA1 in the hippocampal cultures with a mean Pearson’s 
Correlation value of 0.307 (n = 3) However paired t-test shows that the difference between 
cortical and hippocampal neurons is considered to be not statistically significant with a P 
value of 0.676. 
Given that we found Alix weakly correlated with Phalloidin in HEK293 cells, we 
wanted to observe endogenous Alix localization with Phalloidin in the cortical and 
hippocampal cultures (Figure 6.9 and 6.11). In both cases, we found that there was a 
moderate correlation in the cortical cultures and the hippocampal cultures with a mean 
Pearson’s Correlation value of 0.538 (n = 3) and 0.415 (n = 3) respectively. This supports 
previous reports that Alix may associate with cytoskeletal proteins in HEK293 cells and 
cortical astrocytes (Schmidt et al. 2003; Cabezas et al. 2005). However, these studies have 
used indirect methods to base their conclusions (siRNA and immunoprecipation of 
cytoskeletal associated proteins) and evidence is still lacking for a direct association of Alix 
with microtubules or the cytoskeleton. It is possible that rather than forming a direct 
interaction, Alix may use similar transport or structural machinery and thus be able to 
influence cytoskeletal regulation. 
Since we previously observed that Alix displayed a moderate correlation with 
NMDAR in HEK293 cells, it was important to examine endogenous Alix localization with 
NMDAR in the cortical and hippocampal cultures. The Colour scatter plot of Alix and 
GluN2A/2B showed that this colocalisation was strong in cortical cultures (Figure 6.13) 
with mean Pearson’s Correlation value of 0.761 (n = 3). However, this correlation was 
much weaker in hippocampal neurons with a mean Pearson’s Correlation value of 0.275 (n 
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= 3) (Figure 6.15). However, paired t-test shows that the difference between cortical and 
hippocampal neurons is considered to be not statistically significant with a P value of 
0.183. Therefore, the difference in Alix and GluN2A/B correlation between the two cell 
types is not statistically different.  
Next we wanted to observe if Alix might correlate with PSD95 in the cortical and 
hippocampal cultures as we know that PSD95 is a well-characterized intracellular protein 
known to associate with NMDARs (Sheng, 2001). We found a moderate correlation rate 
between Alix and PSD95 in the cortical cultures with a mean Pearson’s Correlation value 
of 0.496 (n = 3)(Figure 6.17). However, there was a weaker correlation in hippocampal 
neurons with a mean Pearson’s Correlation value of 0.264 (n = 3) (Figure 6.19). The paired 
t-test shows that the difference between cortical and hippocampal neurons is considered 
statistically significant with a P value of 0.018. This suggests a stronger colocalisation of 
PSD95 with Alix in cortical neurons compared to hippocampal neurons.  
As Alix displays a correlation with PSD95 expression we wanted to examine if Alix 
might correlate with another synaptic protein, synaptophysin in the cortical and 
hippocampal cultures (Figure 6.21 and 6.23). Synaptophysin is a binding partner for the 
SNARE protein, synaptobrevin and is often used as marker for synaptic localization 
(Reisinger et al., 2004). However, we did not see any overlap between Alix and 
synaptophysin in both the cortical and hippocampal cultures. There was a weak correlation 
rate with a mean Pearson’s Correlation value of 0.31 (n = 3) in the cortical cultures and 
0.238 (n = 3) in the hippocampal cultures. Considering that synaptophysin is mainly 
localized to presynaptic compartments of the synapse this observation would support the 
evidence of Alix association with the PSD (Bayes et al. 2011; Chassefeyre et al. 2015). 
Alix correlation seems to follow the same pattern of displaying strong correlation 
with the expression of PSD95 in the cortical cultures but not in the hippocampal cultures. It 
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is unclear why this is the case and may suggest a neuronal specific localization of Alix that 
distinguishes between these cell types. There is little information in the literature reporting 
differences between cortical and hippocampal localization of specific proteins. But it has 
been reported that these cell types can produce differential changes in mGluR5 expression 
following exposure to certain pharmacological treatments (Yu et al 2001). Another factor 
that may contribute to this observation could be based on the variety of cell types within the 
cortices or hippocampi used in both cultures and the ratio of neurons to glia within both 
types of cultures and how this could influence the correlation analysis of PSD95 with Alix. 
 It is also possible that the correlation could be influenced by microvesicles released 
into the intercellular space as observed by Guescini et al., 2010 where glioblastoma and 
astrocytes released microvesicles with some protein markers of exosomes such as CD9 and 
Alix that are transferred between cells. However, as mentioned earlier this would be 
dependent on the level of Alix expression in astrocytes and the ratio of neurons to glia 
within our primary cultures. 
  Another possible explanation for the differences in colocalisation between cell 
types could be caused by the visualization of synaptic protein markers by detecting puncta 
following immunocytochemistry and measurement of colocalisation using Pearson’s 
coefficient. The limitations of this method of protein detection include spatial resolution to 
subcellular compartments, sensitivity for low protein expression, appropriate comparison of 
pixel intensity distributions and the level of noise generated by background fluorescence 
(Bolte and Cordelieres, 2006). Although, there is a popular assumption that most proteins 
required for neuronal function are made in the cell body Sutton, 2006 found that dendritic 
protein synthesis is essential in the neurons. This highlights the limitation of colocalization 
analysis using synaptic markers in cell culture rather than visualizing the whole synaptic 
structure from sections of whole brain using electron microscopy.  
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However, there is strong evidence that Alix is highly expressed in neurons 
following neuronal insults. Hemming et al., 2004 found that Alix expression was increased 
in neuronal cell bodies very rapidly after kainate induced neurodegeneration and this 
occurred before/during neuronal eosinophilia and cell oedema. This increased Alix 
expression persisted 24 hours after kainate injection in the piriform cortex and it has been 
postulated that Alix may play an early role in the cell death mechanism. To support this, 
Blum et al., 2004 also found that Alix upregulation in the cerebellar granule cells may be 
instrumental in inducing cell death. It is not completely clear whether Alix is a trigger or an 
early marker for neurodegenerative processes and the role it plays within the ESCRT-III 
complex. Evidence suggests that Alix is important for endosomal trafficking and triggering 
caspase dependent and independent pathways (Trioulier et al. 2004), but loss of Alix has 
been shown to disrupt normal cytoskeletal organization within the cell (Cebezas et al. 2005) 
and thus may play an important role in supporting the structure of the PSD within dendritic 
spines (Chassefeyre et al. 2015). It is intriguingly to note that C-terminal truncations in one 
of the core components of the ESCRT-III complex, Chmp2b have been linked to familial 
frontotemporal dementia (Isaacs et al., 2011) but how this leads to neurodegeneration 
requires further investigation. 
 
7.4 General summary 
 The investigations described in this thesis can be split into two parts; the effects of 
Alix on NMDAR triggered cell death and the protein expression and localisation of Alix in 
primary neurons. In the first part we have examined the influence of Alix from different 
species (human and mouse) on NMDAR triggered cell death during NMDA treatment and 
in the absence of NMDA treatment. The most interesting finding is the fact that Alix 
coexpression increased the proportion of cell death in the absence of NMDA treatment 
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compared to cells expressing only NMDARs. Further investigation of this observation has 
shown that this requires the formation of a complete NMDA receptor and requires 
NMDAR activation (no enhanced cell death seen with control experiments with Alix alone 
or incubation with the NMDAR antagonist, AP5) and can be partly explained by Alix 
increasing the glutamate/glycine sensitivity of NMDAR expressing cells in triggering cell 
death. We observed similar effects with the mouse variant of Alix and using deletion 
mutants and have identified the C-terminal of Alix as important for this process. The 
increased cell death in the presence of Alix does not affect GluN1 or Alix protein 
expression or cellular localisation in HEK293 cells. 
 For the second part of this study, our results have described the protein expression 
in synaptosomes and the cellular localisation of Alix in hippocampal and cortical primary 
neurons. Alix was detected in synaptosome preparations supporting the previous reports of 
Alix expression within the PSD. Furthemore, there is little information on the cellular 
localisation of Alix within neurons and we performed immunocytochemistry to examine 
Alix localisation in primary neuron cultures prepared from rodent hippocampus and cortex. 
Although there are limitations with the analysis we have used, our initial observations of 
the immunofluorescent images suggest that Alix exhibits a punctate expression throughout 
the cytoplasm of both types of neurons and may show colocalisation with the endosomal 
marker, EEA1, the cytoskeletal proteins and the well characterised postsynaptic density 
protein, PSD95. 
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7.5 Future studies 
 To give us an idea of how Alix may affect NMDAR triggered cell death and the 
NMDA receptor pathway, we could perform a protein complex immunoprecipitation (Co-
IP) of Alix to analyse protein to protein interactions with NMDAR subunits or associated 
intracellular proteins such as PSD95. One of the limitations of our NMDAR cell death 
assay is whether this is replicated in neuronal environment and we could also repeat our 
NMDA cell death assay in the cortical and hippocampal cultures to assess if Alix would 
still cause a higher percentage of cell death when activated. Another avenue would be to 
manipulate expression levels of Alix with RNAi on primary neuronal cultures by knocking 
down Alix expression and determining the effect on glutamate receptor function in culture. 
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